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Abstract 
 
 
The diversity of antigen receptors and the specificity it underlies are the hallmarks 
of the cellular arm of the adaptive immune system. T and B lymphocytes are indeed 
truly unique in their ability to generate receptors capable of recognising virtually any 
pathogen. It has been known for several decades that T lymphocytes recognise short 
peptides derived from degraded proteins that are presented by major histocompatibility 
complex (MHC) molecules. Nonetheless, the molecular basis of this interaction is still a 
matter of debate, the central issue being the roles played by the complementarity-
determining regions (CDR) in this context. 
 
In this study we have generated a transgenic mouse line lacking all three TCR-β 
chain CDR loops and a second line lacking the hypervariable CDR3 loop only. This 
project is the first attempt to characterise such transgenic mice, which were found to 
develop normally and to generate functional T lymphocytes. We demonstrate that in this 
murine TCR-β transgenic system, CDR-modified thymocytes can be selected on MHC 
and develop into functional peripheral T cells. We show for the first time that T cells 
lacking all three TCR-β chain CDR loops respond to protein antigen in an MHC-
restricted manner. This will provide insight into the structural basis of the TCR-MHC-
peptide interaction and increase our current knowledge of the requirements for the 
selection and functionality of MHC-restricted T cells. 
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Chapter 1: Introduction 
 
 
1.1. The adaptive immune system 
 
The immune system is a collection of cells and molecules dedicated to the 
eradication of potentially harmful pathogens. All multicellular organisms rely on several 
lines of defense to protect themselves from infectious agents. For invertebrates, several 
of these immune strategies are innate, employing chemical and physical barriers to 
prevent pathogen entry (Medzhitov and Janeway, 2000). In addition to innate 
mechanisms, jawed vertebrates have evolved adaptive immunity as a more sophisticated 
system able to deal specifically with highly complex and mutable pathogens (Pancer 
and Cooper, 2006). Innate immunity is characterised by the detection of molecular 
patterns associated with broad classes of foreign organisms (Janeway, 1992). By 
contrast, recognition of specific foreign agents by the adaptive immune system is 
acquired during the development of specialised cell subsets – T and B lymphocytes – 
generated in primary lymphoid tissues. Specific molecular components capable of 
triggering a T cell or a B cell response are called antigen. Antigen-driven activation of T 
and B cells initiates cell-mediated and humoral immune responses that are specific for 
that antigen. 
 
1.1.1. Lymphocytes 
 
After birth, all blood cells arise from a self-renewing pluripotent haematopoietic 
stem cell (HSC) in the bone marrow. Lymphocytes are derived from the common 
lymphoid progenitor (CLP), giving rise to T cells, B cells and natural killer (NK) cells 
(Hardy and Hayakawa, 2001; Chi et al., 2009; Ichii et al., 2010). T and B lymphocytes 
are the only cells of the immune system capable of recognising specific antigen. The 
ability to respond to an immense array of pathogens rests on the unique capacity of 
lymphocytes to rearrange genomic DNA in order to produce a diverse repertoire of 
antigen receptors (Tonegawa, 1983). In addition, T and B cells are classically 
recognised as the only cells with immunological memory, being able to respond more 
vigorously to secondary challenge with a previously encountered antigen. Thus, T and 
B lymphocytes are the two pillars of the adaptive system and their variegated receptors 
are the fundamental element underlying all specific antigen recognition events. 
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B cells recognise conformational epitopes on native antigen through the B cell 
receptor (BCR) and differentiate into antibody-secreting cells (Batista and Harwood, 
2009; Harwood and Batista, 2010). Affinity-matured antibodies display remarkable 
specificity and can distinguish very subtle differences between related antigens and 
even between stereoisomers (Hoffstetter et al., 2005). The T cell arm of the adaptive 
immune system, by contrast, is triggered by the recognition of short peptides derived 
from foreign proteins, which are presented in the context of major histocompatibility 
complex (MHC) molecules (Zinkernagel and Doherty, 1974). Ligation of the T cell 
receptor (TCR) to peptide-MHC (pMHC) complexes contributes to the recruitment of 
cell surface molecules required for T cell activation. TCR engagement thus provides the 
cell with the earliest signals required for many aspects of activation including 
proliferation, differentiation, cytoskeletal rearrangement and secretion of effector 
molecules and cytokines (reviewed by Smith-Garvin, Koretzky and Jordan, 2008).  
The importance of lymphocytic populations is apparent in a number of congenital 
and acquired diseases. Severe combined immune deficiency (SCID) is a primary 
immunodeficiency, either X-linked or autosomal recessive, which can be the result of 
one of at least ten known genetic defects leading to T cell deficiency. Infants with SCID 
are affected by chronic infection with persistent pathogens and opportunistic organisms, 
usually leading to death before their first or second birthday (Buckley, 2004). Di George 
syndrome is a complex congenital disease associated with thymic hypoplasia. Patients 
with complete Di George show profound T cell deficiency and, consequently lack of T 
cellular immunity and antibody-mediated responses (Greenberg, 1993).  
Immunopathology associated with CD4
+
 T cell depletion in the context of human 
immunodeficiency virus 1 (HIV-1) infection is another illustration of the vital role 
played by lymphocytes in containing life-threatening pathogens and long-term 
persistence of such organisms. T cells are also known to provide anti-tumour protection, 
as they are capable of eliciting responses of varying magnitude against tumour-
associated antigens, expressed on transformed but not normal cells (Trinchieri, Aden 
and Knowles, 1976). 
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1.1.2. Antigen-presenting cells 
 
The clonal selection theory presented by Franck M Burnet in 1957 posits that, 
although lymphocytes develop and express their receptors prior to immune challenge, 
only those cells specific for a given antigen can be primed to mount a specific immune 
response against that antigenic determinant (Burnet, 1957). However, the frequency of 
naïve lymphocytes capable of recognising a given antigen is very low. Thus, in order to 
fight an infection, lymphocytes must be organised in appropriate anatomical sites. 
Secondary lymphoid organs provide a specialised cellular and molecular framework 
which allows naive cells to be mobilised against foreign antigen (Fu and Chaplin, 
1999). Early studies conducted in the rat by Gowans showed that lymphocytes 
constantly recirculate between the blood and secondary lymphoid structures, including 
the spleen, lymph nodes, mucosal sites and Peyer’s patches in the gut (Gowans, 1959).  
It is now established that antigen-specific cells are selected and primed by interaction 
with dedicated cell types acting as antigen-presenting cells (APC) while in transit within 
the secondary lymphoid organs (Steinman, Pack and Inaba, 1997).  
Dendritic cells are the archetypal APC. Typically, follicular dendritic cells act as a 
reservoir for immune complexes that prime B cells, while bone-marrow derived 
dendritic cells specialise in priming the T cell compartment (Weih and Caamano, 2003). 
These cells, like other phagocytic cell types, reside at the periphery and continuously 
sample the main portals of antigen entry such as the skin, mucosa and parenchymal 
organs. Tissue-resident immature dendritic cells are highly phagocytic and are best-
suited for trapping foreign antigen (Romani et al., 1989). Antigen capture is mediated 
by several types of mechanisms, including micropinocytosis, Fragment constant (Fc) 
receptor-mediated endocytosis and phagocytosis (reviewed by Guermonprez et al., 
2002; and by Lanzavecchia, 1990). In response to inflammatory signals such as 
chemokines and cytokines, dendritic cells rapidly migrate rapidly to the site of antigenic 
deposition (Banchereau et al., 2000). Antigen uptake then triggers a sophisticated 
differentiation programme which starts with antigen processing and ends in the 
secondary lymphoid organs with the dendritic cell – T cell interaction. 
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Dendritic cells can only activate T cells once they themselves have been activated. 
This generally occurs through recognition of broad classes of molecular structures 
associated with distinct pathogens, called pathogen-associated molecular patterns 
(PAMP) (Janeway, 1992). PAMP like lipopolysaccharide (LPS), bacterial DNA, or 
viral double-stranded RNA contribute to dendritic cell maturation and induce the 
expression of co-stimulatory molecules that are required for full T cell activation 
(Janeway and Medzhitov, 2002). In addition, such signals also alter the antigen 
processing machinery in the dendritic cell to optimise peptide processing and favour 
continuous presentation of immunogenic peptides (Théry and Amigorena, 2001). 
Thus, mature dendritic cells are uniquely equipped as APC to prime antigen-
specific precursors and initiate T cell-mediated immune responses. Nevertheless, other 
potent phagocytic cells can as APC in secondary lymphoid organs; these include 
macrophages and B cells. Macrophages are characterised by exceptional phagocytic 
capacity. It has been estimated that a macrophage could engulf twice its surface area 
within an hour (Trombetta and Mellman, 2005). B cells by contrast are much less 
efficient at engulfing antigen, except through their membrane-bound antigen receptor 
(Chesnut and Grey, 1981). Antigen presentation can also be enhanced by antibodies 
secreted by B cells. Indeed, exogenous antigen trapped by circulating antibodies can 
also be internalised by macrophages and dendritic cells following Fc receptor binding to 
the constant region (Celis, Zurawski and Chang, 1984). Therefore, although antigen 
presentation is the primary function of dendritic cells, macrophages and B cells are also 
armed with unique features that qualify them as highly efficient APC. 
 
 
1.2.  T cell development 
 
1.2.1. T cell lineage commitment 
 
T cell precursors seed the thymus from foetal liver and adult bone marrow and 
enter a complex developmental programme involving the gradual loss of non-lymphoid 
potential and induction of T cell fate commitment. In addition, this is accompanied by a 
highly regulated selection process which ensures restriction to self MHC molecules 
while limiting reactivity to self peptides. T cells arise from the CLP population 
migrating from the bone marrow to the thymus (Chi et al., 2009). 
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Early thymic precursors (ETP) are best described as cells expressing the 
chemokine receptor CCR9, as well as the progenitor cell markers Sca-1, Kit and Flt-3 
(Rothernberg, Moore and Yui, 2008). Thymic colonisation is regulated by chemotactic 
factors including chemokines and their receptors such as CCL2, CCL22 and CXCL12, 
as well as adhesion molecules (Anderson et al., 2006). Maturation of T cells from such 
precursors involves a number of key stages including rearrangement of TCR gene 
segments, extensive proliferation and highly regulated selection checkpoints.  
The T cell pool is functionally and phenotypically heterogeneous and consists of 
several T cell sub-populations. T cells are broadly classified as αβ or γδ according to the 
somatically rearranged antigen receptor they express at their surface. γδ T cells 
represent 1 to 5% of circulating lymphocytes but about half the lymphocytic population 
in epithelia (Carding and Egan, 2002). These cells have a clear role in pathogen 
clearance and tumour surveillance (Pennington, Silva-Santos and Hayday, 2005). αβ T 
cells are by far the most abundant T cells and also certainly the best characterised. 
Moreover, the αβ pool itself also consists of rarer T lymphocytes such as CD8αα-
expressing cells that accumulate in the gastrointestinal tract known as intraepithelial 
lymphocytes (IEL). Other atypical lymphocytes in mucosal sites include mucosa-
associated invariant T (MAIT) cells which display limited diversity and are involved in 
antibacterial immunity (Treiner et al., 2003; Le Bourhis et al., 2010). Invariant NK T 
(iNKT) cells have also been described. These are cells with restricted diversity which, 
unlike all other lymphocytes, are dedicated to recognition of glycolipids in the context 
of the class I MHC related CD1 family of molecules (Beckman et al., 1994). 
Nevertheless, despite the functional and phenotypic differences between subsets, 
all T cells arise from the same precursors and share their early differentiation history. 
Many key genes involved in late T cell maturation and function are expressed early in 
development, even before expression of rearranged TCR chains. Initiation of gene 
rearrangement marks the full acquisition of T cell identity where nearly all T cell-
specific components are expressed. These include genes involved in rearrangement, but 
also in TCR assembly and T cell signalling (Rothenberg, Moore and Yui, 2008). Up to 
this stage, alternate lineage decisions, including myeloid potential, are still possible and 
are irrevocably lost only at initiation of gene rearrangement (Thompson and Zuniga-
Pflucker, 2011). 
 
 
 
 
25 
 
1.2.2. Thymocyte development 
 
Committed thymocytes enter the thymus as CD4 and CD8 co-receptor double 
negative (DN) cells whose TCR-encoding gene segments (tr) are in the germline 
configuration (Lind et al., 2001). The DN population is further divided into four 
different sub-populations (DN1 to DN4), which are distinguishable phenotypically by 
differential expression of the surface markers CD44 and CD25 (Godfrey et al., 1993, 
Ceredig and Rolink, 2002). Diversity in the TCR repertoire is produced through gene 
rearrangement at the tr loci, which is initiated at the DN1 to DN2 transition. The events 
that further shape this repertoire take place at the double positive (DP) stage where 
thymocytes express both co-receptors and assemble a TCRαβ heterodimer. 
Subsequently, mature single positive (SP) thymocytes expressing only one of the two 
co-receptors will differentiate from the DP pool (Figure 1.1). 
 During the development of αβ T cells, the β chain rearranges first (Capone, 
Hockett and Zlotnik, 1998). For these thymocytes, TCR-β expression is required to 
progress beyond the DN stage (Mallick et al.; 1993) and this is independent of TCR-α 
(Mombaerts et al., 1993). Indeed, this is exemplified by the fact that thymocytes from 
rag
-/- 
mice arrest at the DN stage, while those from TCR-α-deficient mice are blocked at 
the DP stage (Shinkai et al., 1992; Mallick et al., 1993; Shinkai et al., 1993). Successful 
rearrangement of a TCR-β chain in DN3 cells is followed by expression of a pre-TCR 
composed of the rearranged β chain and the monomorphic pre-TCR-α chain, or pTα 
(Godfrey et al., 1994; von Boehmer and Fehling, 1997). The DN3 population is 
therefore heterogeneous, being composed of immature cells that have not yet rearranged 
and expressed a TCR-β chain and of pre-TCR-expressing cells (Taghon et al., 2006).  
Expression of the pre-TCR is necessary and sufficient to abrogate further TCR-β 
chain rearrangement by allelic exclusion (Borgulya et al., 1992; Malissen et al., 1992) 
and to initiate TCR-α rearrangement (Koyasu et al., 1997). In pTα-deficient mice, 
immature DP thymocytes are under-represented, indicating that pre-TCR signalling also 
drives the transition to the DP stage (Fehling et al., 1995). Thymocytes which rearrange 
TCR-γ and TCR-δ and express TCRγδ at their surface will not progress to the DP stage 
but differentiate into γδ T cells (Gerber, Boucontet and Pereira, 2004). Thus, in order to 
differentiate further from DN precursors, thymocytes must express either TCRγδ or the 
pre-TCR (Wilson et al., 1996). Indeed, pre-TCR and TCRγδ provide signals that dictate 
αβ or γδ fate respectively, most likely in a ligand independent manner (Mahtani-
Patching et al., 2011).  
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The DP population is the most abundant in the thymus and represents about 80% 
of the thymocyte population, although these cells are short-lived and renewed at a rate 
as high as 5 × 10
7
 cells a day. About half this population expresses TCRαβ at low 
density; these cells are then tested for MHC reactivity, a process referred to as thymic 
selection. Selection purges the TCR repertoire by discarding cells that are useless or 
even detrimental to the host. An estimated 97 to 99% of these thymocytes will die as a 
result of thymic selection (Huesmann et al., 1991; Goldrath and Bevan, 1999). 
 
 
 
 
 
 
Figure 1.1. Schematic view of T cell development, adapted from Ceredig and Rolink 
(2002). T cell precursors arise in the bone marrow and seed the thymus as ETP which 
lack co-receptor expression. T cell identity is acquired at the DN2 stage when tr 
rearrangement is initiated. The TCR-β chain is expressed in DN3 cells, where β 
selection takes place. DP cells express both co-receptors together with the TCRαβ 
heterodimer and undergo thymic selection on self pMHC complexes to differentiate into 
CD4
+
 or CD8
+
 SP cells. 
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1.2.3. Thymic selection 
 
The thymic stroma is a complex collection of cells including epithelial and 
endothelial cells, fibroblasts, dendritic cells and macrophages, working to promote the 
maturation of T cell precursors into functionally competent T cells (Anderson et al., 
1994; Anderson and Jenkinson, 2001; Anderson, Lane and Jenkinson, 2007). In 
addition, key factors such as interleukin-7 (IL-7) and Notch ligands play an important 
role in this process. Notch signalling is crucial for T cell fate determination in thymic 
precursors at the DN1 stage, and later, for intrathymic homing and survival (Pui et al., 
1999; Wilson, MacDonald and Radtke, 2001). Among thymic stromal cells, distinct 
populations specialise in the ability to promote selection of developing thymocytes 
(Anderson, Partington and Jenkinson, 1998, Anderson and Jenkinson, 2000).  
The thymic cortex constitutes an important microenvironment for the transition to 
the DP stage and for positive selection of T cells expressing TCR which recognise self 
pMHC complexes (Anderson et al., 1994; Hogquist et al., 1994a; Hu et al., 1997). 
Negative selection in the medulla deletes thymocytes bearing a TCR with high affinity 
for the selecting pMHC ligand, thereby preventing development of autoreactive and 
potentially harmful T cells (Rammensee, Fink and Bevan, 1984). TCR with too little 
affinity for pMHC complexes fail to transduce signals required for survival and T cells 
with such TCR die by neglect. Therefore, the process of selection ensures that only 
those TCR within a narrow affinity range will be rescued from deletion in the thymus 
(Ashton Rickardt et al., 1994; Munir Alam et al., 1996). 
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Figure 1.2. Thymic selection. In the cortex, DP thymocytes first audition for selection 
by pMHC ligands present on thymic cortical epithelial cells (cTEC). Thymocytes with 
low affinity TCR will fail to receive signals that promote cell survival and will die by 
neglect. Those cells bearing TCR with sufficient affinity will migrate to the medulla 
where bone-marrow derived dendritic cells (DC) will delete thymocytes with high 
affinity for the selecting ligand. 
 
 
 
 
1.2.4. Commitment to the CD4+ and the CD8+ T cell fate 
 
Commitment to the CD4
+
 or CD8
+
 T cell fate is established in parallel to positive 
selection where SP thymocytes differentiate from DP cells. The remarkable feature of 
this process is that the resulting CD4
+
 and CD8
+
 SP cells show near perfect restriction 
to class II or class I MHC molecules respectively (Swain, 1983; Teh et al., 1988; 
Marusic-Galesic et al., 1989). Several models have been proposed to explain CD4
+
 and 
CD8
+
 T cell lineage decision (reviewed by Germain, 2002 and by Kappes, He and He, 
2005). The stochastic model suggests that T cells can express a co-receptor that does not 
match their MHC-restricting element, but these cells are selectively purged from the T 
cell pool because they fail to mediate effective signalling (Robey, Fowlkes and Pardoll, 
1990). This view was quickly challenged by studies in which constitutive co-receptor 
expression failed to rescue the co-receptor mismatched T cells (Borgulya et al., 1991).  
 
29 
 
The TCR-instructive model proposes that TCR specificity controls entry to the 
CD4
+
 or CD8
+
 T cell lineage (reviewed by Germain, 2002). It was originally proposed 
that commitment to CD4
+
 or CD8
+
 T cell fate would then depend on qualitatively 
different signals that direct lineage choice (Itano et al., 1996). The model was later 
modified to suggest that commitment is in fact dependent on the strength of signal 
received from the TCR, whereby strong signals generate CD4
+
 SP cells and weaker 
signals generate CD8
+
 SP cells (Matechak et al., 1996). Another recent view of lineage 
commitement suggests that duration of TCR signalling is also a factor. The kinetic 
signalling model proposes that long signals favour the CD4
+
 lineage, whereas short 
signals preferentially yield CD8
+
 cells. How a developing thymocyte could sense the 
duration of signalling was somewhat unclear until the identification of a CD4
+
CD8
low
 
intermediate stage. All DP thymocytes down-regulate CD8, regardless of the identity of 
the TCR they bear at their surface, and the effect of CD8 absence is what directs lineage 
decision. Thus, in CD4
+
CD8
low
 thymocytes, class II MHC signals will persist because 
they are CD8-independent and this will direct T cell fate towards the CD4 path, but 
class I MHC derived signals will cease, giving rise to CD8
+
 cells. 
 
 
1.3.  Diversification of the TCR repertoire 
 
1.3.1. Organisation of the TCR and Immunoglobulin loci 
 
Diversity of antigen receptors at the surface of T and B lymphocytes is the 
hallmark of adaptive immunity. It was first recognised in the B cell compartment, as 
antibody responses can be triggered against an immense variety of antigens of any 
chemical class. Indeed, antibodies can be raised even against synthetic compounds, 
reflecting the unique ability of B cells to mount a response against virtually any 
compound including those not found in nature, as highlighted by Paul Ehrlich more than 
a century ago. It later became clear that antigen receptors were generated by the 
immune system prior to antigenic challenge and that the genetic basis of the immune 
response was imprinted in the immunoglobulin (Ig) loci for B cells, and in the tr loci in 
the case of T cells. Thus, rearrangement of TCR and Ig gene segments is a key event 
during the development of T and B cells from immature precursors.  
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Gene rearrangement is a highly regulated process and there are rules for 
generating lymphocyte receptor diversity (Haars et al., 1986). In the mouse the TCR-β 
(trb) locus is located on chromosome 6 and comprises 37 functional variable (V), 
diversity (D), joining (J) and constant (C) gene segment. The TCR-α (tra) locus on 
chromosome 14 is composed of a total of 112 to 123 functional gene segments. As 
opposed to the trb locus, tra only has one C gene and there are no D segments 
(ImMunoGeneTics [IGMT] website). Both tr loci are fully described in Table 1.1 
below. 
 
Table 1.1. Description of the murine trb and tra genetic loci. 
 
A) trb locus 
 
  Number of genes Number of Functional Genes 
TRBV 35 22 
TRBD 2 2 
TRBJ 14 11 
TRBC 2 2 
Total 53 37 
 
B) tra locus 
 
  Number of genes Number of Functional Genes 
TRAV 98 73-84 
TRAD 0 0 
TRAJ 60 38 
TRAC 1 1 
Total 159 112-123 
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Recombination events bring together one of many V segments and a J segment to 
form the N-terminal variable domain of antigen receptors (Tonegawa, 1983) with the 
inclusion, in the case of the TCR-β chain, of an additional D segment (Born et al., 
1985). The primary nuclear transcript will contain the intron between the newly 
recombined V (D) J exon and the C segment. This region is subsequently spliced to 
form the mature messenger RNA (mRNA) in which V, (D), J and C segments are 
directly juxtaposed. Translation of this mRNA generates the full-length TCR chain, as 
illustrated in Figure 1.3.  
 
 
 
  
 
 
 
Figure 1.3. V (D) J Recombination. The recombination machinery brings together the 
V, (D), J and C segments to form a rearranged TCR chain. Rearranged chains are 
further processed and spliced to form the TCR-α and TCR-β transcripts (adapted from 
Schatz and Ji, 2011). 
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B cells on the other hand are generated in foetal liver and adult bone marrow 
through a developmental pathway that shares some but not all features of T cell 
development. In murine and human B cells, V (D) J recombination drives the generation 
of antibody diversity through rearrangement at three genetic loci located on different 
chromosomes, namely the Ig heavy (Igh), Ig light-κ (Igk) and the Ig light-λ (Igl) loci 
(IMGT website). Recombination produces sufficient diversity to form the primary 
repertoire of B cells. In contrast to T cells, antigen encounter by B cells triggers somatic 
hypermutation in the antigen-binding site. Point mutations in the variable region, 
coupled with repeated rounds of antigen-mediated selection of those B lymphocytes 
expressing receptors of higher affinity create further diversity in the B cell repertoire 
(Brenner and Milstein, 1966; Peled et al., 2008). Therefore, this secondary B cell 
repertoire generated after antigen encounter is composed of high affinity antibodies. In 
addition, these antibodies, through the process of class-switch recombination, can be of 
different isotypes with distinct properties and physiological functions (reviewed by Di 
Noia and Neuberger, 2007). 
 
1.3.2. V(D)J recombination 
 
Diversification of the tr and Ig loci is a distinguishing feature of the adaptive 
immune system. Genetic rearrangement can be achieved through very different 
mechanisms in different species, including germline joining in cartilaginous fish and 
gene conversion in avians, for instance (reviewed by Litman, Anderson and Rast, 1999). 
This section describes genetic rearrangement by V (D) J recombination in mice and 
humans. In both T and B cells, recombination is mediated by a lymphoid-specific 
enzymatic complex, the recombinase-activating gene (RAG) 1 and -2 complex.  The 
importance of RAG enzymes in the T cell lineage is evidenced by the absence of 
thymocyte development beyond the DN stage in rag1 or rag2 deficient mice (Shinkai et 
al., 1992). RAG recognises highly conserved recombination signal sequences (RSS) 
flanking the 3’ end of V, the 5’ end of J and both the 3’ and the 5’ end of D segments. 
The RSS are composed of conserved heptamer and nonamer sequences separated by 12 
or 23 base pairs (bp) and the 12/23 rule posits that recombination is strongly favoured 
between a 12 bp RSS and a 23 bp RSS (Sakano et al., 1979). During the process of 
recombination, target genomic regions must be brought together and made accessible 
for the RAG complex by a looping event. This loop is held in place by RAG1/2 
tetramerisation for subsequent cleavage, processing and ligation.  
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The RAG1 unit contains the endonuclease catalytic core of the complex and 
functions to introduce double strand breaks to target DNA, leaving behind a free 3’ 
hydroxyl group available for nucleophilic attack on the other strand. Broken ends are 
further modified by random removal and addition of template and non-template 
nucleotides by terminal deoxynucleotidyl transferase (TdT), thereby contributing to the 
generation of junctional diversity. Finally, broken ends are brought together and ligated 
by DNA repair enzymes through non-homologous end-joining (Jung et al., 2006). 
In a nutshell, generation of antigen receptor diversity is a complex process and 
receptor variability is manifest on several levels. First, the theoretical recombination 
potential is the product of the number of V, D and J segments in the genome. In 
addition, any antigen receptor chain has the possibility to pair with a number of partner 
chains, which contributes to further combinatorial diversity. Finally, the largest 
contribution to diversity is produced at junctions between segments by addition and 
removal of nucleotides, thus forming a hypervariable region (Cabaniols et al., 2001). 
Therefore, while different TCR may share the same constituent gene segments, each 
must be exclusive in its junctional region, the result being the emergence of unique T 
cell clones with unique specificity. Compared to Ig, tr loci are relatively enriched with a 
high number of J segments consistent with a bias towards junctional diversity in the 
TCR (Davis and Bjorkman, 1988). 
The importance of receptor diversification is apparent in murine models and in a 
number of genetic deficiencies. For instance, rag-deficient mice are devoid of 
lymphocytes, as mentioned above (Shinkai et al., 1992). Moreover in humans, rag 
deficiency is linked to SCID, and other rag mutations can lead to immunodeficiency 
with expansion of γδ T cells or with granuloma and idiopathic CD4+ T cell 
lymphopaenia (Villa et al., 2001). Mis-sense mutations in rag1 and rag2 are the cause 
of Omenn syndrome (Villa et al., 1998), a disease with graft-versus-host disease 
(GvHD)-like clinical presentation. Omenn syndrome is characterised by expansion of 
autoreactive CD4
+
 T cells with an oligoclonal repertoire and is fatal to infants between 
two and six months of age as a result of recurrent infections (Aleman et al., 2001).  
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1.3.3. TCR diversification and immune coverage 
 
The theoretical diversity in TCRαβ is extremely vast and has been estimated at 
10
15
 clones in mice and 10
18
 in humans. The collection of somatically rearranged 
receptors is thus considerably large and is inherently unpredictable. Therefore, reactivity 
to self is an inevitable risk associated with diversification of the TCR repertoire. Indeed, 
while the emergence of receptor clonality over evolutionary time has allowed the 
adaptive immune system to achieve antigen specificity, it has created another problem: 
the inability to discriminate between self and non-self (Janeway, 1992; Boehm, 2011).  
However, several mechanisms have evolved to ensure that reactivity to self is 
minimised. Indeed, thymic selection restricts the number of different specificities in the 
peripheral repertoire to 10
13
 and 10
16
 in mice and humans respectively, as only one in a 
hundred T cells are thought to be selected to the periphery (Goldrath and Bevan 1999). 
These figures are still several orders of magnitude greater than the actual number of 
total T cells in a mouse (10
8
) or human (10
12
) (Venturi et al., 2008). Thus, even 
assuming that each cell bears a different specificity, only a fraction of the repertoire can 
ever be used at any given time during the lifespan. Experimental evidence suggests that 
the actual diversity in peripheral T cells is 2×10
6
 clones in mice and 2.5×10
7
 in humans 
(Arstila et al., 1999; Casrouge et al., 2000; Robins et al., 2010). It follows that the 
peptide universe is far greater than the TCR diversity present at any given time in the 
life of any individual. 
Therefore, one of the most crucial challenges that the adaptive immune system is 
faced with is the need to use a large, but nonetheless finite, TCR repertoire in order to 
deal with a tremendous array of life-threatening pathogens. This puzzle implies that the 
immune system must be armed with enough cells with relevant specificities throughout 
the lifetime of an individual, and simultaneously, not be reactive to self. The key 
question arising from this is the degree of variability and functional plasticity needed to 
tackle all threats to the host.  
Tackling the entire peptide universe using TCR repertoires in which each receptor 
is specific for a single pMHC is a virtually impossible challenge because it requires a 
total number of T cell clones that simply cannot be accommodated in the host. The 
simplest solution to this challenge would be the enhancement of immune coverage 
using TCR that have specificity for several peptides, as originally suggested by Mason 
(1998).  
 
 
35 
 
It is now well established that a single TCR indeed recognises several peptides, a 
property referred to as cross-reactivity. Cross-reactivity is defined as the ability of a 
single TCR to recognise distinct ligands either when facing peptides with obvious 
sequence similarity, or even in the context of peptides with unrelated primary sequences 
(Wilson et al., 2004; Ishizuka et al., 2009). However, the degree of cross-reactivity 
achieved by T cells has long been left unclear, with the earliest studies suggesting that a 
single TCR could recognise between a few hundred peptides, to about 20,000 (Wraith, 
Bruun and Fairchild, 1992; Reay, Kantor and Davis, 1994; Gundlach et al., 1996). The 
use of large synthetic peptide libraries has proven particularly useful in dissecting this 
aspect of T cell biology (Wilson et al., 1999; Nino-Vasquez et al., 2004; Lee et al., 
2004). Strikingly, a number of studies have indicated that an individual TCR could 
recognise over a million peptides, which far exceeds previous calculations (Maynard et 
al., 2005; Wooldridge et al., 2012).  
Thus, it is becoming increasingly manifest that cross-reactivity is a key property 
that has evolved to maximise immune coverage by the T cell compartment (Mason, 
1998). At the molecular level, at least five different mechanisms have been described to 
account for TCR cross-reactivity: induced fit, structural degeneracy, differential 
docking, mimicry and fine tuning of pMHC flexibility (reviewed by Yin and Mariuzza, 
2009). These mechanisms highlight both structural and conformational flexibility as a 
key feature of cross-reactive TCR (Lee et al., 2004). 
 
1.4.  T cell receptor secondary structure and hypervariable regions 
 
The TCR is a heterodimer of one α and one β chain, or one γ and one δ chain, 
which are disulfide-linked (Kappler et al., 1983a; Raulet, 1989). It is a member of the Ig 
gene superfamily and each chain folds into two extracellular Ig-like domains, a double-
layer of ten anti-parallel β-pleated strands stabilised by a disulfide bond (Saito et al., 
1984). Each TCR chain is composed of a constant and a variable domain, followed by a 
membrane-spanning region and short cytosolic tail of three amino acids (Figure 1.4). 
Diversity in the TCR is predominantly confined to three hypervariable hairpin loop 
structures in the variable domain, called complementarity-determining regions (CDR) 1, 
-2 and -3 (Chothia, Boswell and Lesk, 1988; Jardetzky et al., 1997). While CDR1 and -
2 are entirely encoded in germline DNA, CDR3 is the product of junctional diversity 
and is consequently hypervariable, as depicted in Figure 1.5 below. 
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Figure 1.4. The T cell receptor. Each chain of the TCR is composed of a constant 
(green) and a variable (blue) Ig-like domain, followed by a membrane-spanning region 
and short cytosolic tail. 
 
The variable domain consists of ten β-strands, whose arrangement is similar to 
that in antibody variable regions. In this arrangement, the CDR loops are hairpin turns 
linking adjacent β-strands. Similar to the antibody molecule, all six CDR from the α and 
the β chain form the antigen-binding site of the TCR. The antigen-binding sites of 
antibody and TCR are thus homologous, but in early cloning studies, it was observed 
that TCR variability was strongly biased towards junctional diversity. Therefore, it was 
well anticipated that the junctional CDR3 would serve as recognition unit of antigenic 
determinants bound to MHC (Davis and Bjorkman, 1988). 
The conformation of individual germline-encoded CDR is well-defined. It has 
been proposed that the hypervariable regions of the TCR, as well as antibodies, can only 
adopt one of a number of conserved canonical forms, which were first described by Al-
Lazikani, Lesk and Chothia (2000). These conformations are determined by the 
presence of key amino acids within the CDR primary sequence, allowing different TCR 
composed of distinct V segments to use the same canonical unit. Nevertheless, although 
the structure and conformation of individual CDR loops can be described accurately in 
terms of canonical units, the roles played by these hypervariable loops in recognition of 
MHC by the TCR remains a matter of debate. 
Vα Vβ
Cα Cβ
Ig fold
Disulfide bond
Variable
Constant
Cytoplasm
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Figure 1.5. Schematic representation of the TCR-β chain CDR loops. V(D)J 
recombination produces three CDR loops. CDR1 and CDR2 lie in the V region and are 
entirely germline-encoded. CDR3 is formed at the junction between recombined V, D, 
and J segments. Joining at this site is imprecise and incorporates random nucleotides 
resulting in a hypervariable loop. 
 
 
 
1.5.  The TCR signalling complex and T cell activation 
 
The TCRαβ dimer was first identified in 1983 by Kappler et al. and cloned by 
Hedrick et al. a year later (Kappler et al., 1983a; Kappler et al., 1983b; Hedrick et al., 
1984). Soon after, it was observed that a number of additional surface molecules co-
precipitated with the TCR (Meuer et al., 1983; Borst et al., 1984). We now know that 
the TCRαβ and γδ heterodimers are in fact only one component of a larger, 
multimolecular complex. For the αβ T cell, the TCR signalling complex is strictly 
composed of three elements: the TCR heterodimer for antigen recognition, the T cell co-
receptors for cellular interaction and the CD3 molecule for signal transduction (Kappler 
et al., 1983; Hedrick et al., 1984; Davis and Bjorkman, 1988). 
 
 
 
V-encoded 
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1.5.1. The CD4 and CD8 co-receptors 
 
The CD4 and CD8 co-receptors are transmembrane proteins of the Ig gene 
superfamily. CD4 is a monomer consisting of a short cytosolic tail, a transmembrane 
region and four extracellular Ig-like domains (Harrison, 1993). CD8 is either 
heterodimeric or homodimeric, each chain consisting of a cytosolic and a membrane-
spanning region linked to four extracellular Ig-like domains. CD8 heterodimers (αβ) or 
homodimers (αα) are differentially expressed on different T cell sub-populations 
(Norment and Littman, 1988).  
Despite their structural differences, CD4 and CD8 co-receptors essentially 
perform the same function. On the one hand, the extracellular domains of CD4 and CD8 
bind to non-polymorphic regions of class II and class I MHC respectively (Salter et al., 
1989). This interaction has been shown to stabilise the TCR-pMHC interaction 
(Luescher et al., 1995; Garcia et al., 1996) and increases the half-life of TCR-pMHC 
complexes (Gakamsky et al., 2005). On the other hand, the intracellular portion of the 
co-receptor interacts with the Src family member lymphoid cell kinase (Lck
p56
, hereafter 
referred to as Lck). Lck is a protein tyrosine kinase recruited to the T cell plasma 
membrane by lipid modification for interaction with CD4 and CD8 (Haughn et al., 
1992). With the discovery that co-receptors precipitated with this kinase, it became 
apparent that CD4 and CD8 were a functional component of proximal T cellular 
signalling (Veillette et al., 1988). Indeed, only simultaneous engagement of TCR and 
co-receptor to pMHC can mobilise sufficient amounts of Lck to trigger T cellular 
signalling and activation (Barber et al., 1989).  
Co-receptors are crucial during T cell development starting at the DP stage where 
signalling determines commitment to the helper or cytotoxic T cell subsets (Kappes, He 
and He, 2005) and selection on pMHC ligands (Van Laethem et al., 2007). In 
thymocytes, disrupted co-receptor-Lck association impairs T cell development (Killeen 
and Littman, 1993; Fung-Leung et al., 1993). CD8α chain deficient mice are devoid of 
cytotoxic T lymphocytes (Fung-Leung et al., 1991) and CD4-deficient mice are 
enriched with mismatched class II restricted CD8
+
 T cells which fail to provide 
protective immunity against epitopes presented by class I MHC (Tyznik, Sun and 
Bevan, 2004). Co-receptors are equally important in the periphery upon antigenic 
challenge, as co-receptor binding to MHC molecules promotes cellular interaction with 
the APC, which in turn allows naïve T cell priming.  
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The functional outcomes of co-receptor engagement are non negligible. For class I 
pMHC, CD8 binding has been shown to enhance the half-life of the TCR-pMHC 
interaction by influencing the dissociation rate (Luescher et al., 1995). In addition, CD8 
blockade can turn a poor TCR antagonist into a strong antagonist (Jameson, Hogquist 
and Bevan, 1994). In the case of class II pMHC, CD4 blockade can change a weak 
agonist into an antagonist (Mannie et al., 1995). CD4
+
 T cell hybridomas are more 
sensitive to stimulation than CD4
-
 variants in vitro (Hampl et al., 1997). Thus, there is 
ample evidence in the literature to suggest that functional outcomes of TCR ligation to 
pMHC ligands are greatly influenced by recruitment and engagement of co-receptors. 
 
1.5.2. CD3 chains and T cellular signal transduction 
 
Over the last thirty years, the observations drawn from several studies on various 
cell types have allowed T cell activation to be thoroughly investigated. These studies 
culminated in the description of the two-signal model of T cell activation and the 
characterisation of the signalling pathways involved in T cell-mediated responses 
(Lafferty and Cunningham, 1975). This model suggests that T cells are only partially 
activated by TCR-induced signals and that additional co-stimulation is required from 
accessory molecules to fully activate T lymphocytes. It is now well-established that T 
cells are triggered by the recognition of peptides on MHC molecules, but signals 
delivered by the TCR in conjunction with the CD4 or the CD8 co-receptor provide only 
the first part of the signals required for optimal activation. Furthermore, T cells 
receiving TCR-induced signals in the absence of co-stimulation become unresponsive to 
further stimulation (Quill and Schwartz, 1987). 
In early studies of T cell signalling, it was well-anticipated that the short 
cytoplasmic tails of the TCR were too short to allow it to transduce signals on its own. 
It was subsequently discovered that the receptor would associate with CD3 molecules to 
form a TCR complex (Weiss and Stobo, 1984). CD3 is formed by four chain types 
assembled as ζζ, δε and γε disulfide-linked dimers (Kuhns, Davis and Garcia, 2006). 
The assembly of the TCRαβ complex is tightly regulated and strictly dependent on 
charge-charge interactions between TCR-α and CD3δ, ε and ζ, and between TCR-β and 
CD3γ and ε (Call et al., 2002). The stoichiometry of the heterodimer with ζζ, δε and γε 
is 1:1:1:1 (Hayes, Shores and Love, 2003; Call, Pyrdol and Wucherpfennig, 2004).  
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The CD3 chains possess a distinct, conserved motif called the immunoreceptor 
tyrosine-based activation motif (ITAM). The ITAM is a double-repeat of the sequence 
Y-X-X-L/I separated by six to twelve amino acids (Irving, Chan and Weiss, 1993). 
Phosphorylation of tyrosine residues within this sequence is crucial for T cell activation 
and for this reason the role of kinases has been extensively studied. Chimaeric CD3 
molecules with CD3 intracellular domains fused to the extracellular portions of other, 
unrelated proteins transfected into TCR-deficient cell lines can recapitulate the 
membrane-proximal events that lead to cellular activation following antibody cross-
linking, unless the key tyrosine residues within ITAM are mutated (Imboden and Stobo, 
1985; Irving and Weiss, 2000; reviewed by Isakov, Wange and Samelson, 1994 and by 
Smith-Garvin, Koretzky and Jordan, 2008). It is now widely accepted that the co-
receptor-associated adaptor protein Lck initially phosphorylates the three ITAM present 
on CD3-ζ intracellular domains (Barber et al., 1989). The purpose of this initial 
phosphorylation step is to generate phosphorylated tyrosines serving as docking sites for 
Src homology 2 domain (SH2)-containing proteins. As such, phosphotyrosines function 
as recruitment platforms for a number of signalling components (Machida and Mayer, 
2005) and ultimately allow the induction of signalling cascades that are crucial for 
functional activation, as depicted in Figure 1.6. 
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Figure 1.6. T cellular signalling events in response to pMHC engagement. Adapted 
from Smith-Garvin, Korezky and Jordan, 2008. Red stars represent ITAM on TCR-
proximal components. Signalling molecules are abbreviated as follows: diacylglycerol 
(DAG), extracellular signal regulated kinase (ERK), growth factor receptor-bound 
protein 2 (Grb2), Grb2-related adapter protein 2 (Gads),  inositol 1,4,5-triphosphate 
(IP3), c-Jun N-terminal kinase (JNK), linker of activated T cells (LAT), mitogen 
activated kinase (MAP), nuclear factor of activated T cells (NFAT), nuclear factor κ 
light chain enhancer of activated B cells (NF-κB), protein kinase (PKC), phospholipase 
C γ1 (PLCγ1), SH2 domain containing leukocyte protein of 76 kDa (SLP-76), son of 
sevenless (Sos). 
 
 
1.6. The MHC locus and MHC proteins 
 
The mhc locus was first described as the set of genes that determine the outcome 
of tissue transplantation. The elucidation of the biological role for MHC proteins started 
with the discovery of immune response (ir) genes. Benacerraf observed that the 
response to poly-L-lysine polymers in guinea pigs was under the control of a single 
gene, referred to as ir (Levine, Ojeda and Benacerraf, 1963). Later, McDevitt and 
Chinitz (1969) showed that the response to similar compounds could be predicted in 
mice on the basis of their H-2 haplotype, the mouse mhc counterpart, and that the ir 
genes mapped to the mhc locus.  
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Key to understanding this phenomenon was the concept of genetic polymorphism 
at the mhc locus. Together, the studies conducted by Benacerraf and McDevitt indicated 
that responder strains actually inherited MHC products able to present the polymers to T 
cells, while the non-responders expressed MHC molecules unable to bind such 
compounds.  
 
1.6.1. The MHC locus  
 
The mhc is highly polymorphic, and is in fact the most polymorphic genetic 
complex known in jawed vertebrates, reflecting strong evolutionary pressure from 
highly mutable pathogens (Potts and Slev, 1995). Thus, while antigen receptor diversity 
is achieved somatically in each individual, MHC diversity is apparent at the population 
level. The mhc locus is on the short arm of chromosome 6 in humans and spans a region 
of four million bp. The mhc is referred to as human leukocyte antigen (HLA) in humans 
and histocompatibility-2 (H-2) in the mouse and the organisation of the HLA and H-2 
systems is highly conserved (Kulski et al., 2002). The mhc genes encode two 
homologous types of MHC proteins, the class I and class II MHC molecules. Other non-
classical MHC as well as class III gene products do not necessarily function in peptide 
presentation but are involved in immunity (IMGT website).  
 Whereas class I MHC molecules are present on the surface of all nucleated cells, 
the expression of class II MHC molecules is far more restricted. B cells, dendritic cells 
and macrophages are defined as the only professional APC in the immune system 
because they are the only cell types that co-express class I and class II MHC as well as 
co-stimulatory molecules needed for full T cell activation. All classical MHC molecules 
bind and display peptides derived from the cytosolic or the exogenous processing 
pathway for presentation to T cells. Class I MHC proteins constantly present a sample 
of the proteome, while class II MHC constantly examine the contents of the 
extracellular milieu (reviewed by Nathenson et al., 1986), as shall be described later.  
The polymorphic residues of MHC proteins are confined to the peptide-binding 
groove so that specific side chains of the peptide known as anchor residues can be 
accommodated in specificity pockets. A single peptide will bind to a limited set of 
MHC variants, if any. Conversely, a given MHC product may accommodate at most a 
small fraction of the peptide spectrum derived from a protein (Harding and Unanue, 
1990).  
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Polymorphism at the mhc therefore affects an individual’s immune status by 
determining the collection of peptides made available to T cells during development and 
shaping of the TCR repertoire and also upon antigenic challenge. (Bevan, 1997; Dyall et 
al., 2000). Because a given peptide will only bind to a subset of MHC alleles, the 
immune response to that peptide is said to be “restricted” to those alleles. 
 
 
 
1.6.2. Structure of MHC products 
 
The first MHC protein structure to be solved was the human HLA-A2, which was 
reported in 1987 by Bjorkman et al. Class I MHC molecules consist of two polypeptide 
chains, one 44 kDa membrane-spanning heavy chain associated with a conserved 12 
kDa β2 microglobulin (β2m) domain. The heavy chain is composed of three domains 
designated α1, α2 and α3. Only the membrane-distal α1 and α2 domains are polymorphic; 
these represent the antigen-binding groove, a network of eight β-strands supporting two 
α helices. Symmetry within the antigen-binding groove is such that four strands from 
each domain form a single β-pleated sheet of eight strands in total (Bjorkman et al., 
1987a). The membrane-proximal α3 and β2 are non-polymorphic and fold into Ig-like 
domains (Bjorkman et al., 1987b; Harding and Unanue, 1990).  
The first report of a class II MHC structure came in 1993 (Brown et al., 1993) and 
confirmed that class II MHC molecules also consisted of two glycosylated polypeptides 
of approximately 35 kDa, α and β, both of which are anchored to the plasma membrane. 
Each chain folds into one membrane-distal polymorphic domain followed by an Ig-like 
domain. In addition to the apparent structural differences, it soon became clear that the 
antigen-binding site was also different from class I molecules and that, as a 
consequence, class I and class II proteins would present different types of peptides. 
Class I molecules normally bind peptides eight to ten residues long in an extended 
conformation, leaving the peptide side chains protruding for interaction with the TCR. 
In class II molecules, the peptide-binding groove is open at both ends, allowing longer 
peptides to be accommodated (reviewed by Jones, 1993). Longer peptides can also be 
accommodated by class I MHC, but these will be fixed at both termini and, as a result, 
bulge out of the groove (Wilson and Fremont, 1993).  
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Peptide elution studies have shown that anchor residues within the primary 
sequence of a peptide mediate MHC binding (Falk et al., 1991). Substitutions at these 
positions abrogate binding to MHC and consequently, the T cell response. Other amino 
acid side chains that protrude out of the peptide-binding pocket are left to interact with 
the TCR, and mutating these residues abrogates the T cell response despite appropriate 
MHC binding (reviewed by Harding and Unanue, 1990; Germain and Margulies, 1993). 
 
1.7. Antigen presentation by MHC proteins and selection of MHC-restricted T cells 
 
1.7.1. Antigen processing and presentation by class I MHC 
 
The biosynthesis and loading of the class I MHC heavy chain requires a number 
of enzymes and endoplasmic reticulum (ER)-associated molecular chaperones. 
Chaperones such as calnexin stabilise the class I heavy chain before its association with 
β2m and its incorporation into the peptide loading complex. The peptide loading 
complex consists of TAP and tapasin, the chaperone calreticulin and the thiol 
oxidoreductase ERp57. These molecules are involved in stabilisation of the newly 
synthesised MHC, folding, disulfide bond formation and peptide loading. TAP 
transports peptides generated in the cytosol by the proteasome and trimmed by ER-
associated aminopeptidase (ERAAP). ERAAP is required to achieve the peptide length 
necessary for association with class I MHC. Peptides that associate with MHC leave the 
ER as a stable pMHC complex to reach the T cell plasma membrane via the Golgi 
apparatus (Harding and Unanue, 1990; Pamer and Creswell, 1998). 
The binding affinity for MHC varies between peptides according to their primary 
sequence. Both self and foreign peptides can compete for binding to MHC. However, 
during the course of an infection it is vital that foreign pMHC complexes are 
preferentially generated to allow for rapid induction of CD8
+
 T cell-mediated immunity. 
In the context of an immune response, proteasomes are swapped for 
immunoproteasomes by addition of specific catalytic subunits. Thus, the class I 
processing machinery is designed to expose a sample of the proteome on the cell surface 
at all times. However, during an immune response, the proteasome system also allows 
presentation of a different spectrum of peptides through the addition of inducible 
subunits with distinct cleavage specificities. 
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1.7.2. Antigen processing and presentation by class II MHC 
 
The class II exogenous pathway for antigen processing begins with antigen uptake 
into phagosomes. As mentioned before, this is mediated by specialised APC, which 
internalise antigen via phagocytosis or receptor-mediated endocytosis. Phagosomal 
acidification and fusion with endolysosomes then allow degradation of the antigen load 
by hydrolases and cathepsins and interaction with newly synthesised class II MHC 
molecules (Vyas et al., 2008). 
The biosynthesis of class II MHC takes place in the ER. Nascent class II MHC 
proteins are transported to endosomes with by an invariant chain (Ii) lodged in the 
peptide-binding groove.  Ii stabilises the newly synthesised class II dimers but also 
serves to prevent premature binding to peptides in the ER, which are reserved for class I 
MHC molecules. Proteolytic cleavage of Ii leads to the formation of a small peptide 
chain of approximately 3 kDa lodged in the peptide-binding site called class II invariant 
chain peptide (CLIP). Several enzymes are involved in this process, including 
asparagine endopeptidase (AEP) and cathepsins (Watts, 2004). After gaining access to 
the contents of phagosomes, Ii is exchanged with incoming peptides generated by 
hydrolytic degradation and the peptide exchange step is catalysed by HLA-DO and 
HLA-DM. Class II MHC molecules are only transported to the cell surface after 
removal of CLIP and exchange for endosomal peptides. 
 
1.7.3. Selection of MHC-restricted T cells 
 
Independent experiments carried out by Bevan (1977) and by Zinkernagel et al. 
(1978) established the role of the thymus in imprinting MHC specificity in developing 
thymocytes.  Balb/c × C57BL/6 (B6) F1  Balb/c bone marrow chimaeric mice 
generate virus-specific cells which kill targets of the recipient type, implying that H-2 
specificity in the mouse is established during early thymocyte ontogeny, regardless of 
the donor’s own H-2 haplotype (von Boehmer and Hafen, 1986; and reviewed by 
Hedrick, 2012).  In the thymus, MHC molecules are now known to be expressed on 
non-haematopoietic cell types, with thymic cortical epithelial cells (cTEC) displaying 
pMHC ligands to thymocytes auditioning for selection.  
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The role of the MHC-bound peptide in positive selection is clear from 
experiments with foetal thymic organ cultures (FTOC) in which the major route for 
class I MHC loading and surface expression is blocked by deficiency in the transporter 
associated with antigen processing 1 (TAP1). In TAP1-deficient FTOC, a single 
exogenous peptide can restore both class I expression and selection of mature CD8
+
 T 
cells. Moreover, when two peptides are added simultaneously, the number of selected T 
cells is close to the sum of the numbers observed when the peptides are added alone, 
indicating that individual peptides can select discrete CD8
+
 T cell populations (Ashton-
Rickardt et al., 1993). Later experiments demonstrated that larger peptide mixtures were 
better at positively selecting T cells with a broad repertoire than single peptides 
(Hogquist, Gavin and Bevan, 1994), suggesting that peptide diversity in the thymic 
stroma correlates with TCR diversity. 
The size and diversity of the thymocyte population is therefore regulated by the 
ligands made available in the thymus by processing and presentation (Nikolich-Zugich 
and Bevan, 1990). Indeed, Anderson et al. (1998) demonstrated that positive selection 
by cTEC bearing a small peptide collection is reduced three-fold compared to wildtype 
epithelium (Anderson, Partington and Jenkinson, 1998). For class I-restricted CD8
+
 T 
cells, this will correlate with the peptide universe generated by thymoproteasomes that 
are able to bind to class I MHC molecules. Mice deficient in the cTEC-specific 
thymoproteasome subunit β5t select fewer CD8+ T cells than their β5t+ counterpart and 
the peptide set displayed by cTEC is unique to this cell type due to the enzymatic 
activity conferred by the β5t subunit (Nitta et al., 2010).  
 
 
1.8. MHC restriction 
 
1.8.1.  Overview of the TCR-MHC interaction 
 
From the earliest studies on T cell biology, with the observation that T cells 
recognise processed antigen in the context of self MHC proteins, major efforts have 
been made to unravel the structural basis of this interaction. Above all, the most 
important issue has been to understand how an immensely diverse class of proteins - the 
TCR- would become efficient at reacting to another class of proteins that are highly 
polymorphic themselves- the MHC.  
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It is clear that the thymic compartment provides a specialised environment that 
promotes the selection of T cells that are MHC-reactive (Kruisbeek et al., 1981). 
However, with the realisation that an unexpectedly high proportion of T cells in the 
periphery are also able to recognise foreign MHC, a number of ideas have been put 
forward that suggest that the TCR is intrinsically biased towards recognition of 
histocompatibility antigens. Indeed, early experiments have noted a bias towards MHC 
prior to selection, with one particular study pointing to as many as 20% of pre-selection 
TCR recognising MHC alleles in any given individual (Blackman et al., 1986; 
Merkenschlager et al., 1997; Zerrahn et al., 1997). 
Structural analysis of several TCR, both in their ligated and free states, has 
provided much insight into the interactions which govern TCR engagement to MHC 
molecules. Although the molecular aspect of these interactions is still unclear, several 
observations have been made based on a number of available TCR-pMHC crystal 
structures. Most TCR bind to MHC using the same docking mode (Garboczi et al., 
1996), as exemplified by the HA1 TCR shown in Figure 1.7.  Indeed, although the 
docking angles vary considerably between the structures studied to date, it is generally 
accepted that the TCR engages MHC in a diagonal or orthogonal orientation relative to 
the long axis of the peptide-binding groove. Moreover, CDR1 and -2 are normally in 
contact with MHC helices and CDR3 centred over the peptide (reviewed by Rudolph, 
Stanfield and Wilson, 2006). Based on this observation, it was initially suggested that 
CDR1 and -2 would initially engage in a loose interaction with MHC, allowing the 
more flexible CDR3 to subsequently scan and recognise the presented peptide (Wu et 
al., 2002). Therefore, this two-step binding model does not envisage the pMHC 
complex as a single entity. Rather, it supports the idea that MHC and peptide may be 
separable elements that are recognised sequentially. Nevertheless, biophysical data from 
some TCR do not fit a two-step binding mechanism, which suggests that the model 
might not be applicable to all TCR (Reiser et al., 2003; Borg et al., 2005).  
Compared to antibody recognition, the TCR-pMHC interaction is of low affinity, 
with a dissociation constant in the low micromolar range (van der Merwe and Davis, 
2003), and is characterised by slow association rates and fast dissociation rates 
(Boniface et al., 1999). One interpretation would be that the hypervariable loops of the 
TCR are flexible, but may be stabilised upon binding to pMHC, whereby an entropic 
penalty is incurred. Crystal structures from TCR in their bound and free states suggest 
that the CDR loops, particularly CDR3, undergo extensive conformational changes 
upon binding (Reiser et al., 2002; Jones et al., 2008).  
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However, different studies carried out so far have failed to reach a consensus on 
the relative energetic contributions of each CDR loop. Thus, it is likely that the role of 
individual CDR to the kinetics of the TCR-pMHC interaction is more subtle than 
previously thought and certainly involves cooperation between these hypervariable 
loops (Boniface et al., 1999). In the case of LC13 for instance, residues in the CDR1 of 
both the TCR-α and β chain are essential for the stabilisation of CDR3 and do not 
directly account for MHC binding. This, as suggested by Kranz (2005), points to a role 
for the germline-encoded CDR1 and CDR2 in supporting pMHC binding by CDR3 
loops. 
 
 
 
Figure 1.7. Structure of the human HA1.7 TCR in complex with the influenza HA 
peptide bound to the human class II MHC molecule HLA-DR1. The TCR-α and β 
chains are shown in yellow and pink, respectively. The α and β chains of class II MHC 
are is green and blue, respectively. The TCR engages pMHC by interacting with both 
MHC helices and peptide. 
 
 
 
 
 
 
 
Adapted from Hennecke, Carfi and Wiley, 2000. 
Adapted from Hennecke, Carfi and Wiley, 2000). 
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1.8.2. Contributions of positive and negative selection to MHC restriction 
 
As mentioned before, it is clear that thymic selection will shape the composition 
of the T cell repertoire, (Ashton-Rickardt et al., 1993) as MHC-expressing cells bearing 
different sets of peptides in the thymus will exclude certain TCR or include others from 
the naïve pool entering the periphery (Dyall et al., 2000). However, the relative 
contribution of positive and negative selection to the generation of MHC-restricted cells 
remains controversial (reviewed by Bevan, 1997). Whether MHC reactivity stems from 
a pre-existing “germline code” or from selection of cells expressing a TCR with 
appropriate affinity is still a matter of debate.  
It has long been assumed that positive selection functions to enrich the peripheral 
T cell repertoire with relatively rare, protective T cells that are self MHC-restricted. 
(Bevan, 1975; Fink and Bevan, 1978; Zinkernagel et al., 1978; Kisielow et al., 1988). 
However, others have proposed that rather than positive selection, deletion of 
thymocytes establishes MHC reactivity (Marrack and Kappler, 1997). Indeed, if 
variable elements have evolved to react with MHC, this reactivity must also be 
attenuated to allow at least some thymocytes to be rescued from negative selection. 
Marrack et al. (2008) hypothesised that CDR1 and -2 combinations will produce an 
MHC-reactive TCR while the somatically rearranged CDR3 will cause steric clashes to 
interfere with this reactivity, thereby producing a TCR repertoire with a wide range of 
affinities. The process of negative selection will further shape this repertoire and 
therefore only some of the germline-encoded MHC interactions of CDR1 and -2 will 
still be apparent in the peripheral T cell repertoire. 
To examine this issue, Ignatowicz et al. (1996) have described the generation of a 
mouse strain expressing a single pMHC complex, the I-A
b
 molecule covalently bound 
to the Eα52-68 peptide. In this setting, where the impact of negative selection is limited, 
CD4
+
 T cells were selected and interacted with I-A
b
 presenting a variety of peptides, 
and with other class II MHC molecules at high frequency. This increased rate of 
alloreactivity in single pMHC mice implied that in a normal setting, a high number of 
thymocytes are deleted because they react with high avidity with MHC, highlighting a 
predominant role for negative selection in a shaping a TCR repertoire that is already 
biased towards recognition of MHC molecules. 
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1.9. Germline rules for TCR interaction with classical MHC molecules 
 
As mentioned above, previous studies have suggested that the germline-encoded 
CDR1 and -2 interact primarily with MHC α helices while CDR3 contacts the MHC-
bound peptide (reviewed by Rudolph, Stanfield and Wilson, 2006 and by Mazza and 
Malissen, 2007). Many interpret the conservation of this binding orientation as the 
result of co-evolution between TCR variable elements and MHC. 
In 1971, Niels Jerne was the first to suggest that antigen receptors might be 
intrinsically biased toward recognition of histocompatibility antigens. Because 
histocompatibility alleles are randomly allocated across a given population, he proposed 
that any animal would have a set of TCR directed against self MHC antigens, and 
another set against the MHC of another member of the same species, or allogeneic 
MHC. Focusing on B cell biology, Jerne presented a theory that linked generation of 
antigen receptor diversity to genetic determination of the immune response. His theory 
assumed that the TCR, which was poorly characterised at the time, would undergo 
somatic hypermutation in the V gene segment like Ig on the surface of B cells. Those T 
cells that can alter their TCR so that their reactivity to self is no longer overtly high will 
be selected and the remainder will be eliminated because they fail to attenuate self 
reactivity of their TCR (Jerne, 1971). This theory eventually fell out of favour because 
the assumption that TCR loci would also undergo somatic hypermutation later proved to 
be incorrect. Nonetheless, over the years, others have extended this idea to suggest that 
TCR, through their germline-encoded elements, might have developed some 
evolutionarily conserved means of reacting with MHC proteins (Garcia et al., 2009). In 
other words, the TCR “bias” for recognition of MHC molecules would have arisen 
through co-evolution so that MHC restriction could largely be attributed to 
complementarity between the structures of MHC molecules and of the germline-
encoded CDR1 and -2 (Marrack et al., 2008). If this were the case, one would expect a 
number of conserved sets of amino acids on the TCR, or “interaction codons”, to 
govern recognition of MHC ligands. 
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1.9.1. Functional studies supporting the germline theory 
 
Despite numerous attempts to identify key amino acids responsible for this “bias”, 
the earliest structural studies on TCR-pMHC complexes failed to reveal any conserved 
patterns to support the idea of a germline code linking TCR and MHC. More recently 
however, Scott-Browne et al. (2009) showed that pMHC binding by several Vβ8.2-
expressing TCR, including the class II restricted DO TCR, depended on amino acids 
Y46, Y48 and E54 within the TCR-β CDR2 loop. Mutating these amino acids to an 
alanine residue reduced interaction with MHC molecules. In addition, when the effect of 
these mutations on thymic selection was assessed in vivo using a TCR-β retroviral 
transduction system, it was found that Y46, Y48 and E54 mutant DO TCR-β chains did 
not fully restore T cell development in TCR-β deficient mice. 
Rubstova et al. (2009) introduced a number of mutations in the CDR loops of the 
I-A
b
-specific YAe62 T cell clone and showed that many mutant CDR3 sequences still 
supported recognition of the I-A
b
 molecule. Furthermore, only mutations introduced in 
the CDR1 and CDR2 loops could abrogate MHC recognition, thereby demonstrating the 
predominant role of these two loops in reactivity for MHC in vitro. 
 
1.9.2. Structural data supporting the germline code 
 
In addition to the functional studies described above, several reports have 
described structural features that could underlie a germline code for MHC restriction. 
For several decades, attempts to identify so-called “interaction codons” have proven 
elusive, again reflecting the great degree of variation that exists in the binding geometry 
of TCR-pMHC complexes. It then became apparent that this difficulty stemmed from 
the fact that all available TCR-pMHC structures represented different combinations of 
V segments, peptide and MHC molecules. It was therefore speculated that “interaction 
codons”, if they exist, would have to be specific to TCR containing a common V region. 
Feng et al. (2007)  looked into the crystal structures of four Vβ8.2-expressing 
TCR. Three of these, the 1934.4, cl19 and 172.10 TCR, were specific for myelin basic 
protein (MBP) in the context of the class II I-A
u
 molecule. While 1934.4 and cl19 only 
differed by their TCR-β chain CDR3, 172.10 used a different TCR-α chain. All three 
complexes adopted similar binding footprints, suggesting that TCR composed of the 
same germline TCR-β chain CDR loops followed the same MHC docking strategy. 
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In addition, another Vβ8.2-containing TCR, the conalbumin-specific D10 TCR, 
also assumed a similar footprint to dock onto the I-A
k
 molecule. Most importantly, 
using an alanine scan, the authors identified four germline-encoded positions in Vβ8.2 
which proved to be crucial contact points. They concluded from this analysis that TCR 
with a given germline V element would mobilise the same conserved residues to 
interact with MHC helices, regardless of the identity of the partner chain or the MHC 
ligand (Feng et al., 2007). 
However, more recently, Stadinski et al. elegantly demonstrated that TCR 
specificity for unique MHC alleles is achieved through differential pairing of TCR-α 
and -β chains. Using the structures of TCR composed of Vβ8.2 with different TCR-α 
chains, bound to the same pMHC complex, they showed that pairing with different 
TCR-α partners modified the interaction site through the TCR-β CDR loops. The 
authors concluded that the conserved pairwise contacts that supposedly define 
“germline specificity” were not consistently present across Vβ8.2 TCR. This study 
therefore argues that the bias for MHC does not lie in the identity of the amino acids 
within the V segment of a particular TCR chain, but is strictly dependent on the nature 
of the partner chain (Stadinski et al., 2011). Most importantly, differential usage of 
TCR-α partners allows a single TCR-β to recognise different regions of an MHC 
molecule, and not the same, conserved MHC determinants. Thus, it follows that idea of 
germline-encoded MHC specificity is incorrect, at least for the Vβ8.2 containing TCR 
studied here (Turner and Rossjohn, 2011). 
 
 
1.10. Role of CD4 and CD8 co-receptors in MHC “bias” 
 
An alternative to the germline theory is the notion that MHC restriction is the 
result of a selection process through which the peripheral repertoire is enriched with 
MHC-specific TCR. Accordingly, this concept suggests that MHC-independent TCR 
can and do exist but that the mature T cell repertoire will be purged from such TCR in 
the thymus. This alternative concept assumes that the thymic selection machinery 
allows the distinction between MHC-specific and MHC-independent TCR. Although 
the role of selection in shaping the pre-selection repertoire into a mature MHC-restricted 
repertoire is widely accepted, the potential mechanism for the exclusion of MHC-
independent TCR is largely unknown.  
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1.10.1. Role of CD4 and CD8 co-receptors in MHC restriction 
 
A number of studies supporting the view that MHC restriction is not, or at least 
not entirely, germline-encoded have studied the role of the CD4 and CD8 co-receptors 
in directing the reactivity of the TCR to MHC molecules during thymic selection (Van 
Laethem et al., 2007). Recently, the influence of co-receptor-independent signalling was 
assessed in mice deficient in CD4 and CD8, as well as class I and class II MHC 
molecules, which were designated “quad-deficient” mice. This study was based on the 
assumption that co-receptor-independent signalling can occur and is initiated by non-
MHC ligand binding to the TCR, akin to cross-linking antibodies.  In contrast, co-
receptor dependent signalling is limited and constrained by MHC associations and can 
only be initiated by MHC ligands. Using this system, Van Laethem et al. (2007) showed 
that deletion of both co-receptors in MHC-deficient mice did not impair T cell 
signalling and allowed the selection of T cells in the absence of both class I and class II 
MHC molecules. MHC-independent signalling was presumably mediated by 
intracellular, co-receptor-free Lck. This result implied a dominant role for CD4 and 
CD8 in imprinting MHC “bias”, rather than signalling alone. Thus, the authors 
proposed for the first time that selection of MHC-restricted TCR was under the control 
of the T cell co-receptors. This idea fits well with a previous observation that DP 
thymocytes do not respond to stimulation by TCR cross-linking alone, because most of 
the available Lck is sequestered by CD4 and CD8 (Wiest et al., 1996). By preventing 
co-receptor-independent signalling, T cell co-receptors force the pre-selection repertoire 
towards MHC recognition and ensure the maintenance of MHC-specific TCR.  
 
1.10.2. Recognition of antigen by MHC-independent TCR 
 
In addition, more recent analysis of the “quad-deficient” mouse strain has 
unequivocally demonstrated that T cells which do not undergo thymic selection possess 
antibody-like features. Indeed, T hybridomas generated in a more recent study by 
Tikhonova et al. (2012) recognised conformational epitopes on the cell surface protein 
CD155, which is structurally dissimilar to MHC class I or II. Therefore, there is 
increasing evidence to suggest that all TCR must be MHC-restricted predominantly 
because they are screened for MHC specificity in the thymus and not because they are 
intrinsically biased towards MHC ligands (reviewed by Van Laethem, Tikhonova and 
Singer, 2012).  
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Supporting this idea is the observation that other antigen receptors homologous to 
the TCR can recognise MHC ligands in a TCR-like fashion. Numerous structural 
studies have shown that MHC-specific Fab fragments dock onto pMHC much like the 
TCR does (Mareeva et al., 2004; Stewart-Jones et al., 2009). Recently, it was shown 
that recognition of the MHC-like molecule T22 by γδ T cells was reminiscent of a 
classical pMHC/TCR interaction (Sandstrom et al., 2012). This structural data is 
therefore suggestive of a common recognition strategy by all lymphocyte antigen 
receptors. 
 
 
1.11. Aims of the study 
 
The two-step binding model describes an elegant, although limited, picture of the 
relationship between the germline-encoded CDR loops, as well as the hypervariable 
CDR3, and their interaction with selecting pMHC ligands. Although it has been shown 
that CDR1, -2 and -3 binding is not temporally segregated, a model for the molecular 
basis of MHC recognition by the TCR has emerged, in which CDR1 and -2 would be 
the main drivers of MHC reactivity, dictating the energetic profile of the interaction and 
positioning CDR3 over the bound peptide for optimal binding (Manning et al., 1998). 
This model too, may have its limitations, as CDR1 and -2 have been shown in a number 
of cases to interact with peptide instead of MHC (reviewed by Godfrey et al., 2008). 
This is the case of the immunodominant MHC class I-restricted LC13 TCR, where most 
of the energetic contribution can be attributed to CDR3 loops rather that the germline-
encoded CDR1 and -2 (Borg et al., 2005). Moreover exhaustive analysis of TCR 
structures shows that the contribution of CDR1 and CDR2 loops to MHC binding in 
terms of buried surface area (BSA) varies considerably between TCR-pMHC 
complexes. While CDR1 and CDR2 BSA upon contacting MHC is 60% on average, the 
BSA was found to be less than 50% in as many as five TCR-pMHC complexes, 
demonstrating that in some cases CDR1 and CDR2 play a lesser role in MHC 
recognition (Burrows et al., 2010). In parallel, the debate has been fuelled by numerous 
studies attempting to investigate the selection requirements of T cells during their 
development in the thymus, yet few have looked into the individual roles played by the 
CDR with regards to selection and functionality. Furthermore, most studies have been 
focusing only on single amino acid substitutions within or near the CDR (reviewed by 
Marrack et al., 2008).  
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As explained above, it had been concluded from these mutagenesis experiments 
that at least some amino acids were crucial in the context of the TCR-pMHC interaction 
and represented key conserved contact points with MHC, or “interaction codons” 
(Feng et al., 2007; Dai et al., 2008; Rubstova et al., 2009; Scott-Browne et al., 2009). 
Many interpret these results in favour of the germline theory for MHC restriction, 
arguing that the existence of conserved contact amino acids within CDR1 and -2 
supports the idea that these loops drive MHC “bias” and impose the diagonal docking 
mode of the TCR (Garcia, 2012). Our approach, however, is concerned with the role 
played by the CDR loops as a whole in the context of thymic selection. 
The purpose of this project was to establish two novel transgenic mouse lines 
expressing a mutant TCR where the CDR loops from the TCR-β chain have been 
replaced by short alanine and glycine-rich stretches, which would have lost any putative 
germline code for MHC reactivity. The first TCR-β transgenic line lacks the CDR3 
hypervariable region only, while the second lacks all three CDR regions. In parallel, we 
have also designed two additional retroviral TCR-β constructs in which CDR1 and -2 
have been exchanged with the CDR1 and -2 from Ig V gene segments in their germline 
configuration. Although antigen recognition by B cell antigen receptors and by 
antibodies is MHC-independent, recent crystal structures of a Fab fragment and of a 
TCR bound to the same pMHC complex have shown that the two receptors adopted the 
same docking orientation to bind pMHC (Mareeva, Martinez-Hackert and Sykulev, 
2008). Thus, we hypothesise that the TCR might not be so unique in its ability to react 
with MHC. We propose that the requirements for selection and maturation of a diverse, 
functional T cell repertoire are not or at least not entirely TCR-intrinsic and might be 
less strict than previously thought. In this context, the germline-encoded CDR1 and -2 
could play a role in regulating the diversification of the T cell repertoire and maturation 
of functional CD4
+
 and CD8
+
 T cells.  
In this Thesis, we aim to demonstrate: 
1. that TCR-β transgenic mice lacking germline-encoded CDR loops can be 
generated and are populated by MHC-restricted T cells, 
2. that MHC restriction is likely the result of the thymic selection process and 
is largely independent of the germline-encoded CDR, 
3. that such TCR-β transgenic mice are immunologically competent and can 
mount an MHC-restricted response against various antigens, 
4. and that the germline CDR influence several aspects of T cellular biology 
by modulating the pMHC-TCR interaction. 
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Chapter 2: Materials and Methods 
 
 
This Chapter describes the reagents and protocols used throughout the study. 
Protocols used only in specific chapters are described last. Further experimental details 
will be highlighted in relevant result sections. 
 
2.1.    Mice 
 
Mice used in this project were housed under specific pathogen-free conditions in 
the Central Biomedical Services unit at the Hammersmith Hospital, Imperial College 
School of Medicine. All animals were used in accordance with the Home Office 
guidelines, as defined by the Animal Scientific Procedures Act (ASPA, 1986). 
Both TCR-β chain transgenic lines were generated on a FVB TCR-β/δKO 
background (H-2
q
), where the disruption at the trb locus prevents expression of 
endogenous TCR-β chains (kind gift from Dr Daniel Pennington). Wildtype FVB/n 
mice were used as controls in various parts of this study (Harlan Laboratories, 
Loughborough, UK). The original FVB/n was established in the early 1970s as a strain 
carrying an allele for susceptibility to Friend virus B and has widely been used since 
then for the purpose of establishing transgenic lines (Taketo, 1991). Indeed, FVB/n 
mice usually have vigourous reproductive capacity with larger litters and show a high 
success rate with DNA pro-nuclear injection (Taketo, 1991). 
Female DBA 1/J mice (Harlan) were also used as H-2
q
 tissue donors for 
syngeneic cell transfer experiments. Wildtype B6 mice and β2m-/-, A-/- B6 mice 
(MHC
KO
) were used as H-2
b
 or H-2-deficient tissue donors respectively (kindly 
provided by Dr Jian-Guo Chai and Prof Matthias Merkenschlager). The MHC
KO
 strain 
was also used as bone marrow recipient in the experiments described in Chapter 4. 
Female rag-/- mice were used as lymphopaenic recipients (kind gift from Prof Marina 
Botto). 
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2.2.    Reagents and buffers 
 
All reagents and buffers, with the exception of those supplied as part of a 
commercial kit are listed in Table 2.1. Their composition and use are also indicated. 
 
Table 2.1. List of reagents and buffers. 
 
Reagent Composition Use 
Blood buffer 
 
PBS, 2 mM EDTA, 100U/ml heparin  Blood collection 
 
Microinjection TE 
(miTE) buffer 
10mM Tris, 0.25 mM EDTA  
in high quality water (all from Sigma) 
DNA microinjection 
 
Tris-Acetate-EDTA 
(TAE) buffer 
Supplied by the MRC (unspecified) 
 
Agarose gel 
electrophoresis 
 
Phosphate buffered  
saline (PBS) 
Made from tablets (Oxoid Ltd, Hampshire, UK) 
 
Cell suspension; 
antibody dilutions 
 
RBC lysis buffer 
(Qiagen, Hilden, 
Germany) 
Unspecified (NaCl, EDTA and sodium bicarbonate)     
 
Red blood cell lysis 
 
T cell medium  
(TCM) 
 
 
 
RPMI-1640 (Invitrogen, Paisley, UK),  
10% heat-inactivated fetal calf serum (FCS), 100μg/ml 
 penicillin, streptomycin, 2mM L-glutamine 
 2x10-5 M β2-mercaptoethanol 
Polyclonal T cell 
culture, maintenance of 
T cell clones, functional 
assays 
Transduction medium 
 
IMDM, 10% heat-inactivated FCS and 2mM L-glutamine 
 
Bone marrow 
transduction  
T cell depletion buffer 
 
 
PBS,  0.1% bovine serum albumin (BSA) 
 
 
T cell isolation from 
bone marrow 
suspensions 
Freezing medium 10% dimethylsulphoxide (DMSO) in FCS Cryopreservation 
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2.3.   TCR nomenclature 
 
The C6 TCR is specific for male antigen (HY)-derived epitope TENSGKDI from 
the smcy gene in the context of the class I MHC molecule H-2K
k
. All tr and Ig gene 
segments are described using the ImMunoGeneTics (IMGT) nomenclature 
(http://www.imgt.org/IMGTrepertoire). Accordingly, TCR-α and -β chain segments are 
designated TRA and TRB respectively, followed by the letter V, D or J. Similarly, Ig 
heavy and light chains are designated IGH and IGL, followed by the letters V, D or J. 
According to the IMGT nomenclature, the C6 TCR uses the TRAV12.2 (Vα8.3) and 
TRBV16 (Vβ11) variable gene segments.  
 
2.4.    Plasmid vectors 
 
All transgenic constructs are based on the pVA-hCD2 vector. The pVA-hCD2 
plasmid is 14,499 bp in size and contains the human CD2 promoter and locus control 
region (LCR) allowing T cell-specific, position-independent transgene expression 
(Zhumabekov, 1995).  
The Ig “retrogenic” constructs used in Chapter 7 were sub-cloned into the 
pMigR1 vector. pMigR1 is a murine stem cell virus (MSCV) retroviral vector 
containing an IRES-GFP cassette. Plasmid maps are shown in Figure 2.1. 
hCD2 
promoter
hCD2 LCR
amp ori
MCS:
BglII
XhoI
XpaI
EcoRI
pVA-hCD2
IRES-
GFP
5’ LTR
3’ LTR
amp ori
MCS:
BglII
XhoI
XpaI
EcoRI
pMigR1
 
Figure 2.1. Plasmid vectors. Plasmid vector maps are shown for pVA (top) and 
pMigR1 (bottom). The abbreviations amp and ori designate the ampicillin resistance 
gene and origin of the vector. Multiple cloning sites (MCS) are also indicated for both 
vectors, with a list of restriction sites. Other abbreviations are as follows: long-terminal 
repeat (LTR), human CD2 (hCD2), locus control region (LCR). 
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2.5.   Cell preparation 
 
Cell suspensions were prepared from appropriate organs using a cell strainer (BD 
Biosciences, Oxford, UK) and washed twice in 2 ml of PBS by spinning at 1,500 rpm 
for five minutes. Cell counts were obtained using a haemocytometer. Blood and spleen 
preparations were lysed for 30 minutes at room temperature in RBC lysis buffer 
(Qiagen). All other samples were used directly for downstream experiments and kept on 
ice at all times. 
 
2.6.    Animal procedures 
 
All animal procedures were carried out as outlined by our project licence and in 
accordance with the Home Office guidelines defined by ASPA 1986. Intravenous (i.v.) 
injections of cell suspensions were carried out with a 29-gauge insulin injector (Terumo, 
Egham, UK). Subcutaneous (s.c.) injections were done on the right flank of the animal 
using a 27-gauge sterile plastic needle (Kendall). 
 
2.7.    Flow cytometry 
 
Cell suspensions were prepared as described in Section 2.5. For each flow 
cytometry staining condition, 10
6
 cells were re-suspended in 400 μl of PBS. Specific, 
fluorochrome-conjugated antibodies were added to the cell suspension in individual 
FACS tubes (see Table 2.2. for technical information). Samples were then left to 
incubate in the dark at room temperature for 20 minutes. After incubation, cells were 
washed in 2 ml of PBS by centrifuging at 1,500 rpm for five minutes. 
The supernatant was discarded and the cell pellet re-suspended in 400 μl of PBS 
until acquisition. The samples were kept at 4ºC before being acquired on the BD 
FACSCalibur
TM
 flow cytometer using the Cellquest
TM
 Software (BD). Data analysis 
was performed on FlowJo version 5.7 (Tree Star Inc, US). 
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Table 2.2. List of monoclonal antibodies. 
 
Specificity Fluorochrome Clone 
CD127 PE A7R34 
CD19 PE-Cy5 6D5 
CD4 PerCP RM4-5 
CD40L PE MR1 
CD44 PE G44-26 
CD44 PE IM7 
CD44 PerCP IM7 
CD44 APC IM7 
CD45RB PE 16A 
CD5 PE L17F12 
CD62-L FITC MEL-14 
CD69 PE H1.2F3 
CD8α APC 53-6.7 
CD95 PE Jo2 
CTLA-4 PE UC10-4F10-11 
Foxp3 FITC FJK-16s 
IFN-γ PE 4S.B3 
IL7Rα PE A7R34 
Mac-1 FITC M1/70 
NK.1.1 FITC DX5 
TCR-β constant PE H57-597 
Thy 1.2  PerCP 53-2.1 
Thy1.1. APC 5E10 
Vα11 PE RR8-1 
Vα2 PE B20.1 
Vα3.2 PE RR3-16 
Vα8.3 PE B21.14 
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2.8.    Carboxyfluorescein diacetate succinimidyl ester (CFSE) labelling 
 
Cell samples were labelled with CFSE prior to injection or to assess proliferation 
in stimulation experiments in vitro. Up to 10
7
 cells were re-suspended in a volume of 
200 μl of sterile PBS. CFSE was then added in an equal volume whilst vortexing the 
cells. The samples were then left to incubate at room temperature for 15 minutes. To 
stop the labelling reaction, 2 ml of PBS were added to each tube and samples were then 
left on ice for another five minutes. After incubation, cells were centrifuged at 1,500 
rpm for five minutes, then washed again twice in the same fashion. For injections, cells 
are left on ice until the procedure. For proliferation assays, samples were stimulated 
with antigen for a minimum of 18 hours and analysed the next day by flow cytometry. 
 
2.9.   Bone marrow chimaeras 
 
Bone marrow was taken from donor mice sacrificed at six to eight weeks of age. 
Femur and tibiae were taken from the animal, with skin and muscle removed using a 
size 11 disposable scalpel. Bone marrow was flushed from the bone with sterile PBS 
using a 30-gauge needle. The samples were then washed in 50 ml of ice-cold sterile 
PBS and re-suspended at a concentration of 10
7
 cells/ml for T cell depletion. The T cell 
depletion procedure is described below. T cell-depleted samples were kept on ice until 
injection. Recipient mice were irradiated with 600 rad then received 2 × 10
7
 cells i.v. 
 
2.10.    T cell depletion 
 
For T cell depletion from bone marrow suspensions, anti-Thy1.1. Dynabeads® 
were used according to the manufacturer’s recommendations (Invitrogen). Briefly, 107 
donor cells were prepared in a volume of 1 ml of sterile PBS with 50 μl of anti-Thy1.1. 
beads. Samples were then incubated at 4ºC for 20 minutes before being placed in a 
magnet. The T cell-free supernatant was then taken out and distributed to a fresh tube 
for downstream use. 
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2.11.    Protocols used in Chapter 3 
 
Single and triple mutant constructs were sub-cloned from MigR1 into the pVA-
hCD2 plasmid. The TCR-β inserts were amplified by standard PCR and digested with 
restriction enzymes. The digests were then ligated into pVA-hCD2 (cut with the same 
enzyme and treated with shrimp alkaline phosphatase). The ligation was used to 
transform competent TOP10® E.coli cells (Invitrogen) and individual colonies were 
then picked for Miniprep® plasmid extraction (Qiagen) and sent for sequencing at the 
Medical Research Council Genomics Core laboratory. Samples with correct sequences 
were further purified before microinjection. All procedures are further described in the 
following sections. 
 
 
2.11.1.     Polymerase chain reaction (PCR) 
 
TCR-β chains inserts were amplified using TRBV and TRBC-specific primers in 
separate 50 μl reactions containing: 
-  1μl of template DNA, 
-  1 μl primers at a final concentration of 10 μM, 
-     1 μl deoxyribonucleoside triphosphate (dNTP) mix at 10 mM, 
-     0.5 μl Taq polymerase,  
-     1.5 μl MgCl2, 
-     1.25 μl of 1% W1,  
-     Distilled water for PCR, added for a final reaction volume of 50 μl. 
All reagents were from Invitrogen and the samples were cycled as shown is Table 2.3 
below, using the 2720 Thermal Cycler (Applied Biosystems, Wallington, UK). 
 
Table 2.3. Cycling conditions for standard PCR amplification of TCR-β chains. 
 
Number of cycles Temperature (ºC) Time (seconds) 
 
1 94 ºC 5 min 
30 94 ºC 30 sec 
30 60 ºC 30 sec 
30 72 ºC 30 sec 
1 
 
72 ºC 
 
7 min 
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2.11.2.  Bacterial Transformation 
 
TOP10® chemically competent E.coli cells were used for bacterial 
transformation, following the manufacturer’s instructions (Invitrogen). Transformation 
mixtures were plated on LB Agar plates with ampicillin and incubated overnight at 
37ºC. 
 
2.11.3.  Miniprep® and Maxiprep® DNA extraction 
 
Following bacterial transformation, individual colonies obtained from LB Agar + 
amp plates were picked and grown further in 5 ml of LB Broth medium with ampicillin. 
Plasmid DNA extraction from these cultures was performed following overnight 
incubation using the Quicklyse Miniprep® kit (Qiagen). For large scale extraction, the 
EndoFree Plasmid Maxi® kit was used instead (Qiagen). 
 
2.11.4.  DNA digestion with restriction enzymes 
 
For digestion of 1 μg of DNA, Restriction digestion samples were prepared as 20 
μl reaction volumes containing 2 μl of 10X restriction enzyme buffer, and 4 units (U) of 
enzyme in distilled water (all from New England Biolabs, Herts, UK). 
 
2.11.5.  DNA dephosphorylation 
 
Cut pVA-hCD2 samples were dephosphorylated using shrimp alkaline 
phosphatase (SAP) following the manufacturer’s recommendations (Promega, 
Southampton, UK). Restriction-digested pVA-hCD2 samples in water were incubated 
with 1U/μg of in SAP in a total reaction volume of 30 μl. The reaction was left to 
incubate at 37ºC for 15 minutes then heated at 65ºC for another 15 minutes. The 
samples were then used directly for downstream application or stored at -20ºC. 
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2.11.6.  Agarose gel electrophoresis 
 
Electrophoresis gels were prepared as 1% agarose powder (Invitrogen) dissolved 
in TAE buffer. For DNA visualisation, Sybr®Safe was added before allowing the gels 
to set (Invitrogen). Samples were allowed to run at 90V on the gel along with 5 μl of 
DNA hyperladder (Bioline, London, UK). Gels were visualised under the Gel Doc
TM
 
gel analyser using the Quantity One software, v.6.3 (Bio-rad, Hertfordshire, UK). 
 
2.11.7. TOPO® ligation 
 
TOPO® TA ligations were carried out according to the manufacturer’s 
recommendations (Invitrogen). 0.5 to 4 μl of PCR product were added to 1 μl of 
TOPO® vector and 1 μl of saline solution, then incubated at room temperature for 5 
minutes. Samples were then used for downstream applications or stored at -20ºC. 
 
2.11.8.  T4 ligation 
 
Ligations were performed using the T4 ligase kit (Invitrogen) according to the 
manufacturer’s protocol. Restriction-digested target insert and vector are mixed a 5:1 
molar ratio to allow for efficient ligation. Ligation mixtures were stored at -20
o
C. 
 
2.11.9.  DNA gel extraction and purification of DNA for microinjection 
 
Prior to pro-nuclear microinjection, DNA samples were prepared to high purity 
and re-suspended at a final concentration of 2 ng/μl. Samples were first purified by gel 
extraction. DNA fragments run on agarose gels were excised using a size 11 disposable 
scalpel and purified using the Qiaex II® Gel extraction kit (Qiagen).  Samples were 
further purified by ethanol purification. Briefly, 50 μg of DNA were re-suspended in 
absolute ethanol and 5.3 M sodium acetate. The samples were then incubated overnight 
at -20ºC. The following day, the DNA was centrifuged for ten minutes and washed in 
70% ethanol twice. Finally, the samples were loaded in a CoStar SpinX 0.22 μm 
cellulose acetate cartridge (Corning, Amsterdam, The Netherlands) and centrifuged for 
ten minutes in a tabletop micro-centrifuge, before being re-suspended in twice-filtered 
miTE buffer. To avoid unnecessary freeze-thaw cycles, the final purification steps were 
performed on the day of the pro-nuclear injection procedure. 
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2.12.  Protocols used in Chapter 5 and Chapter 6 
 
This section describes the protocols used to characterise the immune response to 
experimental antigenic challenge in single and triple mutant mice. Specific 
immunisation regimens will be further described in relevant sections. 
 
2.12.1.   Antigenic proteins, peptides and adjuvants 
 
Hen egg lysozyme (HEL) is the protein antigen used throughout the study for 
immunisation of 6 week-old female mice. HEL is a 129 amino acid protein which has 
been extensively used as a common, inexpensive reagent for immunisation. HEL 
(Sigma, Poole, UK), HEL-derived peptides (GL Biochem, Shanghai, China) or Epstein-
Barr virus nuclear antigen 1 (EBNA-1) were used in combination with adjuvants 
(Sigma), as described in Table 2.4. Phorbol 12-myristate 13-acetate (PMA) and 
ionomycin stimulation was used as positive control (both from Merck-Millipore). PMA 
is a potent activator of protein kinase C and ionomycin is a calcium ionophore. In T 
lymphocytes, combined PMA + ionomycin stimulation induces TCR-independent 
activation of polyclonal populations. 
 
Table 2.4. List of antigens and adjuvants. 
 
Reagent Composition Final concentration 
HEL  95% pure HEL  7 nmol 
HEL peptides 15-mers overlapping by 10 amino acids 7 nmol each 
EBNA-1  15-mers overlapping by 11 amino acids 6 nmol each 
PMA 99% pure PMA 1 ng/ml 
Ionomycin 99% pure ionomycin 1 μM 
Complete Freund’s adjuvant (CFA) 
 
 
85% paraffin in mannide monooleate with 
1 mg/ml heat-killed M. tuberculosis    
Diluted 1:1 
 
Incomplete Freund’s adjuvant (IFA) 85% paraffin in mannide monooleate Diluted 1:1 
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All proteins and peptides prepared in sterile PBS were emulsified in adjuvant by 
vortexing for 50 min at 4ºC. Each mouse received 200 μl of emulsion administered s.c. 
on the right flank using a 29-gauge needle. Of note, HEL peptides were supplied in 
lyophilised form and were re-suspended in DMSO for long-term storage. However, 
serial dilutions were carried out so that the final concentration of DMSO was 0.01% 
prior to immunisation. EBNA-1 was supplied as sterile solution and diluted according to 
the manufacturer’s recommendations (Miltenyi). 
 
2.12.2.  MIP-1β Enzyme-Linked Immunosorbent Assay (ELISA) 
 
ELISA for murine MIP-1β expression were carried out to assess cytokine 
production in response to in vitro HEL challenge, using a murine MIP-1β mini kit 
(Peprotech, Germany). All reagent dilutions were performed following the 
manufacturer’s instructions. MaxisorpTM plates (Thermo Fisher Scientific, Germany) 
were coated with 50 μl of capture antibody and incubated overnight at room 
temperature. The following day, plates were washed four times with PBS with 0.05% 
Tween-20. The plates were then blocked with PBS containing 1% BSA. After one hour 
incubation, plates were washed again as before and samples and standards were plated 
in duplicates before being left to incubate for two hours at room temperature. All wells 
were then washed again, 50 μl of detection antibody added and plates incubated for 
another two hours at room temperature. After another washing step, 50 μl of horseradish 
peroxidise were added to each well for a 20 minute incubation. Finally, the plates were 
developed by adding the TMB substrate for about 20 minutes. The plates were 
monitored until full colour development, where the reaction was stopped by addition of 
50 μl of 2N sulphuric acid (R&D Systems, Minneapolis, USA). The plates were read 
immediately by assessing light absorbance at two different wavelengths, 450 and 540 
nm, with the Spectra Max M2 plate reader (Molecular Devices, USA). The absorbance 
values, standard curves and sample concentrations are obtained using the SoftMax pro® 
software v5.4 (Molecular Devices). 
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2.12.3.     Enzyme-linked Immunospot (ELISpot) assay 
 
ELISpot assays for murine IFN-γ expression were carried out to assess cytokine 
production in response to in vitro HEL challenge, using a murine IFN-γ ELISpot kit 
(Genprobe-Diaclone, Besançon, France). All reagent dilutions were performed 
following the manufacturer’s instructions. PVDF 96-well plates (Millipore, Watford, 
UK) were activated with 70% ethanol then coated with 100 μl of capture antibody at a 
final concentration of 10 μg/ml. Plates were left to incubate overnight a 4ºC then 
washed six times with sterile PBS. The ELISpot plates were then blocked by addition of 
PBS with 2% powdered milk or with the supplied sterile liquid milk and incubated for 
an hour at room temperature. All wells were then emptied by flicking the plates and 
tapping them onto absorbent paper and subsequently, 10
5
 responder cells were added to 
each well along with HEL. HEL solution was prepared at a final concentration of 1 
μg/μl (equivalent to 7 nmol per 100 μl volume dispensed in each well). Plates were 
incubated at 37ºC and 5% CO2 overnight. After incubation, the plates were washed six 
times with 100 μl PBS with 0.1% Tween-20. The biotinylated detection antibody was 
added and following a two-hour incubation, the plates were again washed six times as 
before. 100 μl of streptavidin-alkaline phosphatase was added into each well and 
incubated at 37ºC and 5% CO2 for one hour. To develop the plates, the chromogen was 
prepared fresh for each experiment and 100 μl added to the wells. Spot formation was 
monitored visually until the plates were washed under running distilled water. Plates 
were allowed to dry overnight before reading, and spot-forming cells were visualised 
using the AID ELISpot plate reader (AID Diagnostika, Germany).  
 
2.12.5.   Mixed lymphocyte reaction (MLR) 
 
Splenocytes from single and triple mutant mice were prepared as described on 
Section 2.5 and used as responder cells in MLR. The frequency of alloreactive T cells in 
the repertoire is remarkably high; therefore, the MLR setup does not require in vivo 
immunisation. CFSE-labelled responder cells were plated in triplicate with different 
doses of allogeneic stimulator cells for a final responder to stimulator ratio of 1:3, 1:5 or 
1:10 in a flat-bottomed 96-well plate. Samples were harvested, and analysed for CFSE 
dilution by flow cytometry at two different time points. 
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2.13.  Protocols used in Chapter 7 
 
This section describes the experimental procedures used for the generation of 
retroviral constructs encoding a TCR-β chain in which CDR1 and CDR2 loops have 
been exchanged for germline antibody hypervariable regions. 
 
2.13.1. Maintenance of the Phoenix
TM
 packaging cell line 
 
The Phoenix cell line was kindly provided by Dr Caroline Addey. Phoenix cells 
were plated at 2 × 10
6
 cells/ml in 20 ml transfection medium supplemented with 
penicillin and streptomycin and incubated at 37ºC with 5% CO2. The cells are 
trypsined, washed and split every three days. 
 
2.13.2.   Lipofectamine-based transfection of Phoenix
TM
 ecotropic cells 
 
Phoenix
TM
 ecotropic cells were plated at 10
5
 cells/ml in 2 ml of transduction 
medium and incubated at 37ºC and 5% CO2. To optimise transduction efficiency, the 
transduction medium did not contain antibiotics (Table 2.1). The following day, the 
medium was replaced and cells were transfected with 3 μg of retroviral construct along 
with 1 μg of helper vector pCLE. The LipofectamineTM 2000 transfection step was 
performed according to the manufacturer’s instructions (Invitrogen). Briefly, target and 
helper DNA were prepared in 250 μl Opti-MEM medium and 10 μl LipofectamineTM 
were added to 250 μl of the same medium then left at room temperature for 20 minutes. 
Both mixtures are then merged for a final transfecting solution volume of 500 μl, left to 
incubate at room temperature for another 20 minutes. The transfection mixture is ten 
added to each well and plates are left to incubate overnight at 37ºC in 5% CO2. 
On day 3, viral supernatant was removed from individual wells and used to 
transduce target cells as described below. In parallel, Phoenix cells were harvested to 
estimate transfection efficiency using GFP fluorescence. Briefly, Phoenix
TM
 cells are 
trypsinised for five minutes at room temperature then washed twice in PBS 
supplemented with 10% FCS.  Samples are distributed to FACS tubes and analysed 
immediately by flow cytometry. 
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2.13.3.    Transduction of murine HSC 
 
Bone marrow was harvested from the femur and tibiae of donor mice as described 
in Section 2.9. Cell suspensions were washed and plated at 1.5 × 10
6
 cells/ml in 2ml of 
transduction medium in the presence of recombinant mouse IL-3 (20 ng/ml), IL-6 (10 
ng/ml), SCF (50 ng/ml) and recombinant human Flt3-L (50 ng/ml). All were from 
Invitrogen. The medium was replaced on day 2, then three to four hours before 
transduction the following day. For transduction, cells were re-suspended in 1.5 ml of 
viral supernatant and 4 μg of polybrene (Invitrogen) and centrifuged for 90 minutes at 
2,000 rpm, room temperature. After centrifugation, plates were incubated overnight at 
37ºC and 5% CO2. Donor cells were analysed by flow cytometry to assess the efficiency 
of transduction, as measured by GFP expression. 10
5
 GFP
+
 donor cells were injected i.v. 
into 5’-fluorouracil-treated recipients.  
 
2.14.  Statistical analysis 
 
Inter-group variations were analysed by two-tailed, unpaired t-tests using 
GraphPad Prism 5 (GraphPad Software Inc., La Jolla, USA). All results are shown 
graphically as mean and standard error of the mean (SEM). P values are given for 95% 
confidence intervals as follows: p < 0.0001 (****) extremely significant; p < 0.001 
(***) extremely significant; p < 0.01 (**) very significant; p < 0.05 (*) significant; p > 
0.05 not significant (ns). 
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Chapter 3 
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Chapter 3: Generation of transgenic mouse lines lacking T cell 
receptor complementarity-determining regions 
 
 
 
 
3.1.   Background 
 
The pre-selection T cell repertoire contains a relatively high frequency of TCR 
that can recognise MHC (Merkenschlager et al., 1997; Zerrahn et al., 1997). This 
observation has led to the formulation of the “germline theory” for MHC restriction 
(reviewed by Garcia, 2012). Accordingly, MHC restriction is an evolutionarily 
conserved feature of the TCR and is encoded in the germline sequences of the V gene 
segment, or in other words, within CDR1 and CDR2. As described in the Introduction, 
several functional and structural studies conducted by Marrack et al. and by Garcia et 
al. have shown that conserved amino acids in these regions are involved in the 
interaction with MHC (Feng et al., 2007; Dai et al., 2008; Scott-Browne et al., 2009; 
Garcia et al., 2009; Scott-Browne et al., 2011; reviewed by Marrack et al., 2008 and by 
Garcia, 2012). These authors suggested that in any given V segment, conserved amino 
acids recognised key determinants in specific MHC variants and these pairwise contacts 
were termed “interaction codons”. In contradiction to the germline theory for MHC 
restriction, Tikhonova et al. (2012) recently demonstrated that the same amino acids 
were also required for recognition of non-MHC ligands and might in fact be involved in 
promoting general protein-protein interaction rather than specific reactivity with MHC. 
A series of studies conducted by the same authors suggests that MHC reactivity is under 
the control of the T cell co-receptors, which engage the invariant domains of MHC 
molecules (Van Laethem et al., 2007, Tikhonova et al., 2012 and reviewed by Van 
Laethem et al., 2012). Casting further doubt over the role of these putative “interaction 
codons” in recognition of pMHC, Stadinski et al. (2011) showed that these amino acids 
recognised different contact residues within MHC ligands. Thus, the role of these 
“interaction codons” is still controversial. 
While such studies were focused on the role of single amino acids in the context 
of the TCR-pMHC interaction, the approach we adopted for this project was concerned 
with the role played by the CDR loops as a whole in the context of thymic selection and 
the generation of T cells that are MHC-restricted. 
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3.1.1. Use of TCR transgenic mouse lines 
 
TCR transgenic mouse lines have been used extensively in T cell biology, 
particularly to circumvent the difficulties associated with the complexity of the T cell 
repertoire. Analysis of T cell specificity, selection and activation within polyclonal 
populations has long been hindered by experimental considerations. Until the 
development of the first TCR transgenic mouse in 1988 by Van Boehmer et al., analysis 
of clonotypic specificity in the context of thymic selection required animals immunised 
with a model antigen in order to increase the frequency of cells with single specificity. 
This approach, being based on mature T cell activation, is inherently flawed when 
attempting to dissect the requirements of developing thymocytes. The pMHC ligands 
that activate T cells in the periphery are not necessarily selecting ligands for DP cells. In 
fact, the requirements for activation of peripheral T cells and for selection of 
thymocytes are almost invariably different (Alam et al., 1996; Alam et al., 1999; Juang 
et al., 2010). Usually the antigenic peptides that induce peripheral T activation will 
delete thymocytes whereas sub-optimal ligands are compatible with selection (Hogquist 
et al., 1994b; Sebzda et al., 1996). 
The transgenic system developed by Van Boehmer et al. was a HY-specific H-
2D
b
-restricted line in which female mice could be used to study positive selection of 
HY-specific T cells, while negative selection and central tolerance could be examined 
by comparing males and females (Van Boehmer, Teh and Kisielow, 1989). Thus, as 
opposed to the immunisation approach described above, the TCR transgenic mouse 
allows the examination of single specificity in the steady state (Kisielow et al., 1988).  
 
          3.1.2. Single chain TCR transgenic mice  
 
Mice transgenic for a TCR-β chain or a TCR-α chain have also been described 
(Ferreira et al. 2006; Baldwin et al., 2005; and reviewed by He, Viret and Janeway, 
2002b). In TCR-α chain transgenic mice, as well as αβ transgenic animals, the timing of 
α chain expression is inappropriate and leads to premature deletion of thymocytes. 
Moreover, early TCR-α expression has also been shown to result in the generation of T 
cells that are phenotypically TCRαβ positive but resemble γδ T cells functionally and 
transcriptionally (Buer et al., 1997; Terrence et al., 2000; Baldwin et al., 2005; 
Krevslavsky et al., 2008).  
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The prematurely expressed TCR-α chain is thought to interfere with normal 
thymocyte development because it prevents the dimerisation of the pre-TCR, as TCR-β 
chains have higher affinity for TCR-α than for pTα (Trop et al., 2000). In addition, 
TCRαβ expressed at the DN stage are inefficient mediators of β-selection (Borowski et 
al., 2004). In TCR-β transgenic mice, such as the ones used in this study, timing of β 
chain expression allows for normal pairing with the pre TCR-α chain and β selection at 
the DN3 stage. At the DP stage, the transgenic chain pairs with endogenous TCR-α 
partners to form true TCRαβ heterodimers (Fehling and von Boehmer, 1997). Thus, the 
functional and phenotypic differences observed in TCR-α and αβ transgenic animals do 
not hold for TCR-β transgenic systems because these differences are largely attributable 
to TCR-α expression patterns (Baldwin et al., 2005). 
Previous work carried out in our laboratory involved the use of TCR-β deficient 
mice injected with retrovirally transduced HSC (Holland et al., 2012). These HSC 
carried TCR-β chains with CDR loops replaced with various mutant sequences. These 
so called “retrogenic” mice have proven useful for dissecting the role of the CDR in a 
relatively short timeframe. However, there are several shortfalls to this approach and the 
transgenic system may be more suited to the type of work undertaken in this project. 
For example, the “retrogenic” mouse is typically an adult mouse established on a T cell 
deficient background, with an atrophied thymus, even after reconstitution of the T cell 
compartment by the donor TCR-β chain. The generation of CD4+ and CD8+ T cells in 
this setting is often accompanied by homeostatic expansion and by a shift towards an 
effector-like phenotype. In our hands, some “retrogenic” mice, but not all, even display 
autoimmune symptoms, including weight loss and changes in skin histology as well as 
secretion of class-switched auto-antibodies. Because autoimmunity did not arise 
systematically in all mice, we reasoned this was likely unrelated to the nature of the 
TCR-β chains we used. As shall be illustrated in this Chapter and others, the transgenic 
system avoids these issues altogether because the donor TCR-β chain is expressed 
during development at the appropriate stage, as opposed to being abruptly introduced in 
adult life. 
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         3.1.3. Aims 
 
This Chapter describes the design of the C6β single and the C6β triple transgenes 
and the establishment of the two transgenic mouse lines used in this project (hereafter 
referred to as “single” and “triple” mutants). As explained in Chapter 2, in the single 
mutant, only the hypervariable CDR3 loop has been exchanged for a glycine and 
alanine-rich linker while in the triple mutant, all three CDR have been replaced. This 
system is the first to make changes of this scale and is set to bring about further 
knowledge regarding the roles played by the germline-encoded loops and the junctional 
CDR3 in pMHC recognition. 
In this Chapter, we show how the successful expression of these transgenes 
restores the T lymphocyte compartment in an otherwise T-lymphopaenic mouse strain. 
This section will focus on the preliminary phenotypic characterisation of the single and 
triple mutant mice, and the distribution of T cell sub-populations in the thymus. 
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3.2.   Results 
 
          3.2.1.    Preparation and purification of DNA for microinjection 
 
The single and triple mutant transgenes were prepared as described in Chapter 2 
by sub-cloning the TCR-β chain inserts of interest from a MigR1 vector (available in 
our laboratory prior to the start of this study) to pVA-hCD2. Briefly, TCR-β chains 
were amplified using TRBV and TRBC specific primers containing restriction sites for 
cloning into pVA-hCD2. The products were purified by gel extraction, digested, then 
ligated to pVA-hCD2 vector treated with the same restriction enzymes and with 
phosphatase. Due to the large size of the vector, the insert to vector molar ratio was 5:1. 
For optimal ligation, we set the total DNA amounts to 150 fmol of insert and 30 fmol of 
vector. To check for ligated constructs, ligation reactions were transformed into 
competent E.coli; the bacteria were grown overnight and colonies were picked for 
Miniprep® DNA extraction. The Miniprep® samples were digested with same 
restriction enzymes as before, and loaded onto a 1% agarose gel, as shown in the 
example in Figure 3.1 (left).  Samples containing the insert of interest were stored and 
used again for a Maxiprep®. All DNA sequences were confirmed at the MRC 
Genomics Laboratory. 
Vector sequences were further digested with NotI and XhoI cutting at the 5’ end 
of the pVA-hCD2 promoter sequence and the 3’ of the pVA-hCD2 LCR (Figure 3.1, 
right). The digestion reactions were run on an agarose gel and the relevant fragments 
were excised from the gel, further purified twice by ethanol precipitation to reduce 
toxicity and re-suspended in miTE buffer at a final concentration of 2 ng/μl. To avoid 
unnecessary freeze-thaw cycles, the final purification steps were performed on the day 
of the pro-nuclear microinjection procedure. 
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       A)             Single   Triple                         B)                        Single                              Triple 
                                                                                          1        2       3         4       1       2        3        4 
                                
 
 
Figure 3.1. Agarose gel electrophoresis of single and triple transgenes. A) TCR-β 
chain inserts (997 kb) were purified by gel extraction and analysed by electrophoresis 
before ligation. B) After ligation, vector sequences were excised by restriction digestion 
with NotI and XhoI. Lanes1 and 2 represent single digestions with NotI and XhoI 
respectively, 3 is the double cut, and 4 is a control undigested sample. All samples were 
loaded in glycerol loading buffer and run for 45 minutes at 90V. 
 
 
 
A sequence alignment of the single and triple mutant, together with a reference 
sequence for the triple mutant, is shown in Figure 3.2. The reference sequence was 
obtained from Stephen Holland. Previous studies carried out in our laboratory focused 
on retroviral constructs of single or double mutant C6 TCR-β chains lacking CDR1, 
CDR2 or both. The original C6 TCR is specific for the HY-derived epitope TENSGKDI 
from the smcy gene in the context of the class I MHC molecule H-2K
k
. According to the 
IMGT nomenclature, the C6 TCR uses the TRAV12 (Vα8.3) and TRBV16 (Vβ11) 
variable gene segments. 
 
 
 
 
1 kbp 
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Figure 3.2. TCR-β sequence alignment. A) Full length TCR-β chain transgenes are shown as a sequence alignment. Mutated sequences are indicated 
by the red boxes. A reference sequence of a CDR1 and CDR2 double mutant TCR-β chain is also included. B) Schematic representation of the single 
(top) and triple (bottom) mutant TCR- β chain transgenes.
A) B) 
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The single mutant used in this study only has the mutant CDR3 sequence 
CASSGGGT, together with wild-type C6 CDR1 and CDR2 loops. In the triple mutant 
TCR-β chain, the CDR1 and -2 loops were additionally replaced with the sequence 
GAGA or AGAG, respectively. One important feature in both mutants is thus the 
reduced CDR3 length, due to deletion of seven residues originally present in the C6 
TCR-β chain (Figure 3.2). The C6 CDR3 is known to be above the usual range of 
CDR3 lengths (personal communication, Prof Julian Dyson). We therefore opted to 
reduce CDR3 length in both mutants to exclude the possibility that the unusually long 
CDR3 will interfere with selection. 
These structural changes therefore produce CDR loops that are both shorter than 
the native C6 TCR-β chain and unrelated in sequence. The tyrosine at position 55 
(Y55), which is part of the CDR2 framework region, is highly conserved across species 
including the mouse, goat, man, night monkey and rhesus macaque (IGMT website).  
Y55 has previously been identified by Scott-Browne et al. (2009) as one of the putative 
“interaction codons” supporting germline-encoded MHC specificity. It is important to 
note that in the triple mutant used in this project Y55 is deleted.  
 
 
 3.2.2.    Establishment of transgenic mouse lines 
 
Pro-nuclear microinjections were carried out by the Transgenesis unit in the 
Clinical Sciences Centre of the Medical Research Council on ten pseudo-pregnant 
females for each transgene. First generation founders were screened by blood sampling 
and staining with anti-CD4, CD8 and TCR-β chain constant region fluorochrome-
conjugated monoclonal antibodies. Two founders for each transgenic line were initially 
obtained, all of which were males. All founders were bred against the FVB TCR-β/δKO 
background. All transgenic mice and their FVB TCR-β/δKO partner bred well, yielding 
large litters for a minimum of six months. 
In both lines the transgene was transmitted with low frequency following pro-
nuclear injection, presumably due to partial transgenesis in germ cells. Transmission 
was closer to the expected 50% rate in the offspring of heterozygous F1 carrier × FVB 
TCR-β/δKO crosses (Table 3.1). Following this initial screen, we sacrificed the lines 
with lowest transmission rates (single mutant founder 2; 31% and triple mutant founder 
2; 41%) and preserved the lines with transmission rates closer to the expected 50% 
(single mutant founder 1; 45% and triple mutant founder 1; 47%). 
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Table 3.1. Screening results from single and triple mutant mice. A) Blood sample 
screen of litters from FVB TCR-β/δKO females receiving pro-nuclear injection with 
single or triple mutant transgene. B) Blood samples screens from crosses involving 
single and triple mutant founders bred against FVB TCR-β/δKO. The (+) signs refer to 
heterozygous carriers, (-) indicates non-carriers. The transmission rate is calculated as 
the ratio [transgene
+
 / total number of mice]. 
 
A) 
 
 
Transgene+ Transgene- Total %Transgene+ 
Single mutant, first litter 2 36 38 5% 
Triple mutant, first litter 2 42 44 5% 
 
B) 
 
 
Transgene+ Transgene- Total %Transgene+ 
Single Founder #1 × FVB TCR-β/δKO 38 47 85 45% 
Single Founder #2 × FVB TCR-β/δKO 24 54 78 31% 
Triple Founder #1 × FVB TCR- β/δKO 21 24 45 47% 
Triple Founder #2 × FVB TCR-β/δKO 14 20 34 41% 
 
 
 
 
 
          3.2.3. The single and triple mutant TCR-β chains restore the peripheral T cell 
compartment in FVB TCR-β/δKO mice 
 
FVB TCR-β/δKO mice used in this study have a disruption at the trb locus 
implying that T cells can only develop in such mice after successful expression of a 
transgenic TCR-β chain and pairing with endogenous TCR-α chains. In single and triple 
mutant mice, expression of the TCR-β chain should occur at the DN stage under the 
control of the human CD2 promoter and LCR. Accordingly, we anticipate that T cell 
development should proceed normally, resulting in the generation of T cells expressing 
the transgenic TCR-β chain together with a full endogenous TCR-α repertoire. Thus, 
against the FVB TCR-β/δKO background, the mere presence of triple mutant T cells will 
indicate that T cell development and selection have taken place independently of the 
germline-encoded CDR loops. 
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To confirm transgenic TCR-β expression in the founding generation, blood 
samples were taken from the tail vein, lysed and stained with fluorochrome-conjugated 
monoclonal antibodies against CD4, CD8 and TCR-β constant region (Figure 3.3). As 
indicated above, two mice from each line were indentified that expressed the transgenes. 
In all four transgenic carriers, CD4
+
 and CD8
+
 T cells were present and as expected 
TCR-β expression was detected in both subsets, indicating that T cells expressing the 
single or triple mutant TCR-β chains can be selected to the periphery. Therefore, we 
conclude that mutating CDR3 alone or all three CDR loops does not impede synthesis, 
expression and pairing of the TCR-β chain with endogenous α chains. Both transgenic 
TCR-β chains are detectable in single and triple mutant mice at six weeks of age, 
allowing them to restore the T cell compartment, including both CD4
+
 and CD8
+
 T cells 
subsets. 
 
 
 
 
 
       FVB TCR-β/δKO                  Single mutant founder             Triple mutant founder 
 
 
 
 
 
Figure 3.3. The peripheral T cell pool is restored in single and triple mutant 
founder mice. Blood was taken from the tail vein then diluted in RBC lysis buffer. All 
samples were then washed and stained with fluorochrome-conjugated monoclonal 
antibodies against CD4, CD8 and TCR-β. Flow cytometry profiles are generated from 
the lymphocyte gate and representative of the two founders for each mouse line.  
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All mice were then routinely screened by flow cytometry. Blood samples were 
taken from the tail vein, lysed and stained as before. The screening data are summarised 
in Figure 3.4. The percentages of CD4
+
 and CD8
+
 T cells were reduced in peripheral 
blood lymphocytes from triple mutant mice compared to single mutants (p < 0.0001 
both for CD4
+
 T cells and CD8
+
 T cells). The reduction in the CD4
+
 T cell compartment 
is more pronounced than that of CD8
+
 T cells, resulting in smaller CD4
+
 to CD8
+
 T cell 
ratios in the triple mutant (p < 0.0001). 
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Figure 3.4. Distribution of CD4
+
 and CD8
+
 T cells in peripheral blood 
lymphocytes. Blood samples were processed as described above. A)  The progeny of 
one single and one triple mutant breeding pair is shown, (n = 38 for single and  for triple 
n = 39) mutants are shown, the non-transgenic FVB TCR-β/δKO animals had less than 
1% CD4
+
 and CD8
+
 T cells in all cases (not shown). B) The CD4 to CD8 ratio is 
calculated as [% CD4
+
 T cells / % CD8
+
 T cells].  
A) 
B) 
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3.2.4.     The distribution of thymocyte subsets is altered in triple mutant mice 
 
 
We showed in the previous section that the frequency of CD4
+
 and CD8
+
 T cells 
was diminished in the periphery of triple mutant mice. We therefore sought to confirm 
whether this reduction in T cell populations was apparent earlier in T cell ontogeny by 
analysing thymocyte populations. Thymi were taken from six-week old single (n = 9) 
and triple mutant female (n = 10) mice. FVB TCR-β/δKO are devoid of thymocytes and 
therefore have an atrophied thymus. The thymi harvested from single and triple mutant 
mice were typically larger than those from FVB TCR-β/δKO (p < 0.0001). However, the 
total thymic cellularity in the triple mutant was significantly reduced compared to the 
single mutant mice (p < 0.0001), as seen in Figure 3.5. 
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Figure 3.5. Thymic size and cellularity in single and triple mutant mice. Thymi 
were harvested from six-week old female single (n = 9) and triple mutant mice (n = 10), 
as well as FVB TCR-β/δKO (n = 6). Cell suspensions were prepared as described in 
Chapter 2. A) Thymus size was measured in six week old single (left) and triple (right) 
female mice. B) Total thymic cellularity was determined from the same animals and 
compared to FVB TCR-β/δKO. 
FVB TCR-β/δKO 
        Single 
FVB TCR-β/δKO 
       Triple 
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Thymocyte suspensions were stained with anti-CD4 and anti-CD8 fluorochrome-
conjugated monoclonal antibodies and analysed by multicolour flow cytometry, 
providing us with more valuable information on the DN, DP and SP subsets. As shown 
in Figure 3.6, the distribution of these populations differed dramatically between the 
single mutant (n = 26) and the triple mutant (n = 13) strain. The earliest T cell 
precursors, or DN cells, accumulated significantly in the triple mutant (p = 0.0090), 
with no change in the frequency of DP thymocytes, indicating a partial block at the DN 
stage of T cell development in these mice. There was also a significant reduction in the 
frequency of CD4
+
 (p = 0.0003) and CD8
+
 SP thymocytes (p = 0.0072), which is 
suggestive of poorer selection efficiency affecting both the CD4
+
 and the CD8
+
 T cell 
compartments. Thus, the differences observed above in the blood arise from events 
taking place in the earliest stages of T cell development.  
 
 
                   
                                                                                    
%
 L
ym
p
h
o
cy
te
s
DN
 S
in
gl
e
DN
 T
rip
le
DP
 S
in
gl
e
DP
 T
rip
le
SP
4 
Si
ng
le
SP
4 
Tr
ip
le
SP
8 
Si
ng
le
SP
8 
Tr
ip
le
0
20
40
60
80
100 ** *** **
 
     
Figure 3.6. Distribution of thymocyte subsets in single and triple mutant mice. 
Thymocyte suspensions from six-week old female mice were stained with monoclonal 
antibodies against CD4 and CD8. A) Flow cytometry plots are generated from the 
lymphocyte gate and are representative of single (n = 26) and triple mutant mice (n = 
13). B) A summary graph is presented as percentage of the lymphocyte gate. C) The DP 
to DN ratio is calculated as [ % DP / % DN cells]. The CD4
+
 to CD8
+
 T cell ratio is 
calculated as [ % CD4
+
 SP cells / % CD8
+
 SP cells]. The mean and SEM were 
calculated and rounded up to the first decimal place. 
DP to DN ratio 
Single Triple 
11.9 7.5 
+ 5.2 + 2.9 
  CD4 to CD8 ratio 
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3.2.5.   The efficiency of thymic selection is altered in triple mutant mice 
 
In a normal setting, DP thymocytes expressing the true TCRαβ at their surface are 
subjected to MHC-dependent thymic selection. T cells that do engage MHC are able to 
induce T cellular signalling and in turn, up-regulate CD5 (Azzam et al., 1998). CD5 has 
widely been used as a marker for DP thymocytes that successfully ligate to MHC 
ligands and CD5 levels correlate with TCR affinity for the selecting ligand (Love, Lee 
and Shores, 2000). 
As described above, in triple mutant mice the frequency of DP thymocytes 
remains unaffected despite the accumulation of DN precursors. Subsequently, both 
CD4
+
 and CD8
+
 SP thymocyte populations are reduced in size. Thus, to gather further 
insight into the selection requirements in triple mutant mice, we looked at CD5 
expression levels as marker of TCR signal strength. We reasoned that the reduction in 
SP thymocytes in triple mutant mice might be the result of abnormal selection. Indeed, 
reduced SP thymocyte frequency could be the consequence of poorer positive selection. 
Alternatively, this could also result from enhanced negative selection.  
To test this, thymocyte suspensions from six-week old female single (n = 13) and 
triple mutants (n = 8) were stained for CD5 expression (Figure 3.7).  We also stained 
thymocytes from FVB TCR-β/δKO as negative control (n = 6).  As shown in Figure 3.7, 
the frequency of CD5-expressing cells was only altered at the DN stage (p = 0.0271). 
CD5 was expressed on 72% ( + 3.3) DN cells in single mutant mice and 54% ( + 8.3) in 
triple mutants. At this stage, changes in CD5 expression are mostly the result of pre-
TCR signalling (Azzam et al., 1998). We noted an increase in the frequency of CD5-
expressing cells in all subsequent stages of T cell development, where virtually all T 
cells expressed CD5 in both mutants. The increase in CD5 expression starting at the DP 
stage in single and triple mutant mice indicates that DP cells from the two mouse lines 
are equally successful in engaging with selecting ligands.  
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To understand how CD5 expression is altered at the single cell level, the mean 
fluorescence intensity (MFI) was computed for CD5-expressing cells within the DN, 
DP, and SP subsets. CD5 MFI was consistently higher across all thymocyte 
development stages in the triple mutant starting from DP cells (not significant in DN 
cells). At the DP stage, when selection takes place, mean CD5 levels in triple mutant 
mice were increased almost three-fold compared to single mutants (p < 0.0001). In the 
SP populations, there was also a two-fold increase for CD4
+
 SP cells and a three-fold 
increase for CD8
+
 SP cells (p < 0.0001 in both cases). 
 
 
        A)         FVB TCR-β/δKO                       Single                              Triple  
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Figure 3.7. CD5 expression on thymocytes from single and triple mutant mice. 
Thymocyte suspensions from FVB TCR-β/δKO (n = 6), single (n = 13) and triple mutant 
mice (n = 8) were stained for CD5 expression. A) Representative  histograms with CD5 
expression gated on DN (grey line), DP (dotted), CD4
+
 SP (red) and CD8
+
 SP cells 
(black). B) Summary graph indicating the frequency of CD5-expressing cells. C) 
Summary graph representing CD5 MFI in DN, DP, and SP thymocytes from single and 
triple mutant mice. 
CD5 
B) C) 
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Thus, a similar fraction of thymocytes is able to engage selecting ligands in the 
thymi of single and triple mutant mice at the DP stage. However, increased CD5 MFI 
from the DP stage in the triple mutant indicates that T cells expressing the TCR 
heterodimer induce stronger signals in response to selecting ligands and in turn, express 
higher levels of CD5. Not only are the CDR1 and CDR2 loops dispensable for 
thymocyte development, DP cells lacking these loops are in fact more efficient at 
engaging selecting ligands. Therefore, we conclude that the reduction in SP thymocytes 
in triple mutant mice is the result of enhanced negative selection rather than poorer 
positive selection.  
 
 
3.2.6.    TCR expression is reduced in thymocytes from triple mutant mice 
 
In a normal setting, the TCR-β chain is first expressed on the DN3 sub-population 
of developing thymocytes. At this stage, β chains are paired with pTα which is thought 
to mediate ligand-independent signalling needed to proceed to subsequent stages of 
development. The true TCR-α is only expressed at the DP stage where the TCR is tested 
for pMHC affinity (Hoffman et al., 1996). To investigate the patterns of TCR-β 
expression throughout T cell developmental stages, thymocyte suspensions were stained 
for TCR-β and analysed by flow cytometry. We noted that the triple mutant TCR-β 
chain was consistently lower at the DN stage, with on average only 9.5% ( + 1.8) of DN 
thymocytes being TCR-β positive compared to 63% ( + 5.7) in single mutant mice (p < 
0.0001). The surface expression of the β chain is only restored at the DP stage of 
development, where nearly 80% of thymocytes express the β chain in both mutants 
(74.1 % + 0.8 for single mutant mice and 72.6% + 2.1 in triple mutants).  In addition, in 
the triple mutant the levels of TCR-β were consistently lower in terms of MFI, except 
for DP cells which displayed similar MFI in single and triple mutant mice (p = 0.0051 
in DN, p < 0.0001 in CD4
+
 SP and p = 0.0038 in CD8
+
 SP thymocytes). 
The differences in TCR-β levels are not likely due to varying transgene copy 
numbers because in initial blood sample screens mice obtained from the two initial 
founders were indistinguishable from one another. Triple mutant mice from either 
founding line display consistently lower levels of TCR-β compared to single mutants 
(described in section 3.2.2). 
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TCR-α expression was also analysed. Monoclonal antibodies specific for the 
TCR-α constant region are not available commercially. To stain for a subset of TCR-α 
available in the endogenous repertoire, we pooled four TRAV-specific antibodies and 
stained thymocyte suspensions as described above for the TCR-β chain. We reasoned 
that the antibody pool should pick up a reasonable fraction of TCR-α-bearing cells and 
that TCR-α expression should follow the same pattern as TCR-β. This was indeed the 
case. As depicted in Figure 3.8, TCR-α expression was lower in triple mutant mice 
across all thymocyte development stages (not significant for DN, DP or CD8
+
 SP, and p 
= 0.0171 for CD4
+
 SP thymocytes). There was also a trend towards lower TCR-α MFI 
but this was not statistically significant (except for CD4
+
 SP cells, where p = 0.0426). 
Surprisingly, TCR-α was already detectable in DN thymocytes from both mutants. As 
discussed above, the timing of TCR-α expression critically influences thymocyte 
development. Premature TCR-α chain surface expression affects the efficiency of β 
selection and often results in the over-representation of γδ-like cells. However, in our 
system, we found that early TCR-α expression on DN thymocytes was a feature of both 
mutants, irrespective of the nature of the transgenic TCR-β. This alone did not affect 
later stages of development, as the frequency of DP cells was comparable in both lines. 
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    A)         
 
                        Single                         Triple                             Single                     Triple                                     
 
          
 
               
 
               
 
               
 
 
 
 
 
 
 
Figure 3.8. TCR-α and TCR-β surface expression in thymocytes from single and 
triple mutant mice. A) TCR-β expression was assessed on DN, DP and SP populations 
from single (n = 14) and triple (n = 7) mutant mice.  TCR-α expression is also shown 
for single (n = 4) and triple mutant mice (n = 10) using a pool of four TRAV-specific 
antibodies. Unstained controls are indicated by the grey shaded peak and stained 
samples are shown by the purple solid line. 
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Figure 3.8. TCR-α and TCR-β surface expression in thymocytes from single and 
triple mutant mice (continued). B) Results are summarised as percentage of TCR-α 
(left) and TCR-β expressing cells (right), gated on DN, DP and SP thymocytes. C) 
Results are shown as TCR-α MFI (left) and TCR-β MFI (right), gated on DN, DP and 
SP thymocytes. 
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We also looked at intracellular levels of expression of both TCR-α and TCR-β 
chains. Intracellular staining was performed as described in Chapter 2 using 
fluorochrome-conjugated monoclonal antibodies against CD4, CD8, TCR-β and TCR-α. 
The frequency of TCR-α and TCR-β expressing cells appeared increased in triple 
mutant mice across all stages of thymocyte development, compared to single mutant 
mice (Figure 3.9.A). However, these differences in TCR expression at the intracellular 
level were not statistically significant. We computed the MFI for intracellular TCR-β 
expression in DN, DP and SP cells and found it, again, to be consistently higher in triple 
mutant than in single mutant mice (p = 0.0126 for DP, p = 0.0142 in CD4
+
 SP and 
0.0494 in CD8
+
 SP thymocytes). Strikingly, TCR-β chain MFI was increased almost 
two-fold in CD4
+
 SP cells (362.80 + 90.52, compared to 196.30  + 92.17 in the single 
mutant) and in CD8
+
 SP thymocytes (473.60 + 89.33, versus 256 + 103.20 in single 
mutant mice). TCR-α chain MFI was also elevated in DN thymocytes (p = 0.0403) and 
in CD8
+
 SP cells (p = 0.0384). Thus, although not apparent in terms of percentage, there 
is an accumulation of intracellular TCR in thymocytes from triple mutant mice. 
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Figure 3.9. Intracellular TCR-α and TCR-β expression in thymocytes from single 
and triple mutant mice. A) TCR-α and TCR-β intracellular expression was assessed 
on DN, DP and SP populations from single (n = 4) and triple (n = 8) mutant mice. 
Unstained controls are indicated by the grey shaded peak and stained samples are shown 
by the purple solid line. 
 
 
                               
 
 
 
 
 
 
 
TCR-β TCR-α 
CD8+ 
SP 
CD4+ 
SP 
DP 
DN 
 
93 
 
 
 
 
B) 
%
 T
C
R
-
-e
x
p
re
s
s
in
g
 c
e
lls
D
N
 S
in
gl
e
D
N
 T
rip
le
D
P
 S
in
gl
e
D
P
 T
rip
le
S
P
4 
S
in
gl
e
S
P
4 
Tr
ip
le
S
P
8 
S
in
gl
e
S
P
8 
Tr
ip
le
0
5
10
15
20
%
 T
C
R
-
-e
x
p
re
s
s
in
g
 c
e
lls
D
N
 S
in
gl
e
D
N
 T
rip
le
D
P
 S
in
gl
e
D
P
 T
rip
le
S
P
4 
S
in
gl
e
S
P
4 
Tr
ip
le
S
P
8 
S
in
gl
e
S
P
8 
Tr
ip
le
0
20
40
60
80
100
 
 
T
C
R
-
 c
h
a
in
 M
F
I
D
N
 S
in
gl
e
D
N
 T
rip
le
D
P
 S
in
gl
e
D
P
 T
rip
le
S
P
4 
S
in
gl
e
S
P
4 
Tr
ip
le
S
P
8 
S
in
gl
e
S
P
8 
Tr
ip
le
0
100
200 * *
T
C
R
- 
 c
h
a
in
 M
F
I
D
N
 S
in
gl
e
D
N
 T
rip
le
D
P
 S
in
gl
e
D
P
 T
rip
le
S
P
4 
S
in
gl
e
S
P
4 
Tr
ip
le
S
P
8 
S
in
gl
e
S
P
8 
Tr
ip
le
0
400
800
1200 * * *
 
 
 
 
 
Figure 3.9. Intracellular TCR expression in thymocyte populations from single and 
triple mutant mice (continued). B) Results are summarised as percentage of TCR-α 
(left) and TCR-β expressing cells (right), gated on DN, DP and SP thymocytes. C) 
Results are shown as TCR-α MFI (left) and TCR-β MFI (right), gated on DN, DP and 
SP thymocytes. 
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TCR-β expression on DP thymocytes is heterogenous, with the majority of DP 
thymocytes being TCR
lo
 and a smaller fraction TCR
hi
. Sato et al. (1996) first 
demonstrated that TCR expression in DP thymocytes against a selecting H-2 haplotype 
was increased, compared to a non-selecting background. This suggests that positively 
selected cells up-regulate TCR expression, while non-selected DP thymocytes remain 
TCR
lo
, producing a DP population which is heterogenous for TCR expression overall. 
We examined TCR-β expression in DP thymocytes and noted an accumulation of TCRhi 
cells in triple mutant mice (p = 0.0004) as shown in Figure 3.10. The size of the TCR
lo
 
population remained unchanged. In terms of MFI, the TCR
hi
 population typically 
expressed similar levels of TCR-β in single (690.5 + 112.5) and triple mutant mice 
(628.1 + 48.1), indicating that these two populations were qualitatively equivalent in the 
two mutants. 
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Figure 3.10. TCR expression in DP thymocytes from single and triple mutant mice. 
TCR-β expression on DP thymocytes was assessed as before. A) Representative flow 
cytometry histograms are shown for single (n = 12) and triple mutant mice (n = 7). B) 
Results are summarised as percentage of TCR-βhi and TCR-βlo cells in the DP gate 
(bottom left) and MFI (bottom right).  
TCR-β 
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3.3.    Discussion 
 
 
3.3.1.     Summary 
 
 
The TCR is the fundamental unit underlying all antigen-specific T cell recognition 
events. Indeed, the T cell-APC interaction is essential in all aspects of T cellular 
biology, including development and function. In the thymus, T cell signalling induced 
by pMHC engagement contributes to the process of selection at the DP stage whereby 
only a fraction of thymocytes within a narrow affinity range will be permitted to 
differentiate into mature T cells (Alam et al., 1996). In secondary lymphoid organs, 
ligation of the TCR to pMHC provides the cell with the earliest signals required for the 
execution of a complex differentiation programme associated with effector function. 
Homeostasis is not an exception to this rule, as the maintenance of steady T cell 
numbers is also known to be MHC-dependent (reviewed by Freitas and Rocha, 1999 
and by Almeida et al., 2005). 
In this Chapter, we have uncovered three key findings. First, T cells bearing a 
TCR lacking germline-encoded CDR loops can be generated, allowing the 
reconstitution T cell pool in the T-lymphopaenic FVB TCR-β/δKO mouse. T cells 
expressing the mutated TCR-β chain can pass the β-selection checkpoint and ultimately 
pair with an endogenous TCR-α chain to produce a stable αβ dimer at the cell surface. T 
lymphocytes expressing such TCR are also able to negotiate a favourable interaction 
with pMHC in order to be selected to the periphery, allowing the near-complete 
reconstitution of the T cell pool. It therefore appears that the presence of the germline-
encoded CDR is not an absolute pre-requisite for selection. Second, the distribution of T 
cell subsets is altered in the thymus of mice lacking all three CDR loops. The frequency 
of CD4
+
 SP and CD8
+
 SP cells is reduced despite normal percentages of DP precursors. 
Last but not least, the phenotype of DP thymocytes auditioning for selection is 
consistent with enhanced interaction with self pMHC ligands, as indicated by increased 
CD5 MFI and by the accumulation of TCR
hi
 cells at this stage. Key findings related to 
the initial characterisation of thymocytes from single and triple mutant mice are 
summarised in Table 3.2 and further discussed below. 
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Table 3.2. Summary of selected results from Chapter 3. For each parameter, the 
average is indicated under the “single” and “triple” columns, together with the 
associated fold difference. In the fold change column, negative values indicate a 
reduction, positive values indicate an increase. 
 
 
Parameter Single Triple Fold difference Significance 
% DN 6.62 10.74 1.6 ** 
% DP 57.88 62.80 0 ns 
% CD4+ SP 24.84 19.12 -1.3 *** 
% CD8+ SP 10.58 7.34 -1.4 ** 
TCR-β MFI in DN 172.2 80.49 -2 ** 
TCR-β MFI in DP 83.30 88.79 0 ns 
TCR-β MFI in CD4+ SP 684.10 222.00 -3 **** 
TCR-β MFI in CD8+ SP 373.10 214.10 -1.7 ** 
TCR-β MFI in DN (intra) 59.05 78.58 1.3 ns 
TCR-β MFI in DP (intra) 54.05 103.70 2 * 
TCR-β MFI in CD4+ SP (intra) 196.30 362.80 1.8 * 
TCR-β MFI in CD8+ SP (intra) 256.50 473.60 1.8 * 
MFI CD5 in DP 93.08 212.40 2.3 **** 
MFI CD5 in CD4+ SP 221.20 499.40 2.3 **** 
MFI CD5 in CD8+ SP 118.00 321.10 2.3 **** 
% TCR lo 75.89 81.20 0 ns 
% TCR hi 4.54 12.33 3 *** 
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3.3.2.   Generation of transgenic mouse lines with mutant TCR-β chain CDR  
 
In single and triple mutant mice, the transgenic TCR-β chain is expressed and 
participates in the formation of a true TCRαβ dimer. Expression of a TCR composed of 
the transgenic chain, paired with an endogenous TCR-α allows T cell development to 
proceed normally. The success rate of the pro-nuclear injections was low for both lines 
and we initially only obtained two founder mice for each line. Following a backcross 
against the FVB TCR-β/δKO background, the transmission rate was at the expected 50%. 
In initial screens, offspring from both founders in each line were undistinguishable from 
one another, indicating that transgene localisation had no effect on the observed 
phenotype, consistent with the inclusion of the CD2 LCR in the pVA vector. Thus, the 
results described here solely result from expression of the transgenic TCR-β chains. 
Most mice used here were sacrificed at six weeks of age. However the breeding pairs 
were usually kept for longer periods of time. None of these appeared to develop any 
illness over time. 
 
3.3.3.   T cell selection in the absence of germline CDR 
 
 
The removal of CDR1 and -2 first alters the selection requirements of developing 
T cells in the thymus and the generation of CD4
+
 and CD8
+
 T cells. In light of this 
observation alone, we originally hypothesised that T cells lacking all three CDR loops 
in their TCR-β chain were less efficient at interacting with self pMHC and were 
consequently poorly selected as SP cells. However, we also obtained several clues 
suggesting that this might not be the case. 
The surface molecule CD5 is a transmembrane glycoprotein present on T cells 
and B cells as a negative regulator of antigen receptor signalling. In T cells, CD5-
mediated regulation is dependent of Lck activity, thereby providing a negative feedback 
loop for T cell activation in response to pMHC ligands (Dennehy et al., 2001; Burgess 
et al., 1992, Raab, Yamamoto and Rudd, 1994). CD5 expression varies across 
thymocyte sub-populations. In DN cells, pre-TCR signalling is required to induce up-
regulation of CD5 as thymocytes transit to the DP stage. Amongst DP thymocytes, 
those cells which successfully engage selecting pMHC ligands further increase CD5 
expression. Consequently, CD5 is widely used as a surrogate measure of TCR affinity 
for selecting pMHC.  
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In wild-type B6 mice, CD5 levels are low on DN thymocytes, intermediate at the 
DP stage and high on CD4
+
 and CD8
+
 SP cells. High levels are subsequently 
maintained on peripheral T cells (Azzam et al., 1998). In this study, we found that the 
mean CD5 levels followed this conventional pattern in single and triple mutant mice. 
However, the levels of CD5 in DP thymocytes from triple mutant mice were increased 
almost three-fold, suggesting that the triple mutant TCR-β mediates enhanced binding 
for MHC. Azzam et al. (1998) have previously shown that T cellular signalling intensity 
in response to pMHC engagement positively correlates with CD5 expression. Indeed, 
CD5 levels on DP thymocytes in class I and class II MHC double-deficient mice are 
comparable to those of DN thymocytes indicating a strict requirement for MHC 
engagement.  
Using different TCR transgenic strains, the same authors demonstrated that CD5 
levels are dictated by TCR avidity, as negatively or positively selecting ligands, but not 
non-selecting ligands induced CD5 up-regulation (Azzam et al., 1998; Azzam et al., 
2001). In light of these observations, we conclude that in triple mutant mice, the 
reduction in CD4
+
 and CD8
+
 SP thymocyte frequency is likely due to deletion of clones 
that interact too well with pMHC, rather than inefficient positive selection.  
 
3.3.4. Structural alteration of the germline-encoded CDR loops affects the kinetics 
of TCR expression 
 
Consistent with the idea that DP thymocytes are subjected to increased rates of 
deletion, we also showed that TCR
hi 
cells accumulated in triple mutant mice at the DP 
stage. In normal mice, thymocytes first enter the DP differentiation state as cells 
expressing low levels of TCR. Shortman et al. (1991) first demonstrated that these cells 
proliferated extensively. Subsequently, cell division ceases as TCR
low
 DP cells up-
regulate TCR (Shortman, Vremec and Egerton, 1991). The TCR
hi
 subset is highly 
enriched with cells committed to enter the SP stage and represents a post-selection 
population (reviewed by Jameson, Hogquist and Bevan, 1995). This is evidenced by the 
fact that CD8
+
 SP thymocytes differentiate from TCR
hi
 DP precursors and not from the 
TCR
lo
 population both in vitro and in vivo (Petrie et al., 1993). Moreover, Sato et al. 
(1996) went on to demonstrate that TCR
hi
 cell frequency at the DP stage was increased 
in mice with the selecting haplotype, whereas against a non-selecting haplotype DP 
thymocytes remained TCR
lo
.   
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Later, Davey et al. (1998) used DP thymocytes from OT-1 TAP-null mice, which 
represent a population of pre-selection thymocytes exclusively, and demonstrated that 
these cells retained the TCR
lo
 phenotype whereas wild-type OT-1 DP cells had higher 
TCR expression levels. Therefore, in light of these observations, the increased 
frequency of TCR
hi
 DP thymocytes observed in the triple mutant likely reflects efficient 
positive selection at this stage. Initially, this surprising efficiency in positive selection 
seemed to contradict the reduction in the size of the CD4
+
 and CD8
+
 T cell pool. Indeed, 
the accumulation of TCR
hi
 cells in triple mutant mice should predict efficient generation 
of SP cells. This is because TCR up-regulation is normally restricted to cells that are 
committed to SP generation, whereas the TCR
lo
 phenotype is indicative of cells that will 
die subsequently. 
Lucas et al. (1994) have proposed that DP cells bearing a high affinity TCR will 
be deleted as soon as they express the TCR, even at low levels, because they reach the 
negative selection threshold even at low TCR density (Lucas, Vasseur, and Penit, 1994). 
Similarly, we propose that thymocytes from triple mutant mice are compatible with 
positive selection so long as they maintain low expression of TCR. Further maturation 
induces up-regulation of the TCR, at which point the threshold for negative selection is 
reached. Thus, following TCR up-regulation, DP thymocytes in the triple mutant are 
deleted, resulting in reduced numbers of mature CD4
+
 and CD8
+
 SP thymocytes. 
Consistent with the idea that triple mutant TCR lie within a high affinity range, 
we also found that the levels of TCR-β were reduced on CD4+ and CD8+ SP 
thymocytes, indicating that efficient generation of mature CD4
+
 and CD8
+
 T cells is 
compatible only with low expression of the triple mutant TCR-β chain. Down-
regulation of the TCR has already been described as a peripheral, T cell intrinsic 
mechanism to avoid self-reactivity (Schonrich et al., 1991). Low TCR levels have been 
thought to allow provision of survival signals to the T cell without full activation 
(Kieper, Burghart and Surh, 2004). Thus, we believe that, similarly, the triple mutant 
TCR-β must be expressed at low levels in order to prevent clonal deletion at the DP 
stage. Indeed, we found that the intracellular levels of TCR-β, as well as TCR-α, were 
significantly increased, suggesting that TCR internalisation is the mechanism through 
which triple mutant thymocytes are rescued from deletion. Reduced TCR-β expression 
indicates that the triple mutant TCR can signal extensively, presumably in response to 
pMHC ligands as indicated by elevated CD5 levels.  
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3.3.5. Conclusions 
 
 
The germline theory for MHC restriction states that the TCR-pMHC interaction is 
mediated by evolutionarily conserved pairwise contacts between the TCR and products 
of the MHC. Accordingly, it has been shown that selection of certain TCR expressing 
distinct V segments is influenced by key germline-encoded amino acids. Whether this 
finding can be generalised to all TCR is questionable. There is no doubt that the pre-
selection TCR repertoire does contain a high frequency alloreactive TCR, indicating an 
intrinsic preference for MHC ligands independent of thymic selection (Merkenschlager 
et al., 1997; Zerrahn et al., 1997). However, this was demonstrated by challenging DP 
thymocytes developing in the absence of MHC with MHC-expressing cTEC, which 
does not exclude a role for CD4 and CD8 co-receptors in directing thymic selection on 
pMHC. Thus, this traditional view does not exclude the possibility that most TCR are 
not inherently specific for MHC; rather, most MHC-restricted TCR must be selected for 
throughout development in the thymus.  
Our findings support the idea that MHC restriction is not, or at least not entirely, 
encoded in the germline. TCR chains lacking germline-encoded CDR loops can be 
selected and allow homeostatic maintenance of T cells in the periphery. Thus, the role 
of the thymus and thymic selection in imprinting MHC restriction cannot be 
underestimated. The role of putative “interaction codons”, if any, may be limited to the 
few TCR analysed so far in the studies described and reviewed by Marrack et al. 
(2008). The majority of TCR seen in the periphery, however, will have been screened 
against MHC, likely through the influence of the T cell co-receptors CD4 and CD8, as 
proposed by Van Laethem et al. (2007). Our findings are consistent with a model in 
which engagement of co-receptors to their natural ligands - the class I and class II MHC 
molecules – is coupled to T cellular signalling and selection regardless of the nature of 
the TCR-β chain and the presence of germline-encoded CDR loops. 
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Chapter 4 
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Chapter 4: Peripheral T cell homeostasis and differentiation in 
single and triple mutant mice 
 
 
4.1. Background 
 
The lymphocytic arm of the immune system is constrained with the need to fight 
new pathogens and to respond to challenge with previously encountered antigen. To 
achieve this, the T cell compartment is divided into distinct functional subsets (reviewed 
by Jameson and Masopust, 2009). Understanding the equilibrium between these 
populations is therefore vital to dissect the dynamics of a typical immune response. 
Before antigen exposure, T cells persist in a naïve state. Naïve T cells are maintained 
without cellular division and have a relatively short half-life (von Boehmer and Hafen, 
1993; Bruno, von Boehmer and Kirberg, 1996). Following antigen encounter, memory 
cells generated from naïve precursors engaging cognate ligand are maintained with 
significantly longer half-lives and can be mobilised rapidly upon secondary challenge 
with the same antigen (Zimmermann et al., 1999). The persistence of both naïve and 
memory cells is therefore vital, as this confers protection against newly encountered 
pathogens but also against recurring infections (Salluto, Geginat and Lanzavecchia, 
2004; Moulton and Farber, 2006). Memory cells are themselves further classified into 
several sub-populations (Sallusto et al., 1999), which participate in different aspects of 
the immune response, as shall be discussed below.  
 
4.1.1. Homeostasis of T cell numbers and diversity 
 
In young animals, most T cells are immunologically naïve. The decline in antigen 
sensitivity established as thymocytes develop from early precursors to mature T cells 
ensures that the peripheral naïve population remains quiescent despite continuously 
encountering self pMHC ligands (Grossmann and Singer, 1996; Lucas et al., 1999). 
Indeed, developing thymocytes are significantly more sensitive to pMHC antigens than 
peripheral T cells (Davey et al., 1998). In the absence of foreign antigen, naïve T cells 
only proliferate in the context of lymphopaenia, when total T cell numbers are reduced 
(Rocha, Dautigny and Pereira, 1989). From this observation, it follows that the T cell 
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compartment can invoke specific mechanisms to regulate its size, a process referred to 
as homeostasis. The rate at which T cells are produced is constant up to puberty, then 
declines with age due to thymic involution, yet the size of the T cell pool remains 
unchanged (Blackman and Woodland, 2011). In addition, the patterns of V segment 
usage remain remarkably invariant across the lifespan, except in old age where diversity 
in the T cell compartment becomes increasingly compromised (Rudd et al., 2011; 
Blackman and Woodland, 2011). Thus, the T cell pool is capable of preserving both its 
size and its clonal composition (reviewed by Mahajan, Leskov and Chen 2005). 
Homeostatic proliferation, unlike antigen-induced expansion, is typically slow and 
involves a transition to a memory-like phenotype (Ernst et al., 1999). Interestingly, in 
young mice, up to two weeks after birth when lymphopaenia is severe, almost 50% of 
all peripheral T cells exhibit a memory-like phenotype, but become quiescent again as 
they replenish the naïve pool (Grossmann and Singer, 1996; Wong et al., 2001; Takada 
and Jameson, 2009b). In the steady state, memory-like T cells have long been thought 
of as the progeny of cells responding to environmental antigens (reviewed by Sprent 
and Surh, 2011). Strikingly however, the proportion of such cells is comparable in 
normal, germ-free and specific antigen-free mice (Vos, Jones and Kruisbeek, 1992; 
Huang et al., 2005; Haluszczak et al., 2009). Therefore, homeostasis of naïve and 
memory lymphocytes depends on specific mechanisms rather that bystander activation 
resulting from stochastic encounter with environmental antigens. 
 
4.1.2. Mechanisms for the maintenance of the T cell pool 
 
In the naïve compartment, peripheral T cell survival is clearly dependent on TCR-
pMHC interaction as evidenced by gradual T cell decay in mice lacking either TCR 
expression (Labrecque et al., 2001; Polic et al., 2001) or specific MHC molecules 
(Tanchot et al., 1997a; Tanchot et al., 1997b). H-2D
b
-restricted CD8
+
 T cells survive 
without dividing in D
b
 hosts, but fare poorly in mice expressing lower levels of H-2D
b
. 
The frequency of surviving CD8
+
 T cells in this case is proportional to the levels of D
b
 
(Tanchot et al., 1997a). Similarly, monoclonal CD4
+
 T cells restricted by I-A
d
 die 
shortly after transfer to I-A
d
-deficient recipients (Kirberg, Berns and von Boehmer, 
1997).  
 
 
104 
 
In parallel, the survival of CD4
+
 and CD8
+
 T cells is also dependent on the 
peptide collection displayed by the MHC. Indeed, polyclonal CD4
+
 T cells fail to 
survive in the context of reduced peptide diversity, as seen in H-2M-deficient mice in 
which class II MHC molecules are mostly occupied by the invariant chain peptide CLIP 
(Clarke and Rudensky, 2000; Viret, He and Janeway, 2000).  
Memory T cells express a variety of receptors absent on naïve T cells, which 
synergise with T cellular signalling to promote survival. Such signals, for memory cells, 
include signalling downstream of the IL-7 and IL-15 receptors. These phenotypic 
changes may themselves modify functional T cell avidity for the MHC niche, which in 
turn will alter their survival threshold. Thus, T lymphocytes are able to adjust their 
survival requirements in response to their environment. Unlike their naïve counterpart, 
H-2D
b
-restricted HY memory CD8
+
 T cells survive in the absence of their nominal 
antigen HY or of the D
b
 molecule, but disappear from β2m-deficient mice which 
express very few MHC molecules, if any (Hao et al., 2006). Memory CD4
+
 T cells, but 
not naïve cells, also persist in class II MHC-deficient hosts (Martin et al., 2003; Martin 
et al., 2006). Therefore, memory T cells may require some interaction with MHC but 
are not limited to engaging their restricting MHC element for survival. 
 
4.1.3. Phenotypic characterisation of functional T cell subsets 
 
As mentioned above, naïve and memory cells participate in fundamentally 
different phases of immune responses and both play a vital role in recognition of new or 
of previously encountered antigen. Several memory populations have been identified 
that display distinct homing patterns and differing effector potential. Secondary 
lymphoid organs are enriched in CD62-L
+
CCR7
+
 T cells, known as central memory T 
cells (TCM).T cells which down-regulate CD62-L and CCR7 to become CD62-L
-
CCR7
-
 
are referred to as effector memory T (TEM) cells (Sallusto et al., 1999, Unsoeld and 
Pircher, 2005). In addition, it was also originally noted that TCM and TEM may differ 
with several respects (reviewed by Salluto, Geginat and Lanzavecchia, 2004).  TCM are 
characterised by enhanced IL-2 production which may underlie homeostatic expansion 
and self renewal potential. TEM represent an activated population producing large 
amounts of perforin and pro-inflammatory cytokines including IFN-γ and TNF, as well 
as specific tissue-homing receptors (Hamann et al., 1997; reviewed by Wherry et al., 
2003). 
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The classification of T cell phenotypes has long been a matter of debate, in both 
the CD4
+
 and CD8
+
 compartments (Appay and Rowland-Jones, 2004; Appay et al., 
2008). Numerous surface markers have been used to identify memory cells, including 
CD27, CD28, CD45 isoforms and CD44 but the expression of the homing receptors 
CD62-L and CCR7, or lack of, invariably remains the distinguishing feature of TCM and 
TEM (Sallusto et al., 1999; Appay et al., 2008). The expression of CD45 variants, on its 
own, is not indicative of a naïve or memory phenotype because terminally differentiated 
T cells re-express CD45RA and these cells are known as RA-expressing TEM cells 
(TEMRA). TEMRA cells have often been associated with immunopathology related to 
chronic infections in humans but have not been reported in the mouse. These will not be 
examined in our study.   
 
4.1.4. Aims 
 
In Chapter 3, we showed how CDR-mutated TCR-β chains mediated development 
and maturation of thymocytes across the DN, DP and SP stages. Similar to the single 
mutant, expression of the triple mutant TCR-β chain lacking all three CDR loops 
restored the thymocyte pool, although with a significant reduction in SP cells. We 
demonstrated that the immune phenotype of DP cells in the triple mutant was suggestive 
of increased negative selection, likely in response to enhanced engagement with pMHC 
ligands. Here, we show that T cells from triple mutant mice survive following thymus 
egress and populate the secondary lymphoid organs. In addition, we further characterise 
the composition of the T cell pool. Finally, using bone marrow chimaeras, we seek to 
demonstrate unequivocally that T cells from triple mutant mice are MHC-restricted and 
do not replenish the T cell compartment in the absence of MHC molecules. 
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4.2. Results 
 
4.2.1. The size of the peripheral CD4+ and CD8+ T cell pools is reduced in 
triple mutant mice 
 
We showed in Chapter 3 that the thymi harvested from triple mutant mice were 
significantly smaller than those from single mutants. We therefore sought to determine 
whether this would affect the peripheral T cell pool. Spleens were harvested from seven 
week old single mutant (n = 5) and triple mutant (n = 6) female mice. As shown in 
Figure 4.1, the spleens harvested from triple mutant mice were significantly smaller in 
size, and displayed reduced total cellularity, compared to single mutants (p < 0.0001).  
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Figure 4.1. Splenic size and cellularity in single and triple mutant mice. A) Spleen 
sizes were measured in seven week old female single (n = 5) and triple (n = 6) mice. 
The pictures are representative of five animals in each group. B) Total spleen cellularity 
was determined for the same animals.  
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Splenocyte suspensions from seven week old single (n = 4) and triple mutant mice 
(n = 6) were prepared as described in Chapter 2. We initially sought to determine the 
composition of the splenic population in single and triple mutants by staining for NK 
cells (NK1.1
+
), B cells (CD19
+
) and macrophages (CD11b
+
). As expected, single and 
triple mutant mice displayed comparable frequencies of B cell, NK cells as well as 
macrophages in the spleen (Figure 4.2). Thus, because the mutations we introduced do 
not affect non-T cell populations, we conclude that the expression of our transgenic 
TCR-β chains affects the total size of the spleen through a reduction in total T cell 
numbers. TCR-β expression in our system is under the control of the hCD2 promoter 
and LCR, which confers T cell-specific expression with no aberrant expression on other 
cell types. 
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Figure 4.2. Distribution of selected spleen populations. Splenocyte suspensions from 
seven week old single and triple mutant mice were stained for NK1.1, CD19 and 
CD11b expression. A) Flow cytometry plots representative of single (n = 4) and triple 
mutant mice (n = 6). NK1.1. and CD19 expression was gated on the total lymphocyte 
gate and CD11b according to the monocyte gate. B) Summary graphs showing the 
frequency of NK cells, B cells and macrophages. 
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We showed previously that the CD4
+
 and CD8
+
 SP thymocyte populations from 
the triple mutant mouse were reduced in size. To determine whether this affected mature 
peripheral T cells, splenocyte suspensions from single (n = 15) and triple mutant mice 
(n = 19) were stained as before with anti-CD4 and anti-CD8 fluorochrome-conjugated 
monoclonal antibodies. Similar to blood samples (as described in Chapter 3), the size of 
the splenic CD4
+
 and CD8
+
 T cell populations was significantly reduced. As shown in 
Figure 4.3, compared to single mutants, the frequency of CD4
+
 T cells was halved in 
triple mutant mice (p < 0.0001). The reduction of CD8
+
 T cells, albeit smaller than that 
of CD4
+
 T cells, was also significant (p < 0.0001). Because CD4
+
 T cells were more 
severely affected, there was overall a decrease in the CD4
+
 to CD8
+
 T cell ratio (1.796 + 
0.25 in single mutants, compared to 1.244 + 0.40 in triple mutant mice). 
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Figure 4.3. Distribution of peripheral T cell subsets in single and triple mutant 
mice. Splenocyte suspensions from seven week old female mice were stained for CD4 
and CD8 expression. A) Flow cytometry profiles are representative of single (n = 15) 
and triple mutant mice (n = 19), gated on total lymphocytes. B) The summary graph 
represents the percentage of CD4
+
 and CD8
+
 T cell pools in the lymphocyte gate. 
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4.2.2. The distribution of functional T cell subsets is altered in triple mutant 
mice  
 
 
The distribution of naïve and memory subsets can be determined by virtue of 
distinct markers, including differential CD44 and CD62-L expression (Sallusto et al., 
1999). In this case, naïve T cells are defined as CD44
-
CD62L
+
, while memory cells are 
CD44
+
, with CD44
+
CD62-L
+
 cells designated as TCM and CD44
+
CD62-L
-
 cells as TEM 
cells. We hypothesised that the broad phenotypic changes observed in triple mutant 
mice could also be associated with alterations in the normal frequencies of different T 
lymphocytes functional subsets. To test this, lymph node samples were stained with 
CD4, CD8, CD62-L and CD44 specific monoclonal antibodies. Figure 4.4 summarises 
the results obtained from single (n = 6) and triple (n = 7) female mice sacrificed at six 
weeks of age.  In the triple mutant, the frequency of naïve T cells was reduced in the 
total lymphocyte pool (p = 0.0133) as well as the CD4
+
 T cell subset (p = 0.0025). 
Naïve CD8
+
 T cell frequency was also reduced, although this was not statistically 
significant. In addition, there was no apparent change in the percentage of TCM cells. 
However, we noted an accumulation of TEM cells in all cases (p = 0.0046 for total 
lymphocytes, p = 0.0022 for CD4
+
 and p = 0.0011 for CD8
+
 T cells).  
Thus, the modifications in the TCR-β chain of the triple mutant mice alter the 
normal distribution of T cell functional subsets. Because the TCM population remains 
unaffected, we conclude that TEM cells in the triple mutant mice are preferentially 
generated from the naïve T cell pool, with no apparent transition to the TCM phenotype. 
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Figure 4.4. Distribution of naïve and memory T cell populations in single and triple 
mutant mice. T cell functional subsets were identified by virtue of CD44 and CD62-L 
expression in total lymphocytes, CD4
+
 T cells, and CD8
+
 T cells from lymph node 
suspensions. A) Representative flow cytometry plots are shown for single (n = 6) and 
triple mutant mice (n = 7) gated on lymphocytes, CD4
+
 T cells, and CD8
+
 T cells. B) 
Summary graphs representing the composition of the lymphocyte (left), CD4
+
 T cells 
(middle), and CD8
+
 T cells (right). 
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4.2.3. Peripheral T cells adopt an activated phenotype in triple mutant mice 
 
Considering the accumulation of memory phenotype cells in the triple mutant, we 
reasoned that TEM over-representation could be the result of engagement with self 
pMHC in immunologically naive mice. We therefore sought to assess the functional 
capacity of these cells. Serum samples were taken from single and triple mutant mice. 
Analysis included male and female mice of different age groups, as described in Table 
4.1 below. 
 
Table 4.1. Sample groups used for quantification of pro-inflammatory cytokines in 
single and triple mutant mice. 
 
Group Strain Sex Age Number of samples 
1 Triple Female 6 weeks 5 
2 Triple Male 6 weeks 2 
3 Triple Male 15 months 1 
4 Single Female 6 weeks 6 
5 Single Male 6 weeks 6 
6 Single Female 15 months 3 
7 Single Male 15 months 6 
 
  
Serum samples were prepared as described in Chapter 2 and stored at -20ºC. All 
samples were then used in a Luminex assay to determine the concentration of selected 
analytes: GM-CSF, IL-1β, TNF, IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-10, and IL-12. 
Strikingly, we failed to detect the presence of any of the cytokines listed above, with the 
exception of IL-1β (Figure 4.5), which was present in low, but detectable concentrations 
in the triple mutants. Standard curves for each analyte are shown in Appendix A. 
The absence of multiple pro-inflammatory cytokines in the triple mutant indicates 
that despite the accumulation of memory cells, these mice remain immunologically 
quiescent. This suggests that peripheral mechanisms are in place to keep peripheral T 
cells in check in order to prevent unwanted and potentially harmful activation. 
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Figure 4.5. Detection of serum pro-inflammatory cytokines in single and triple 
mutant mice. Concentrations GM-CSF, IL-1β, TNF, IFN-γ, IL-2, IL-4, IL-5, IL-6, IL-
10, and IL-12 were measured simultaneously using the Luminex platform. Only IL-1β 
is shown here. Samples were taken from female and male single and triple mutant mice 
as described in Table 4.1. Standard curves are included in Appendix A.  
 
We further characterised the peripheral CD4
+
 and CD8
+
 T cells by staining for a 
panel of phenotypic markers (described in Table 4.2). Lymph node suspensions were 
prepared from seven week old female single and triple mutant mice, and stained as 
before for CD4, CD8, CD44, CD69, CD127, CTLA-4 and CD40-L expression. 
 
Table 4.2. List of T cell markers used for phenotypic analysis of single and triple 
mutant mice. 
 
 
Expression 
 
Function 
 
Reference 
 
CD44 
 
Memory T cells 
 
Hyaluronic acid receptor,  
T cell migration 
Shimizu et al., 1989 
 
CD69 
 
Thymocytes, activated T cells  
 
C-type lectin, early signalling 
receptor 
Lopez-Cabrera et al., 
1993 
CTLA-4 
 
Activated, exhausted T cells 
 
Negative TCR signalling 
modulator 
Tivol et al., 1995 
 
CD127 
 
Resting T cells 
 
IL-7 receptor α chain, pro-survival 
signalling in quiescent T cells  
Peschon et al., 1994 
 
CD40-L 
 
Activated T cells 
 
Cell adhesion, T cell help,  
co-stimulation 
Karpusas et al., 1995 
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A)  
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Figure 4.6. Phenotypic characterisation of peripheral T cells from single and triple 
mutant mice. Lymph node suspensions from eight week old female single and triple 
mutant mice were stained with fluorochrome conjugated antibodies specific for CD4, 
CD8, CD44, CD69, CD127, CTLA-4 and CD40-L. A) Representative histograms for 
CD44, CD69, CD127, CTLA-4 and CD40-L gated on CD4
+
 (left) and CD8
+
 T cells 
(right).  
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Figure 4.6. Phenotypic characterisation of peripheral T cells from single and triple 
mutant mice (continued). B) Summary graphs showing the frequency of CD44, CD69, 
CD127, CTLA-4 and CD40-L expressing cells amongst CD4
+
 and CD8
+
 T cells from 
single and triple mutant mice. 
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The overall frequency of peripheral T cells expressing high levels of the memory 
marker CD44 was increased (p = 0.0009 CD4
+
 T cells, but not significant for CD8
+
 T 
cells). Moreover, the frequency of CD69-expressing cells was significantly elevated in 
the CD4
+
 (p < 0.0001) and the CD8
+
 T cell pools (p = 0.0129). CD40-L-expressing cells 
also accumulated in the CD4
+
 T cell compartment (p = 0.0163). We noted an apparent 
increase in CD40-L expression on CD8
+
 T cells, but this was not statistically 
significant. The elevated expression of CD69 and CD40-L strongly suggest an activated 
phenotype. Finally, expression of the naïve T cell marker CD127, the IL-7 receptor α 
chain, was also significantly reduced (p < 0.0001 both in CD4
+
 T and CD8
+
 T cells), 
indicating the presence of effector cells in the triple mutant. 
We were surprised to observe that peripheral CD4
+
 and CD8
+
 T cells from 
immunologically naïve mice displayed an activated phenotype, compared to the single 
mutant. We therefore sought to confirm whether up-regulation of activation markers 
would be exacerbated in a minor sub-population of memory-like cells. We hypothesised 
that the expression of such markers should be elevated mostly on memory cells, defined 
here as CD44
high 
cells. Splenocyte suspensions were stained for CD44 expression as 
well as the following selected markers: CD69 (early activation), CD95 (death receptor) 
and CTLA-4 (exhaustion). As expected, the early activation marker CD69 and the 
exhaustion marker CTLA-4 were virtually absent from CD44
low
 naïve T cells (less than 
1% in all cases). Both were up-regulated on the CD44
high
 pool (p < 0.0001 for CD69 
and p = 0.0013 for CTLA-4). CD95 expression was also lower on CD44
low
 cells 
compared to the CD44
high
 population (p < 0.0001). 
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Figure 4.7. Peripheral T cells from triple mutant mice adopt an effector-like 
phenotype. Splenocyte suspensions from six week old female triple mutant mice (n = 
6) were stained with fluorochrome-conjugated monoclonal antibodies against CD44, 
CD69, CD95 and CTLA-4. A) Representative histograms gated on CD44
low
 (left) and 
CD44
high
 (right) lymphocytes. B) Summary graphs showing the frequency of CD69, 
CD95 and CTLA-4 expressing cells in the CD44
low
 and the CD44
high
 gates. 
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4.2.4. Expression of the triple mutant TCR-β chain is reduced in the periphery 
 
 
Expression of TCRαβ is established during development at the DP stage. TCR 
expression is maintained constitutively on peripheral T cells. In Chapter 3, we showed 
that extracellular expression of TCR-α and TCR-β chains was reduced on triple mutant 
thymocytes. To compare this finding with peripheral T cells, splenocyte suspensions 
from six-week old female single (n = 11) and triple mutant mice  (n = 4) were stained as 
described before with fluorochrome-conjugated monoclonal antibodies specific for 
CD4, CD8 and TCR-β constant region. 
As expected, TCR-β was expressed on all peripheral CD4+ and CD8+ T cells, 
although we noticed a marginal population of CD4
+
 T cells on which TCR-β was absent 
(Figure 4.6). Similar to our previous findings on thymocytes, we found that TCR-β MFI 
was significantly reduced (p < 0.0001, both for CD4
+
 and CD8
+
 T cell populations). 
TCR-β levels reached an average of 850.3 ( + 86.24) in single mutant mice, but only 
101.5 ( + 64.70) in triple mutants. We also stained splenocytes for TCR-α expression 
with a pool of four TRAV-specific antibodies as described in Chapter 3. Consistent with 
reduced TCR-β MFI, we found that TCR-α MFI was also significantly decreased in 
CD4
+
 and CD8
+
 T cells from triple mutant mice, compared to their single mutant 
counterpart (p < 0.0001 in both cases). Thus, expression of the TCR is maintained at 
low levels in peripheral T lymphocytes from triple mutant mice. 
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Figure 4.8. TCR-α and TCR-β extracellular expression in single and triple mutant 
mice. Splenocyte suspensions from six week old single and triple mutant mice were 
stained for TCR-α and TCR-β expression. A) Histograms representative of TCR-α (left) 
and TCR-β expression (right) in single and triple mutants. B) Data is summarised as 
percentage of TCR-α (left) and TCR-β expressing cells (right), gated on CD4+ and 
CD8
+
 T cell gates. C) Results are shown as TCR-α MFI (left) and TCR-β MFI (right).   
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Figure 4.9. TCR-α and TCR-β intracellular expression in single and triple mutant 
mice. Splenocyte suspensions from six week old single and triple mutant mice were 
permeabilised and stained for TCR-α and TCR-β intracellular expression. A) 
Histograms representative of TCR-α (left) and TCR-β expression (right) in single and 
triple mutants. B) Data is summarised as percentage of TCR-α (left) and TCR-β 
expressing cells (right), gated on CD4
+
 and CD8
+
 T cell gates. C) Results are shown as 
TCR-α MFI (left) and TCR-β MFI (right).   
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To determine whether low surface TCR-β expression reflected TCR 
internalisation following self antigen encounter, splenocyte suspensions from triple 
mutant mice (n = 4) were stained with monoclonal antibodies specific for CD4, CD8, 
CD44 and TCR-β. TCR-β expression was assessed in the CD44low and CD44high gates 
(Figure 4.10). We reasoned that if low TCR expression resulted from peripheral 
activation, the CD44
high
 memory population would express lower levels compared to the 
CD44
low
 naïve counterpart. Surface TCR-β expression was significantly lower in the 
CD44
high
 subset, both for CD4
+
 (p = 0.0021) and CD8
+
 T cells (p = 0.0162). In CD4
+
 T 
cells, TCR-β MFI ranged from 34.60 to 42.30 on the CD44low naïve population, but did 
not exceed 30.10 in CD44
high
 T cells. A similar observation applied to CD8
+
 T cells, 
where TCR-β MFI ranged from 96.50 to 189 in CD44high cells, and from 199 to 297 in 
CD44
low
 cells, revealing a two-fold difference in TCR-β surface levels. Intracellular 
staining for TCR-β chain showed the reverse pattern, with TCR-β MFI significantly 
increased in memory cells (p = 0.0161 for CD4
+
 and p = 0.0039 for CD8
+
 T cells). 
 
   A)      In CD4+ T cells         In CD8+ T cells                           In CD4+ T cells            In CD8+ T cells 
                     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. TCR-β expression in CD44high memory cells from triple mutant mice. 
Splenocyte suspensions from triple mutant mice (n = 4) were stained for CD4, CD8, 
CD44, and TCR-β expression. A)  Histograms representative of extracellular (left) and 
intracellular (right) TCR-β expression, gated on CD4+ and CD8+ T cells. TCR-β 
expression is indicated by the purple line for naïve CD44
low
 cells and by the pink shaded 
area for CD44
high
 memory cells. B) Summary graphs for extracellular (left) and 
intracellular TCR-β chain MFI (right).  
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To confirm that low TCR-β expression was the result of TCR engagement to self 
pMHC in vivo, splenocytes from triple mutant mice were injected i.v. to MHC
KO
 
recipients (n = 4) or rag-deficient control mice (n = 3). Blood was taken at two time 
points after injection, lysed and stained for CD4, CD8 and TCR-β expression (Figure 
4.11). A week after transfer, TCR-β chain expression was markedly elevated in MHC-
deficient mice, compared to control recipients (p = 0.0128 for CD4
+
 T cells and p < 
0.0001 for CD8
+
 T cells). This pattern of expression was preserved at 14 days post-
injection (p = 0.01 for CD4
+
 T cells and p = 0.002 for CD8
+
 T cells).  
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Figure 4.11. Self pMHC complexes induce TCR down-regulation in triple mutant 
mice. 2 × 107 splenocytes from triple mutant mice were injected i.v into MHC-deficient 
(n = 4) or rag-deficient recipients (n = 3). Blood samples were taken 7 and 14 days p.i 
and stained for CD4, CD8 and TCR-β expression. A) Flow cytometry plots are 
representative of blood samples from MHC-deficient (top) and rag-deficient (bottom) 
mice analysed at day 7 and day 8. B) Summary graphs indicate TCR-B chain MFI in 
CD4+ and CD8+ T cells from each group. 
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As before, this demonstrates that low TCR-β chain expression in triple mutant 
mice is the consequence of engagement to self pMHC ligands. These results further 
indicate that TCR down-regulation in the triple mutant is reversible, but also 
demonstrate that MHC complexes are the preferred ligand for TCR lacking all three 
CDR loops. 
 
4.2.5. T cell co-receptor expression is altered in triple mutant mice 
 
In previous sections we showed that peripheral T cells from triple mutant mice 
exhibited an activated phenotype, with up-regulation of key activation markers and low 
surface TCR expression. Activated T lymphocytes are also known to modulate co-
receptor levels in order to readjust their activation threshold (Maile et al., 2005; and 
reviewed by Cole et al., 2012).  We sought to determine whether this was also the case 
in our system. Splenocyte suspensions, as well as blood samples, were stained as before 
and the CD4 and CD8 MFI were determined in the CD4
+
 and the CD8
+
 gate 
respectively (Figure 4.12). In the spleen, mean CD4 levels averaged at 115.1 ( + 15.65) 
in the single mutant and 93.3 ( + 7.10) in triple mutant mice. However, CD8 MFI was 
significantly decreased in CD8
+
 T cells from triple mutant mice (p < 0.0001), with a 
mean of 176.3 ( + 65.51) compared to 553.6 ( + 44.10)  in single mutants. Blood sample 
analysis also revealed a similar picture, with no difference in CD4 levels, but 
significantly lower CD8 expression on CD8
+
 T cells (p < 0.0001).  
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Figure 4.12. T cell co-receptor expression levels in peripheral T lymphocytes from 
single and triple mutant mice. A) Splenocyte suspensions from single (n = 13) and 
triple mutant mice (n = 12) were stained and analysed for CD4 and CD8 expression. 
The MFI was computed for CD4
+
 (left) and CD8
+
 T cells (right). 
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Figure 4.12. T cell co-receptor expression levels in peripheral T lymphocytes from 
single and triple mutant mice (continued). B) Blood samples from single (n = 17) and 
triple mutant mice (n = 15) were stained as before and the MFI was computed for CD4
+
 
(left) and CD8
+
 T cells (right). 
 
 
 
4.2.6. T cells from single and triple mutant mice do not develop in the absence of 
MHC molecules 
 
We envisaged that T cells from triple mutant mice might develop in the absence 
of MHC-based selection due to structural alteration of the germline CDR1 and -2 loops. 
The germline theory for MHC restriction suggests that these two loops play a major role 
in MHC reactivity and as a result, MHC-dependent development of T cells is likely to 
take place in triple mutant mice. To test this, we generated bone marrow chimaeras in 
which MHC 
KO
 mice bred against the B6 background (H-2
b
) received bone marrow cell 
suspensions harvested from single or triple mutant mice. These mice were initially 
phenotyped by staining with fluorochrome-conjugated antibodies against CD4, CD8 
and CD19 as a B cell marker. In the thymus, we found that the vast majority of 
thymocytes were stranded at the DP stage (n = 3). In the periphery (n = 10), an average 
75% ( + 7.25) stained positively for CD19, confirming that the mice used here were 
deficient in class I and class II MHC, but not RAG enzymes (Figure 4.13). 
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        Thymus (unstained)                     Thymus 
  
 
          Blood (unstained)                          Blood 
   
 
 
Figure 4.13. Phenotypic analysis of MHC
KO
 mice. MHC
KO
 mice were phenotyped by 
staining thymocyte suspensions for CD4 and CD8 expression (n = 3) and peripheral 
blood lymphocytes for CD19 expression (n = 10).   
 
 
To generate chimaeras, bone marrow was harvested from femur and tibiae as 
outlined in Chapter 2 and injected i.v. as a suspension of 10
7
 T cell-depleted bone 
marrow cells in sterile PBS. Four recipients received bone marrow from triple mutant 
mice and another two received cells from single mutants. Following immune 
reconstitution six weeks after initial injection, blood samples were taken and thymi were 
harvested from all six chimaeric mice. We took advantage of differential expression of 
the congenic marker Thy1 to distinguish between B6 host (Thy1.2.) and FVB donor 
cells (Thy1.1.). The extent of chimaerism was assessed by analysing the frequencies of 
Thy1.1.
+
 and Thy1.2.
+
 cells in individual mice. We found that the chimaeras receiving 
triple mutant bone marrow displayed very different phenotypes due to differential 
engraftment of Thy1.1.
+
 donor cells with frequencies ranging from 18.9% to as high as 
92.1% in the thymus and 1 to 15% in the blood (Figure 4.14). Thymic engraftment of 
donor Thy1.1.
+
 T cells reached frequencies above 80% in the single mutant but were as 
low as 1% in triple mutant mice. In the blood, there were no discrepancies between 
single and triple mutant chimaeras, and the frequency of Thy1.1.
+
 cells was lower than 
15% in all cases.  
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Figure 4.14. T cell engraftment in single and triple mutant chimaeras. All animals 
received 10
7
 T cell-depleted bone marrow cells i.v. and were analysed six weeks 
following injection. Blood and thymus samples were prepared as described before and 
stained with fluorochrome-conjugated monoclonal antibodies against CD4, CD8, 
Thy1.1. and Thy1.2. A) Flow cytometry plots for Thy1.1 and Thy1.2. expression in 
individual chimaeras. B) The summary graphs represent the frequency of Thy1.1.
+
 and 
Thy1.2.
+
 cells in the thymus (left) and blood (right) of six individual mice. Animals 
labelled 1 and 2 represent Single → MHCKO mice and animals 3 to 6 represent Triple 
→ MHCKO chimaeras. 
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Surprisingly, we detected peripheral T cells in all chimaeras, both from donor and 
recipient origin (Figure 4.15).  In the blood, the average frequency of CD8
+
 T cells was 
37% in triple mutants and 18% in single mutant chimaeras. There were virtually no 
CD4
+
 T cells of donor origin. In the B6 host compartment, we also detected between 15 
and 74% CD8
+
 T cells across all six chimaeras. The presence of T cells of host origin 
strongly indicates that these resulted from selection on MHC molecules expressed by 
donor-derived cells which differentiated from transferred HSC. Thus, CD8
+
 T cells of 
both donor and host origin may have arisen as a consequence of introducing class I 
MHC into the thymic microenvironment of the chimaeras. 
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Figure 4.15. Distribution of peripheral T cell subsets in single and triple mutant 
chimaeras. All animals received 10
7
 T cell-depleted bone marrow cells i.v. and were 
analysed six weeks post injection. Blood samples were prepared as described before and 
stained with fluorochrome-conjugated monoclonal antibodies against CD4, CD8, 
Thy1.1. and Thy1.2. A) Flow cytometry plots for CD4 and CD8 expression in 
individual chimaeras, gated on Thy1.1
+
 (top) and Thy1.2
+
 cells (bottom). B) The 
summary graphs represent the frequency of peripheral T cell subsets in the Thy1.1
+
  and 
Thy1.2
+
 populations. 
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Analysis of thymus samples also depicts a similar picture (Figure 4.16). In all 
animals, most thymocytes do not progress beyond the DP stage, again indicating that T 
cell precursors from single and triple mutant mice do not undergo selection on non-
MHC ligands in MHC deficient mice. However, the presence of a small CD8
+
 T cell 
population amongst Thy1.1
+
 and Thy1.2
+
 cells again shows that residual class I MHC 
expression accounts for the observed phenotype. Overall, we conclude from this result 
that bone marrow from single and triple mutant mice does not give rise to mature CD4
+
 
and CD8
+
 T cells in an MHC-deficient setting. Therefore, thymocytes from single and 
triple mutant mice must be selected only on pMHC ligands. 
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Figure 4.16. Distribution of thymocyte subsets in single and triple mutant 
chimaeras. All animals received 10
7
 T cell-depleted bone marrow cells i.v. and were 
analysed six weeks post injection. Thymi were prepared as described before and stained 
with fluorochrome-conjugated monoclonal antibodies against CD4, CD8, Thy1.1. and 
Thy1.2. A) Flow cytometry plots for CD4 and CD8 expression in individual chimaeras, 
gated on Thy1.1
+
 (top) and Thy1.2
+
 cells (bottom). B) The summary graphs represent 
the frequency of DN, DP and SP thymocytes in Thy1.1
+
 and Thy1.2
+
 populations. 
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4.3. Discussion 
 
4.3.1. Summary 
 
The maintenance of the absolute number and relative distributions of T cell 
populations is an active process. T cells are produced continuously throughout life, but 
the total number of T cells that can be accommodated by the host remains unchanged. 
Therefore, for each newly produced T cell to survive and persist in the periphery, 
another resident lymphocyte must die (Freitas, Agenes and Coutinho, 1996; Freitas and 
Rocha, 2000; Takada and Jameson, 2009a). It also follows that during the lifespan, the 
balance between naïve and memory cells will be altered, as well as the clonal 
composition of the T cell repertoire (Hingorani et al., 1993; Le Maoult et al., 2000; 
Rudd et al., 2011). Thus, homeostasis serves three roles. First, it prevents unwanted 
accumulation of lymphocytes. Secondly, it shapes the antigen receptor repertoire of the 
host and finally, it replenishes the immune system following disruptions, such as 
chemotherapy for instance (Almeida et al., 2005).  
In this Chapter, we sought to further characterise the composition and general 
phenotype of the peripheral T cell compartment in single and triple mutant mice. With 
this regard, we described a number of key findings. Firstly, total cellularity and 
frequencies of CD4
+
 and CD8
+
 T cells are reduced in the periphery of triple mutant 
mice. In addition, this is accompanied by a shift towards a memory-like phenotype, with 
a significant increase in the frequency of TEM cells in the CD4
+
 and CD8
+
 T cell 
compartments. Similar to thymocytes, TCR expression is reduced both in CD4
+
 and 
CD8
+
 T cells. TCR down-modulation is a feature of memory cells in the triple mutant, 
as CD44
high
 cells displayed significantly lower surface levels of TCR-β indicating that 
low TCR levels are characteristic of memory T cells that have been primed by antigen, 
presumably self pMHC complexes. The immune phenotype of peripheral T 
lymphocytes in single and triple mutant mice is summarised in Table 4.3 and discussed 
in the following sections. 
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Table 4.3. Summary of selected results from Chapter 4. For each parameter, the 
average is indicated under the “single” and “triple” columns, together with the 
associated fold difference. In the fold change column, negative values indicate a 
reduction, positive values indicate an increase. 
 
Parameter Single Triple Fold difference Significance 
% CD4+ T cells 25.35 10.63 -2.5 **** 
% CD8+ T cells 13.88 8.58 -1.5 **** 
% TEM in CD4+ T cells 2.15 18.47 9 ** 
% TEM in CD8+ T cells 0.45 2.70 6 * 
% CD69 in CD4+ T cells 0.44 7.75 17 **** 
% CD69 in CD8+ T cells 0.43 2.19 5 * 
% CD44 in CD4+ T cells 3.27 20.51 6 *** 
% CD44 in CD8+ T cells 3.60 3.50 0 ns 
% CD40L in CD4+ T cells 0.90 17.12 19 * 
% CD40L in CD8+ T cells 6.12 4.17 0 ns 
% CTLA-4 in CD4+ T cells 0.35 5.09 14 ** 
% CTLA-4 in CD8+ T cells 0.12 2.10 17 ns 
% CD127 in CD4+ T cells 87.52 16.13 5 **** 
% CD127 in CD8+ T cells 85.85 10.83 8 **** 
TCR-β MFI in CD4+CD44high NA 26.55 NA NA 
TCR-β MFI in CD8+CD44high NA 125.10 NA NA 
TCR-β MFI in CD4+CD44low NA 38.10 NA NA 
TCR-β MFI in CD4+CD44low NA 229.30 NA NA 
 
 
Last but not least, we demonstrate using bone marrow chimaeras that T cells from 
single and triple mutant mice are selected on MHC ligands. MHC
KO
 recipients injected 
with bone marrow from single and triple mutant mice did not allow full reconstitution 
of the T cell compartment, strongly suggesting that the generation and maturation of T 
cells of single and triple mutant origins requires MHC ligands. Thus, structural 
alteration of the germline CDR does not abrogate the requirement for MHC ligands in 
the maintenance of the peripheral T cell pool. Therefore, much like normal T cells, the 
efficient generation of T cells lacking germline-encoded CDR strictly requires 
engagement to pMHC complexes. 
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4.3.2. Distribution of functional T cell subsets 
 
In this Chapter, we first showed how triple mutant mice were able to reconstitute 
the T cell pool, although with a significant reduction in the frequency of CD4
+
 and 
CD8
+
 T cells compared to the single mutant.  In addition, the distribution of functional 
T cell subsets was altered in the triple mutant. Strikingly, in triple mutant mice, the 
memory population was over-represented compared to the single mutant. The 
accumulation of effector-like TEM cells provides us with two clues regarding the 
functionality of peripheral T cells from triple mutant mice. 
On one hand, peripheral T cells in the triple mutant are functional because the 
presence of memory cells is evidence of T cellular priming by antigen.  It is traditionally 
assumed that naïve T cells strictly require signals from self pMHC in order to persist in 
the periphery, whereas memory cell may not. Using conditional deletion of the TCR 
proximal signalling molecule SLP-76, Wiehagen et al. (2010) recently demonstrated 
that tonic TCR signalling was indeed required for the maintenance of naïve T cells, a 
finding reminiscent of early studies with MHC-deficient mice (Tanchot et al., 1997a; 
Hao et al., 2006; Wiehagen et al., 2010). In the same study, it was also noted that nearly 
all memory cells adopted the TCM phenotype. Therefore, it appears that only TCM cells 
are exempt from inducing TCR signalling in order to survive. By contrast, TCR signals 
may be required to induce the transcriptional programme that leads to TEM 
differentiation. In our system, the presence of TEM cells clearly indicates that signals 
induced by engagement of the triple mutant TCR-β chain are sufficient to drive effector 
memory differentiation, with the TEM compartment representing 10% of the CD4
+
 T 
cells pool and 5% of the CD8
+
 T cell population. Accordingly, the size of the naïve T 
cell pool is critically reduced.  
On the other hand, much like normal T cells, the tonic signals required for the 
generation of TEM cells are likely self pMHC-induced. Indeed, memory cells are 
generally thought to arise following specific self-pMHC encounter and not in response 
to environmental antigens (Huang et al., 2005; Haluszczak et al., 2009). Therefore, we 
propose that in the triple mutant mouse, T cells entering the periphery differentiate into 
TEM cells in response to self pMHC. Consistent with this idea, memory differentiation in 
response to self pMHC antigen was recently demonstrated by Pospori et al. (2011), who 
showed that peripheral T cells specific for Wilm’s tumour antigen 1 (WT1) acquired a 
CD44
high
 phenotype in WT1-specific TCR transgenic mice in the absence of 
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immunisation. As shall be discussed below, we assume the T cell activation threshold in 
the triple mutant to be lower in comparison to the single mutant, resulting in a 
significant increase in TEM frequency. The frequency of TCM cells remains unchanged 
because TCM do not require TCR signalling for survival (Wiehagen et al., 2010) and 
therefore their relative frequency amongst T lymphocytes is unrelated to the nature of 
the TCR-β chain. 
In support of this idea, we detected significant differences in the expression of 
selected activation markers in the T cell pool. When comparing, the CD44
low 
naïve and 
the CD44
high
 memory pools, we found that the expression of the early activation CD69 
was enhanced more than five-fold in the memory pool derived from triple mutant mice. 
Expression of the CD95 death receptor was also significantly elevated. Peripheral 
mechanisms of tolerance are likely to be in place to keep this population in check. The 
mechanisms involved in preventing immune pathology in the triple mutant are likely to 
include anergy, as T cells were found to express negative regulators of T cell signalling 
like CTLA-4. The other possibility is that most activated T cells in the triple mutant 
setting are clonally deleted in the periphery, an idea consistent with the reduction of 
total T cell numbers in secondary lymphoid organs. 
 
 
4.3.3. Homeostasis of T cell numbers in single and triple mutant mice  
 
The surface expression of TCR-β is reduced in peripheral T cells from triple 
mutant mice. When dissecting the CD44
low
 and CD44
high
 subsets, we found that this 
change in TCR-β expression was exacerbated in the memory population. In addition, 
TCR expression is recovered after parking peripheral T cells from triple mutant mice in 
an MHC-deficient host. Recently, Thomas et al. (2011) generated variants of the 2C 
TCR with 700-fold increased affinity. Peripheral blood T cells transduced with these 
high affinity variants strongly down-regulated TCR expression in response to saturating 
doses of cognate peptide. This result indicates that TCR down-regulation is a feature of 
T cells that engage cognate ligand, but also highlights the link between TCR affinity 
and TCR surface levels. Importantly, TCR down-modulation has been reported as a 
mechanism to prevent unwanted T cellular activation (Schonrich et al., 1991).  
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Altogether, the changes in the distribution of naïve and memory subsets and TCR-
β expression reflect increased affinity achieved through structural alteration of the 
germline encoded CDR loops. This observation indeed indicates that the triple mutant 
TCR-β chain must be present at very low levels in order to prevent unwanted activation. 
In light of these findings, we propose that peripheral T cells bearing the CDR-
modified TCR-β chain can and do recognise MHC and that this interaction is of 
relatively high affinity. Lack of frank autoimmunity in triple mutants suggests that 
peripheral tolerance is not broken and that several mechanisms must be in place to 
prevent immune pathology. This includes, amongst several possibilities, TCR down- 
regulation (Schonrich et al., 1991), expression inhibitory receptors (Tivol et al., 1995), 
and clonal deletion. Deletion of activated lymphocytes would explain the reduction in 
total T cell numbers. Accordingly, we conclude that peripheral T lymphocytes from 
triple mutant mice do colonise the periphery following egress from the thymus but that 
a large fraction will subsequently die, not because they fail to engage MHC, but because 
they react too well with MHC. In the first two weeks after birth, when T cells are first 
released from the thymus, the availability of MHC ligands allows the cells colonising 
the periphery to gauge the amount of space left to repopulate. In this time frame, 
lymphopaenia is severe and therefore naïve cells entering the periphery proliferate and 
acquire a memory-like phenotype (Sprent et al., 2008). One possibility is that newly 
generated T cells in the triple mutant are better able to sense this space by exploiting the 
MHC resource more efficiently and are thus driven towards an activated phenotype.  
Another factor to take into account is competition for other survival resources. 
Competition between lymphocytes is a universal criterion for the maintenance of 
homeostasis in the steady state and following an immune response. For each newly 
generated lymphocyte, another lymphocyte dies. It follows that all T cells compete for 
survival resources including homeostatic cytokines, which are known to govern the 
maintenance of naïve and memory cells (Freitas, Agenes and Coutinho, 1996). The 
mutations we introduced to the TCR-β chain are unlikely to affect cytokine 
requirements independently of TCR signalling. However, quantitative or qualitative 
differences in signalling mediated by the single and triple mutant TCR-β could 
ultimately result in differential expression of cytokine receptors, which would in turn 
alter the cellular survival threshold. For instance, the IL-7R α chain (CD127) was 
consistently down-regulated on the surface of peripheral T cells of triple mutant mice, a 
feature that may account, at least in part, for the reduction of total T cell numbers. 
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4.3.4. MHC restriction in single and triple mutant mice 
 
The last section of this Chapter described the procedure used to generate 
chimaeric mice against an MHC-deficient background. HSC from the bone marrow 
represent the earliest precursor population that gives rise to thymocytes. We harvested 
bone marrow from single and triple mutant donors and injected T cell-depleted 
suspensions into MHC-deficient mice. The strain used in this experiment was rag 
sufficient and lacked expression of both class I and class II MHC molecules. In this 
setting, developing thymocytes do not progress beyond the DP stage due to lack of 
selecting pMHC elements.  
We found that HSC derived from single and triple mutant donors did not give rise 
to CD4
+
 and CD8
+
 thymocytes – and therefore also lacked CD4+ and CD8+ T cells in 
the periphery. However, it is important to note that a sizeable population of CD8
+
 T 
cells was detected. Nevertheless, because these cells were generated from both the 
Thy1.1.
+
 donor and from the host Thy1.2.
+
 host populations, we concluded that single 
and triple mutant thymocytes behaved similarly to donor cells. Therefore, the aberrant 
presence of T cells in our chimaeras must have resulted from residual class I MHC 
expression, possibly coming from the cell inoculum. Thus, despite the large intra-group 
variation observed across chimaeras, the unifying feature emerging from our experiment 
is that donor single and triple mutant mice are selected on MHC and, like the rag
+
 host 
population, remain stranded at the DP stage unless MHC expression is restored. 
Thus, to extend the findings described in Chapter 3, we conclude that thymocytes 
from triple mutant mice are selected on self pMHC and that the maintenance peripheral 
T cells from triple mutant mice strictly requires pMHC complexes. 
 
4.3.5. Conclusions 
 
In Chapter 3 we showed how thymocytes from single and triple mutant mice were 
subjected to selection at the DP stage, presumably in the context of MHC molecules. 
Here, we confirm that the selecting ligand for both the single and the triple mutant is 
indeed a pMHC ligand. In the triple mutant mouse, T cells selected on MHC ligands 
also require self pMHC for their survival and maintenance in the periphery. However, 
engagement to self pMHC induces the acquisition of a memory-like phenotype 
characterised by expression of T cell activation markers and low TCR levels. 
 
134 
 
 
Chapter 5 
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Chapter 5: T cell-mediated immunity in single and triple mutant 
mice 
 
 
 
 
5.1.  Background 
 
          5.1.1. General features of a typical T cell mediated response 
 
Within the naïve repertoire, the frequency of T cells capable of recognising a 
given antigen is extremely low and has been estimated at one in 100,000 T cells in 
humans and mice (Blattmann et al., 2002; Alanio et al., 2010; Kwok et al., 2012). Upon 
antigen encounter, epitope-specific T cells expand rapidly to populate the secondary 
lymphoid organs with cells that are armed to respond to antigenic challenge (Pantaleo et 
al., 1994; Butz and Bevan, 1998; Murali-Krishna et al., 1998). T cellular immunity 
strictly requires such expansion of relevant T cell clones but must also be accompanied 
by qualitative changes affecting the functional T cell population (Mercado et al., 2000). 
Indeed, ligation of the TCR to pMHC complexes triggers the induction of a complex 
differentiation programme culminating in the acquisition of effector function including 
cytokine secretion (Harty and Bevan, 1999; Bachmann et al., 1999) and production of 
effector molecules for cytolysis (Shresta et al., 1998). Once the antigen-specific cell is 
activated, the activation status is passed on to all daughter cells so that protective 
immunity can be sustained independently of antigenic priming (Murali-Krishna et al., 
1998; Wherry and Ahmed, 2004). After antigen clearance, the vast majority of T cells 
will be discarded by apoptosis, leaving behind a pool of long-lived T cells referred to as 
memory cells, as depicted in Figure 5.1 (Vella et al., 1998; Zhou et al., 2002). Thus, the 
contraction phase of the T lymphocyte compartment is under tight homeostatic control, 
which ensures the maintenance of normal T cell homeostasis under steady state 
conditions while allowing the preservation of immunological memory (reviewed by 
Harty and Badovinac, 2008). 
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Protective immunity is conveyed by several effector functions including secretion 
of cytokines and production of effector molecules. Traditionally, the T cell response is 
thought to involve a division of labour between CD4
+
 and CD8
+
 T cells. Class II MHC-
restricted CD4
+
 T cells are potent secretors of cytokines which coordinate the adaptive 
immune response (reviewed by Wan and Flavell, 2009). CD4
+
 T cells provide help to B 
cells in antibody secretion (de Kruyff et al., 1989); the cytokines they produce also help 
to recruit and maintain other cell types including macrophages and cells from the 
granulocyte lineage such as basophils and eosinophils (Zhu and Paul, 2008). 
Class I MHC-restricted CD8
+
 T cells are predominantly target cell killers but can 
also be potent cytokine producers (Harty, Twinnereim and White, 2000). As mentioned 
in the Introduction, the importance of lymphocytes is evidenced by a number of 
congenital diseases and mouse models. In addition, constitutive and conditional 
knockouts of selected cytokines and effector molecules also illustrate the importance of 
the soluble components resulting from T cell-mediated immunity. A protective immune 
response usually requires multiple T cell functions to be coordinated appropriately 
(reviewed by Kaech, Wherry and Ahmed, 2004). 
 
 
Figure 5.1. Natural course of a typical immune response (adapted from Wherry and 
Ahmed, 2004). Antigen-specific T cells (blue line) are expanded from the naïve T cell 
pool upon antigenic priming (red line). After peak expansion, with antigen load decline, 
the pool of antigen-specific effector cells contracts, leaving behind a smaller population 
of long-lived memory cells, which can be mobilised following secondary challenge with 
the same antigen. 
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5.1.2. T cell-mediated immunity to foreign proteins 
 
Our knowledge of the components of T cellular immunity is probably as old as the 
discovery of T cells themselves. The most essential characteristic of all αβ T cells, the 
concept of MHC restriction, emerged from a long study involving immunity to 
lymphocytic choriomeningitis virus (LCMV) in mice (Zinkernagel and Doherty, 1974). 
TCR transgenic mice have been exhaustively used in the field of Immunology to dissect 
the components of the T cell-mediated response.  
The efficacy of a T cell-mediated response depends on numerous factors. T cell -
mediated immunity is typically rapid, specific and sensitive. Firstly, T cell responses are 
fast because soluble factors including cytokines and chemokines resulting from the 
innate line of defense will ensure that antigen-specific T cells are efficiently recruited to 
sites of inflammation (Iezzi, Scheideger and Lanzavecchia, 2001). In parallel, 
specificity stems from antigen-driven expansion and activation of T clones from a wide 
T cell repertoire. Most T cell clones will not tolerate even a single amino acid 
substitution in cognate ligand (Windhagen, 1995). This is indeed illustrated by the fact 
that countless pathogens such as the highly mutable RNA viruses will use epitope 
variation as an immune evasion strategy (Koup, 1994; Oldstone, 1997; Price et al., 
1998). Finally, T cell responses to foreign antigen are exquisitely sensitive. The 
magnitude of T cell immunity is constrained by the fact that the relevant pMHC 
complexes for any T cell clone are present on the cell surface at very low density.  
Nonetheless, it has been shown that T cells can be activated by as few as 1 to 50 
cognate pMHC complexes at the surface of the APC (Sykulev et al., 1996; Irvine et al., 
2002). 
 
 
5.1.3.    Recognition of histocompatibility antigens 
 
While T cells are normally dedicated to providing immunity against potentially 
harmful pathogens, the T cell compartment is in fact equally capable of recognising any 
polymorphism arising between members of the same species. This phenomenon is well-
characterised and referred to as allorecognition (Snell, 1948). Thus, both in vitro and in 
vivo, CD4
+
 and CD8
+
 T cells mount robust responses against allogeneic tissue but are 
tolerant to genetically identical, or syngeneic, components. 
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5.1.3.a.  MHC molecules as histocompatibility antigens 
 
Immune responses against MHC molecules are not a naturally occurring 
phenomenon and thymocytes cannot be educated to recognise foreign MHC. 
Nevertheless, recognition of foreign MHC molecules is the most striking feature of 
transplant rejection. It is now widely known that T cells reject transplanted tissue from 
incompatible MHC backgrounds (Snell, 1948, reviewed by Ayala Garcia, 2012). In fact, 
the MHC products themselves were identified in this way, as described in the 
Introduction. Histocompatibility antigens become T cell targets either directly or 
indirectly. The direct pathway involves recognition of MHC molecules directly on the 
transplanted incompatible tissue. Molecular mimicry explains direct alloreactivity, such 
that a self pMHC specific TCR will cross-react with a foreign pMHC complex on 
allogeneic APC (Game and Lechler, 2002). By contrast, indirect allorecognition 
involves the canonical antigen processing and presentation pathway which operates for 
all T cell antigens. Capture and processing by recipient APC of allogeneic pMHC thus 
results in presentation and recognition of peptide derived from the allogeneic tissue. 
MHC molecules are often the source of peptide in this setting due to their high 
polymorphism and abundance. The frequency of T cells with alloreactive potential is 
thought to be extremely high, thereby explaining the strength of allogeneic responses in 
vivo and in vitro (reviewed by Rogers and Lechler, 2001). Although products of the 
MHC are not the intended ligand for TCR, MHC allelic variants can be exploited as 
potent tools for the examination of T cell responses both in vitro and in vivo, 
particularly in the murine system where inbred strains of known genetic background are 
widely available. Allogeneic stimulation is uniquely strong and is one of the most 
potent immunological stimuli known to T cells, as illustrated by the vigour of MLR in 
vitro and by the rapid rejection of histoincompatible transplants in vivo.  
 
5.1.3.b.    Recognition of minor histocompatibility antigens 
 
Cellular proteins other than MHC molecules can act as transplantation antigens. 
Minor histocompatibility (H) antigens are derived from non-MHC polymorphic proteins 
and are the targets for potent T cell responses in the context of MHC-matched 
allogeneic transplants (reviewed by Simpson and Roopenian, 1997).  
 
139 
 
Indeed, HSC transplants between HLA-identical siblings give rise to graft versus 
host disease (GvHD) (Goulmy et al., 1998), and inbred mice reject skin grafts of other 
strains of the same H-2 haplotype (Snell, 1948; Simpson et al., 2001). In addition, minor 
H are usually the preferential targets of T cells but not humoral responses (Simpson and 
Roopenian, 1997; Simpson et al., 2001). Unlike recognition of allogeneic MHC, 
responses to minor H antigen are identical to classical self MHC-restricted immune 
responses, because the minor H peptides are presented to T cells in the context of self 
MHC molecules (Bevan, 1975, Von Boehmer and Hafen, 1984). 
Nevertheless, immune responses to minor H mismatch are somewhat more 
complex than responses to foreign proteins. Theoretically, any polymorphism can give 
rise to an anti-minor H response. However, in practice the number of minor H peptides 
that give rise to an immune response is much more limited. Responses to minor H are 
typically characterised by immunological hierarchy, with some peptides dominating the 
response (Millrain et al., 2005). These immunodominant peptides are thought to prevail 
because they occupy most self MHC molecules at the cell surface, while the dominated 
peptides are less stable within pMHC complexes. A well-documented example of minor 
H acting as alloantigens includes the Y chromosome-encoded male-specific proteins, 
which have been studied extensively (Scott et al., 1995). 
 
          5.1.4. Aims 
 
In the previous Chapter, we showed that peripheral T cells from single and triple 
mutants were selected on pMHC ligands, as MHC-deficient mice reconstituted with 
donor bone marrow from either mutant failed to generate T cells.  Because T cells in 
both mutants are screened for MHC reactivity in the thymus, it seems likely that these 
mice will harbour functional peripheral T cells that are MHC-restricted. These mice are 
therefore amenable to in vivo immunisation and the response can be further 
characterised in vitro. Having unequivocally demonstrated that T cells from triple 
mutant mice could be selected to the periphery, we aimed to determine whether such T 
cells would also be able to negotiate an interaction with self MHC and foreign peptide. 
In this Chapter, we demonstrate for the first time that T cells lacking all three TCR- 
CDR can respond to foreign antigen, presumably in a self MHC-restricted manner. We 
show how single and triple mutant mice respond to a well-characterised protein antigen 
and to histocompatibility antigens in vitro and in vivo. 
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5.2. Results 
5.2.1. Single and triple mutant mice respond to foreign antigen  
 
We described in Chapter 4 how peripheral CD4
+
 and CD8
+
 T cells from naïve 
triple mutant mice displayed an activated phenotype with a shift toward TEM 
differentiation. In the periphery, the frequency of memory phenotype cells can reach 10 
to 30%, even in germ-free mice indicating that the memory population is generated and 
maintained by self pMHC antigens rather than bystander activation by commensal flora 
(Vos, Jones and Kruisbeek, 1992; reviewed by Sprent et al., 2008). The accumulation of 
TEM cells and up-regulation of T cell activation markers initially suggested to us that T 
cells from triple mutant mice were potentially amenable to peripheral activation at least 
in the context of self antigens. We therefore sought to determine whether these cells 
were able to mount a classical immune response against foreign antigen. Six-week old 
female mice were immunised by s.c. injection of 100 μl of HEL emulsified in CFA. A 
week following initial challenge, mice received a boost immunisation with HEL 
emulsified in IFA. Naïve single or triple mutant mice were also used as control. The 
immunisation protocol is summarised in Table 5.1 and all immunogens were prepared 
as described in Chapter 2. 
 
 
Table 5.1. Protocol for immunisation of single and triple mutant mice. 
 
 Day 0 Day 7 Day 14 
Single HEL + CFA s.c. HEL + IFA s.c. Euthanise 
Triple HEL + CFA s.c. HEL + IFA s.c. Euthanise 
 
 
 
Four mice in each group were initially immunised with HEL. Two weeks post-
injection (p.i.), mice were sacrificed and whole spleens harvested for analysis. 
Splenocyte suspensions were prepared to determine total cellularity (Figure 5.2). Both 
the single and triple mutant showed clear splenomegaly and total splenic cellularity was 
markedly increased compared to naïve mice (p = 0.0002 for single mutant mice and for 
triple mutants p = 0.0071). 
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A)  
 
B) 
 
 
Figure 5.2. Splenic size and cellularity in single and triple mutant mice immunised 
with HEL. A) Splenic size was measured for spleens harvested from single and triple  
mutant mice (n = 4 in each group). B) The total spleen cellularity in immunised single  
and triple mutant is compared to naïve mice (n = 4 for the single murant, and n = 6 for 
naivetriple mutat mice).  
 
To further characterise the immune phenotype induced by HEL challenge, 
splenocyte suspensions were stained with monoclonal antibodies against a wide panel of 
cell surface markers: CD69, CD5, CD40L, CD127, CD95 and CTLA-4. Splenocytes 
from single and triple mutant mice were stained as described in previous Chapters and 
analysed by flow cytometry (Figure 5.3). Age-matched naïve mice were also used as 
controls. Mice were immunised as before and blood samples were taken at the end of 
the immunisation scheme for analysis. Fourteen days post-challenge, CD4
+
 and CD8
+
 T 
cells up-regulated the activation markers CD40-L and CD69, as shown in Figure 5.3 
and discussed below CTLA-4 levels were also increased and CD127 was down-
regulated. Altogether these results suggest that, as expected, peripheral T cells fron sig 
le and triple mutant mice adopt an effector phenotype following HEL challenge.
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A)   Gated on CD4+ T cells 
          Single naïve          Single Immunised                    Triple naïve            Triple Immunised 
                  
                  
                  
                  
 
 
 
 
 
 
Figure 5.3. Immune phenotype in CD4
+
 and CD8
+
 T cells from immunised single 
and triple mutant mice. Blood samples from six week old single and triple mutant 
mice were stained with fluorochrome conjugated monoclonal antibodies against CD4, 
CD8, CD40-L, CTLA-4, CD69 and CD127. A) Histograms show the expression of 
CD40-L, CTLA-4, CD69 and CD127 gated on CD4
+
 T cells from single (left) and triple 
mutant mice (right). The negative control is shown by the grey shaded area. 
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B) Gated on CD8+ T cells 
         Single naïve                Single Immunised                         Triple naïve             Triple Immunised 
                  
                   
                  
                  
 
 
 
 
 
 
 
Figure 5.3. Immune phenotype in CD4
+
 and CD8
+
 T cells from immunised 
single and triple mutant mice (continued). Blood samples from six week old single 
and triple mutant mice were stained with fluorochrome conjugated monoclonal 
antibodies against CD4, CD8, CD40-L, CTLA-4, CD69 and CD127. B) Histograms 
show the expression of CD40-L, CTLA-4, CD69 and CD127 gated on CD8
+
 T cells 
from single (left) and triple mutant mice (right). The negative control is shown by the 
grey shaded area. 
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Figure 5.3 (continued). C) and D) Data is summarised as MFI for CD40-L, CTLA-
4, CD69 and CD127 gated on CD4
+
 (C) and CD8
+
 T cells (D). 
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We computed the MFI for CD40-L, CTLA-4, CD69 and CD127-expressing 
cells (Figure 5.3). In CD4
+
 T cells and CD8
+
 T cells, CD40-L MFI was markedly 
increased both in single mutant (p = 0.0092 for CD4
+
 T cells and p = 0.0027 for 
CD8
+
 T cells) and triple mutant mice (p = 0.0002 for CD8
+
 T cells). Similarly, HEL 
immunisation also induced significant CD69 up-regulation, with a two-fold increase 
in the single mutant (p = 0.0014 for CD4
+
 T cells and p < 0.0001 for CD8
+
 T cells) 
and a three-fold increase in the triple mutant (p = 0.0005 for CD4
+
 and p < 0.0001 for 
CD8
+
 T cells). As described in Chapter 4, the levels of CTLA-4 expression are 
already elevated in peripheral T cells from naïve triple mutant mice, compared to 
single mutants. However, immunisation led to a further increase in CTLA-4 levels in 
CD4
+
 T cells from triple mutants (p = 0.0158), but not in single mutant mice. Also 
consistent with the acquisition of an effector phenotype, CD127 levels were reduced 
following HEL challenge, although this was not statistically significant in all cases (p 
< 0.0001 in CD4
+
 T cells from single mutant mice). 
Thus, the immune status of immunised animals indicates that, as expected, 
peripheral T cells from single and triple mutant mice differentiate to effector cells 
following HEL challenge in vivo. 
 
5.2.2. Single and triple mutant mice respond to antigen in a dose-dependent 
manner 
 
The first parameter we sought to define was the stimulation time needed to 
obtain a sizeable response against HEL, if any. We immunised six week old female 
single mutant mice (n = 4) as before. Splenocyte suspensions were stimulated with 
HEL and left to incubate at 37ºC for 24 hours, 48 hours or 72 hours. All samples 
were plated in triplicate on a sterile PVDF-bottomed ELISpot plate as 10
5
 responder 
cells in the presence of 1μg/ml of HEL (Figure 5.4). At the end of the incubation 
period, the plates were developed as described in Chapter 2 and for each well, IFN-γ 
producing spot-forming cells (SFC) were enumerated.  
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Figure 5.4. Time course experiment for HEL challenge in single mutant mice. 
Six week old single mutant mice (n = 4) were immunised and challenged with HEL 
in vitro for 24, 48 or 72 hours. IFN-γ ELISpot results are shown for each mouse as 
average SFC count per million and SEM for each mouse. 
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At the first time point, all stimulated wells gave a response equal or greater 
than 780 SFC per million, ranging from 780 to 3030 SFC. At 48 hours, the response 
remained of similar magnitude, ranging from 355 to 3425. Finally, on the last time 
point, the response declined to less than 600 SFC in all cases.  
Based on this initial result, all subsequent HEL challenges involved a 24 hour 
stimulation. To determine the optimal concentration of protein needed to analyse 
cytokine production in single and triple mutant mice, we set up a dose-response 
experiment where 10
5
 splenocytes from immunised mice (n = 4 in each group) were 
stimulated in vitro with HEL at 100, 10, 1, 0.1 and 0.01 μg/ml or TCM as a control 
for background IFN-γ production. The samples were plated in triplicate on a sterile 
PVDF-bottomed ELISpot plate in the presence of titrating doses of HEL and left to 
incubate overnight at 37ºC; 5% CO2 (Figure 5.5). After 24 hour incubation, the plates 
were developed and IFN-γ SFC were enumerated. At the lowest dose (0.01 μg/ml), 
the average SFC in the single mutant mice ranges from 54 ( + 14) to 340 ( + 163). 
Against the same dose, the triple mutants responded with similar magnitude (ranging 
from 43 + 23 to 423 + 20). The response from single and triple mutant mice 
remained comparable up to a dose of 10 μg/ml. At 10 μg/ml, the SFC count for the 
single mutant mice ranged from 320 ( + 188) to 877 ( + 149), but did not exceed 680 
( + 193) for the triple mutant. Overall, we found that both mutants secreted IFN-γ 
above background levels and responded to HEL in a dose-dependent manner. We 
therefore adopted a final concentration of 1μg/ml for all subsequent in vitro 
stimulations, corresponding to a dose of 7 nmol per well. 
 
 
 
 
 
148 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Single and triple mutant mice respond to HEL challenge in a dose-
dependent manner. Six week-old female mice (n = 4 in each group) were 
immunised as described Table 5.1. Ten days post-challenge mice were euthanised 
and spleen suspensions were prepared for in vitro stimulation with HEL and 
ELISpot. For each mouse, cells were plated in triplicate in the presence of HEL at the 
final concentration indicated on the x-axis in μg/ml. The results are shown for single 
(top) and triple mutant mice (bottom) as mean SFC count per million and SEM. 
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To expand on these results, more immunisations were carried out on six week-
old female single (n = 7) and triple mutant mice (n = 8). At the end of the in vivo 
priming period, an IFN-γ ELISpot was set up following 24 hour HEL stimulation at 1 
μg/ml in vitro. In addition, we used PMA and ionomycin as a positive control. All 
samples were plated in triplicates of 10
5
 cells in the presence of HEL and incubated 
overnight at 37ºC; 5% CO2. The single mutants displayed a strong response, with 
more than 1000 SFC per million in all cases. The triple mutant response was smaller 
in magnitude but did generate more than 700 SFC in all cases (Figure 5.6.). 
Interestingly, when compared to the positive control, we found that all mutants 
displayed a response stronger than that to PMA and ionomycin. 
The SFC cut off for a positive response was determined using the empirical 
criterion described by Currier et al. (2002) and by Hudgens et al. (2004). For each 
mouse, the cut off value is given by the average number of spots in the unstimulated 
wells, SFCneg. This number is subtracted from the number of spots in the stimulated 
wells, SFCstim. A positive response is then defined as: 
 
SFCstim – SFCneg > 2 × SFCneg 
or  stimulation index (SI) > 2, where SI =      (SFCstim – SFCneg )/ SFCneg 
 
In addition, the internal control is given by SFCpos, the average number of spots 
following PMA + ionomycin stimulation. Mice with SFCpos smaller than 50 were 
considered non-responders and are not shown. All mice analysed here responded 
positively, with  SFCpos > 50 in all cases and with an SI equal or greater than 3 in all 
individual cases (Figure 5.6). Thus, single and triple mutant mice harbour potent 
IFN-γ-producing cells following in vivo challenge with a foreign antigen.  
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    A)                      HEL                         PMA+ ionomycin                            TCM 
 
 
 
 
Figure 5.6. Single and triple mutant mice produce IFN-γ in response to HEL 
challenge. A) An IFN-γ  ELISpot was performed on single (n = 7) and triple mutant 
mice (n = 8) immunised with HEL and on control naïve single mice (n = 2). B) The 
data is shown for individual animals and C) for the pooled data as mean SFC count 
per million and SEM.  
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We summarise the data in Table 5.2 below as SI for all mice immunised in this 
study. Only one animal in each group failed to respond to antigenic challenge  (SI < 
1) and these were not included in the results shown below. SI values ranged from 3 
to 31 in single mutant mice and from 6 to 33.8 in triple mutants, with an average SI 
of 12.16 ( + 6.4) and 12.81 ( + 4.4), respectively. The absolute SFC counts shown 
before for individual mice and for the pooled data indicated that in the triple mutant, 
there may be a trend towards low-magnitude response. However, the difference in SI 
between the two groups was not statistically significant. Therefore, despite a few 
single mutant outliers in the upper SI range, single and triple mutant mice respond to 
HEL challenge with remarkably similar magnitude. 
 
 
 
Table 5.2. Stimulation index in single and triple mutant mice challenged with 
HEL. SI values are shown for each mouse in both groups. The SI was calculated for 
each mouse as SI = (SFCstim – SFCneg )/ SFCneg, rounded up to the first decimal place. 
The mean SI for single and triple mutant mice, and SEM, are given at the bottom of 
the table. 
 
 Single Triple 
 4.6 6 
 2.9 6 
 49.5 5.9 
 4.2 11.5 
 4 19.3 
 14 33.8 
 6.1 11.2 
  8.8 
Mean 12.16 12.81 
SEM 6.4 3.4 
 
 
To confirm that IFN-γ production in immunised mice was not due to an adjuvant 
effect, we set up a mock experiment in which six week old female triple mutant mice 
(n = 4) were injected s.c. with adjuvant only, as described in Table 5.3. On day 0, 
CFA and PBS were emulsified at a 1:1 ratio then 100 μl of suspension were injected 
s.c. into the recipients. A week later, all mice were boosted with 100 μl PBS in IFA. 
 
152 
 
Table 5.3. Experimental set up for mock immunisation of triple mutant mice. 
 Day 0 Day 7 Day 14 
“Mock” 
Single PBS + CFA s.c PBS + IFA s.c Euthanise 
Triple PBS + CFA s.c PBS + IFA s.c Euthanise 
 
At the end of the immunisation scheme, mice were sacrificed and splenocyte 
suspensions were prepared for IFN-γ ELISpot as before. Cells were plated in 
duplicate as 10
5
 cells per well in the presence of HEL and incubated overnight before 
ELISpot. As expected, we found that none of the samples from animals receiving 
mock immunisation produced IFN-γ in vitro. All wells yielded an SFC count below 
background as shown in Figure 5.7. The average stimulation index was 0.37 across 
the pooled data. Therefore, T cells from mice immunised with adjuvant alone are not 
primed to produce IFN-γ. This observation confirms that the results described in the 
previous section are not an artifact resulting from the use of adjuvant. 
 
                                               Adjuvant                      TCM 
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Figure 5.7. Triple mutant mice do not respond to in vivo challenge with 
adjuvant alone. An ELISpot for IFN-γ production was performed on triple mutant 
mice immunised with PBS in CFA (n = 4). The data is shown for individual animals 
(left) and pooled data (right) as mean SFC and SEM.  
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5.2.1. Single and triple mutant mice respond to multiple minor H antigens  
in vivo 
 
Having demonstrated that single and triple mutant mice mounted an efficient 
response to a model protein antigen, we sought to determine whether these mice 
could mount a more complex response against a mixture of antigens in vivo. Minor H 
antigens are derived from non-MHC polymorphic proteins and are the targets for 
potent T cell responses in the context of MHC-matched transplants (reviewed by 
Simpson and Roopenian, 1997). The DBA1/J strain shares the same H-2 haplotype 
as the single and triple mutant mice used in our study (H-2
q
). Therefore, the single 
and triple mutants have the potential to respond to DBA1/J-associated minor H 
antigens. In addition, because minor H are the preferential targets of T cells but not 
humoral responses, they represent an ideal system to dissect the responsiveness of 
our single and triple mutant T cells, without major contributions from other cell types 
such as B lymphocytes. Responses against minor H are usually measured following 
in vivo immunisation because this approach brings T cell precursor frequencies to 
levels similar to a classical MLR (Simpson and Roopenian, 1997; Simpson et al., 
2001). Last but not least, anti-minor H responses are usually mediated both by CD4
+
 
and CD8
+
 T cells. We used an in vivo system in which syngeneic (full minor H 
match) and allogeneic (minor H mismatch) cells can be co-injected into the same 
recipient, allowing us to look at the rates of minor H graft rejection. Bone marrow or 
splenocytes were harvested from donor DBA1/J and FVB/n mice and differentially 
labelled with 10 and 1 nM of CFSE respectively (Figure 5.8). Using this staining 
protocol, the DBA1/J and the FVB/n cells can be identified as two distinct 
populations in the same recipient (Millrain et al.; 2005).  
 
Table 5.4. Immunisation protocol for multiple minor H challenge. 
 Day 0 Day 2, 4 and 21 Day 30 
Bone marrow first challenge 
Single FVB/n 107 cells + DBA 1/J 107  cells i.v. Blood Sampling - 
Triple FVB/n 107 cells + DBA 1/J 107  cells i.v. Blood Sampling - 
Splenocyte second challenge 
Single FVB/n 107 cells + DBA 1/J 107  cells i.v. Blood Sampling Euthanise 
Triple FVB/n 107 cells + DBA 1/J 107  cells i.v. Blood Sampling Euthanise 
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Bone marrow cells were initially co-injected intravenously at a 1:1 ratio and 
the recipient mice were bled on Day 2, 4 and 21 p.i. Blood samples were taken at 
three different time points as indicated above then lysed and analysed for CFSE 
fluorescence as measure of the frequency of syngeneic and minor H mismatched 
cells for each recipient. On day 2 p.i., an average 0.39% ( + 0.1) minor H 
mismatched CFSE
bright
 cells remained in the single mutant recipients, compared to 
0.33% ( + 0.07) in triple mutant mice. The figures declined over time, with all 
mismatched cells being undetectable by day 21 p.i. Unexpectedly, we found that the 
syngeneic CFSE
dim
 cells followed the same fate as the mismatched cells and were 
also rejected in both groups with similar kinetics (Appendix B). We reasoned that 
bone marrow suspensions did not represent a good choice of donor cells.  Bone-
marrow-derived cells represent a heterogeneous collection of cells, most of which 
could have homed to distinct locations and exited the bloodstream, becoming 
undetectable soon after injection. 
To circumvent this issue, we challenged the mice a second time with 
splenocytes from DBA 1/J and FVB/n donors labelled with CFSE as before. We 
hypothesised that the recipients, having been primed with minor H-mismatched bone 
marrow, would reject the donor cells at an accelerated rate. As before, mice were 
injected i.v. with 10
7
 splenocytes of each type, then blood was taken on day 2, 4 and 
21 p.i. From this second challenge with minor H-mismatched splenocytes, we 
observed that the frequency of CFSE
dim 
syngeneic cells declined slowly over a 21 
day period, but more than 0.2% ( + 0.01) cells remained at the end of the observation 
period. The discrepancy between these results and those from primary challenge with 
bone marrow donors confirmed to us the bone marrow-derived syngeneic cells (and 
allogeneic cells) may have exited the bloodstream and were not retained in the 
circulation, which would explain why both the syngeneic and the mismatched 
populations initially appeared to have been rejected over time. 
With splenocyte injections however, the frequency of mismatched CFSE
bright
 
cells on day 2 p.i. was 0.44% ( + 0.02) in the single mutant compared to 0.35 ( + 
0.15) in triple mutant mice. For both mutants, the syngeneic population was retained 
over the course of the 21 day observation period, whereas minor H mismatched cells 
declined over time, as seen in Figure 5.8.   
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A)                         Day 2                                  Day 4                                 Day 21 
  
  
 
 
Figure 5.8. Single and triple mutant mice respond to multiple minor antigens 
from DBA 1/J splenocytes. Splenocytes were harvested from donor DBA1/J and 
FVB/n mice and differentially labelled with CFSE as before. Cells were co-injected 
i.v. at a 1:1 ratio. Recipient mice were bled on day 2, 4 and 21 p.i. and analysed for 
CFSE expression. A) Flow cytometry plots representative of single (n = 2) and triple 
mutant mice (n = 4) gated on the lymphocyte population. B) The frequencies of 
CFSE
dim
 syngeneic cells (left) and CFSE
bright
 mismatched cells (right) are shown for 
two single and four triple mutant mice. 
 
 
Syngeneic
%
 C
F
S
E
d
im
 c
e
ll
s
2 4 21
0.0
0.2
0.4
0.6
Single
Triple
Minor H
%
 C
F
S
E
b
r
ig
h
t
 c
e
ll
s
2 4 21
0.0
0.2
0.4
0.6
Single
Triple
S
in
gl
e 
T
rip
le
 
CFSE 
S
S
C
 
B) 
 
156 
 
As mentioned before, responses against minor H antigens involve cooperation 
between CD4
+
 T cells and CD8
+
 T cells, indicating that the DBA1/J strain used here 
encodes genetic polymorphism that elicit a response from both CD4
+
 an CD8
+
 T 
cells in single and triple mutant. Thus, in single and triple mutant mice, both T cell 
subsets are functional and involved in the rejection of minor H antigen in vivo. 
 
5.2.2. Single and triple mutant mice respond to alloantigens 
T cells respond to tissues from MHC-mismatched, or allogeneic, donor strains. 
MHC mismatch is the major cause of transplant rejection. In MLR experiments, T 
cells proliferate vigorously in response to alloantigens because the frequency of allo-
specific T cells in the repertoire is remarkably high. For this reason, in order to 
obtain an in vitro alloresponse, in vivo immunisation is dispensable. We established 
in previous sections that single and triple mutant mice were able to respond to a 
foreign antigen and to minor H antigen in vivo. To further describe T cell-mediated 
immunity in single and triple mutant mice, we therefore sought to determine whether 
these mice would also to cope with potent stimuli, such as alloantigens. Splenocytes 
from single and triple mutant mice were labelled with CFSE and plated as 10
5
 cells 
per well in the presence of C57BL/6 (B6), Balb/c, MHC
KO
 B6 or FVB TCR-β/δKO 
stimulator cells and 4 U of IL-2. The B6 and Balb/c strains were used as allogeneic 
(H-2
b 
and H-2
d
 respectively) tissue donors, MHC
KO
 for minor H mismatch control 
and FVB TCR-β/δKO as syngeneic control. Responder cells were also plated alone in 
TCM only, as negative control. The responders were plated in duplicate with 
different doses of stimulator cells for a final responder to stimulator ratio of 1:3, 1:5 
or 1:10 in a flat-bottomed 96-well plate.  
 
Table 5.5. Experimental MLR set up. 
 
 Day 0    Day 2 
 Allogeneic Allogeneic Minor H Syngeneic  
Single 105 + B6 105 + Balb/c 105 + B6 MHCKO 105 + FVB Analysis 
Triple 
 
105 + B6 
 
105 + Balb/c 
 
105 + B6 MHCKO 
 
105 + FVB 
 
Analysis 
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On day 2 post-stimulation, proliferation was assessed by flow cytometry using 
CFSE dilution relative to unstimulated controls as readout. The background 
proliferation was deducted from the stimulated samples in all cases, and the 
frequency of CFSE
low
 cells was plotted against APC dose, as shown in Figure 5.9. 
We found that both mutants responded to allogeneic APC from B6 and Balb/c mice 
by proliferating, hence diluting CFSE. In addition, we noted that the alloresponse of 
the triple mutant was remarkably similar to that of the single mutant, with very little 
variation between animals. Both mutants respond in a dose-dependent manner to 
APC numbers ranging from 0 to 10
6
 (Figure 5.9).  
Neither strain responded to B6 MHC
KO
, demonstrating a strong preference for 
MHC ligands. Thus, much like normal T cells, T lymphocytes lacking TCR 
germline-encoded CDR loops are not responsive to non-MHC ligands. We conclude 
that, although single and triple mutant mice elicit a response against syngeneic 
antigen, they respond to alloantigen with similar magnitude and are insensitive to 
non-MHC ligands in vitro.  
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A)  Proliferative response to allogeneic APC (Day2, lower dose of APC)                                        B)   Proliferative response to allogeneic APC (Day 2) 
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Figure 5.9. Single and triple mutant mice proliferate in response to alloantigens in vitro. CFSE-labelled splenocyte suspensions from single and triple mutant 
mice (n = 4 each) were plated as 10
5
 cells in the presence of B6, Balb/c, MHC
KO
 B6 or FVB TCR-β/δKO donor cells and IL-2. Responder cells were plated in 
triplicate with different doses of stimulator cells for a final responder to stimulator ratio of 1:3, 1:5 or 1:10 in a flat-bottomed 96-well plate. A) Samples were 
harvested and analysed for CFSE dilution by flow cytometry. Histograms are representative of two mice in each group stimulated with the lowest dose of APC (3 × 
10
5
 cells per well). B) The summary graphs indicate the mean frequency of CFSE
low
 cells on day 2 with increasing doses of APC.
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We repeated a similar MLR scheme in order to confirm whether the syngeneic 
response was genuine or merely an experimental artefact. The use of CFSE dilution is 
known to produce false positives in vitro (personal communication from Professor 
Julian Dyson and Dr István Bartok). Using the same culture conditions as before, we 
plated splenocytes from single and triple mutant mice in the presence of NOD (H-2
g7
) 
allogeneic stimulator cells. The frequency of dividing cells was evaluated at two time 
points, on day 1 and day 3 p.i. For each experimental condition background 
proliferation was deducted from the frequency of CFSE
low
 cells. The alloreaction rates 
were calculated as: 
 
 
AR = % CFSE
low
 cells in allogeneic reaction - % CFSE
low
 cells in syngeneic control 
 
Splenocytes from single and triple mutant mice responded to allogeneic NOD 
cells in vitro in a dose-dependent manner, as seen in Figure 5.10. For both mutants, we 
found that there was substantial proliferation against syngeneic cells. This was more 
pronounced in the triple mutant, resulting in lower AR values. On day 1 p.i., the 
frequency of CFSE
low
 cells in allo-stimulated wells ranged from 55% ( + 0.4) to 68% ( + 
0.9) across the APC range for the single mutant compared to 43 ( + 1.4) to 54% ( + 2.2) 
in the triple mutant. On day 3, these figures remained similar for the triple mutant, but 
increased to 84% ( + 0.6) at the highest APC dose for the single mutant. 
The rates of alloreaction on day 1 are markedly lower for the triple mutant across 
all APC doses, ranging from  43.3% ( + 1.5) to 54.2% ( + 2.3) compared to 53.5% ( + 
1.2) to 66.2% ( + 0.7) for single mutant responders. On day 3, the alloreaction rates for 
the triple mutant are more closely matched to the single mutant. Thus, although both 
mutants respond to alloantigen, the kinetics of allorecognition differ, with the triple 
mutant displaying slower proliferative potential against allogeneic stimulation. 
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A)           Allogeneic-Day 1                                             Allogeneic-Day 3 
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Figure 5.10. Single and triple mutant mice respond to alloantigens from NOD 
donors in vitro. CFSE-labelled splenocyte suspensions from single and triple mutant 
mice (n = 3 each) were plated as 10
5
 cells in the presence of NOD donor cells and IL-2. 
Responder cells were plated in triplicate with different doses of stimulator cells for a 
final responder to stimulator ratio of 1:3, 1:5 or 1:10 in a flat-bottomed 96-well plate. A) 
Alloantigen-stimulated samples were harvested on day 1 and day 3 p.i and analysed for 
CFSE dilution by flow cytometry. B) Syngeneic control wells were harvested on day 1 
and day 3 p.i and analysed for CFSE dilution by flow cytometry. C) Alloreaction rates 
were calculated as % CFSE
low
 cells in allogeneic reaction - % CFSE
low
 cells in 
syngeneic control. 
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5.3. Discussion 
 
5.3.1. Summary 
 
The induction of protective T cell-mediated immunity rests on the expansion of 
antigen-specific cells which differentiate to perform essential effector functions. The 
importance of T lymphocyte populations is evident from a number of congenital 
diseases as discussed in the Introduction, as well animal models. Lack of CD4
+
 and 
CD8
+
 T cell effector function undermines the ability to mount a protective immune 
response. In the CD8
+
 T cell compartment, perforin deficiency, granzyme B deficiency 
or granzyme A and B double deficiency are linked to increased susceptibility to LCMV 
and ectromelia virus infection in mice (Shresta et al., 1999, and reviewed by Harty, 
Tvinnereim and White, 2000). Influenza virus clearance in humans has been shown to 
involve perforin-mediated cytolysis by CD8
+
 T cells (Topham et al., 1997). Several of 
these processes are regulated by TCR signalling. For instance, it has been demonstrated 
that peptide modifications and CD8 blockade which weaken TCR signalling allow Fas-
mediated but not perforin-mediated cytolysis (Kessler et al., 1998). Therefore, it is 
crucial to dissect the differing effects of T cellular signalling on the various effector 
mechanisms of immunity. 
The induction of T cell-mediated immunity is triggered by recognition of peptide 
epitopes through the T cell antigen-binding site. The MHC plays an essential role in the 
process because peptides need to bind MHC stably in a conformation that allows 
protruding side chains to interact with relevant TCR residues in the CDR loops that 
form the antigen-binding site. Here, we demonstrate for the first time that TCR-β chains 
lacking all three CDR loops can mediate recognition of foreign antigen. Triple mutant 
mice immunised with protein antigen can be primed in vivo and respond to in vitro 
challenge with this antigen by proliferating and producing IFN-γ. Furthermore, these 
mice also recognise complex alloantigen mixtures. On the one hand, we have shown 
how single and triple mutant mice rejected cells derived from minor H mismatched 
strains in vivo. On the other, they proliferated in the presence of allogeneic stimulator 
cells from the H-2
b
 (B6) or H-2
d
 (Balb/c) haplotype in vitro. The response to foreign 
antigen is MHC-restricted because the triple mutant mice did not respond to B6-
associated minor H antigens in the absence of MHC molecules (B6 MHC
KO
). We 
conclude that T cells from a triple mutant TCR-β chain background respond to foreign 
antigen in the context of self MHC molecules.  
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Table 5.6. Summary of selected results from Chapter 5. 
 
  Single Triple 
Stimulation index (HEL) 12.16 12.81 
MLR rate (B6) 8.6 5.8 
MLR rate (Balb/c) 25.15 20.85 
MLR rate (MHCKO) 0.53 0.21 
MLR rate (FVB) 5.6 5 
 
 
5.3.2. Detection of antigen-specific cells in single and triple mutant mice 
 
Numerous methods are available for quantitation of antigen-specific cells and the 
magnitude of the immune response but whatever the method used, functional readouts 
are usually cytokine production and proliferation because these features are 
characteristic of antigen-experienced T cells, and not naïve cells. ELISA, or the more 
sophisticated ELISpot approach, use cytokine production as a functional readout to 
determine the immune status of an individual. While ELISA evaluates the total 
concentration of cytokine in the sample of interest, ELISpot enumerates the number of 
cytokine-producing cells ex vivo. ELISpot assays are amongst the most sensitive assays 
of this nature and can detect cytokine-secreting cells down to a frequency of one in a 
million cells. The culture time for a typical ELISpot is less than 24 hours and for this 
reason the measured response measured ex vivo is believed to accurately mirror the in 
vivo response.  
The induction of type I and type II interferons during an immune response is well-
documented. Type I interferons are part of the early innate line of depense during viral 
infection. IFN-γ is the only known type II interferon and its expression is limited to 
cells of the immune system, predominantly T cells and NK cells. Usually, all agents that 
promote T cell activation induce IFN-γ synthesis, including polyactivators such as 
phorbol esters and calcium ionophores (Sen, 2001). For this reason, IFN-γ production is 
a common readout for T cell stimulation assays, particularly ELISpot assays. In this 
study we used IFN-γ ELISpot following in vivo priming of T cells with protein and 
adjuvant. We determined that for single and triple mutant, IFN-γ induction occurred 24 
hours post stimulation, with the peak response between 24 and 48 hours. In antigen 
titration experiments, T cells from immunised mice respond to antigen in a dose- 
dependent manner.  
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5.3.3. Magnitude of T cell responses in single and triple mutant mice 
 
In the T cell compartment, all specific recognition events are underlied by TCR 
ligation to pMHC complexes. Every immune response reflects the composition of the 
naïve TCR repertoire available prior to antigenic challenge. In the steady state, each 
precursor clone represents only about 1 in a 100,000 T cells. Upon antigenic challenge, 
relevant clones will typically expand to reach a frequency of 1% of total splenic T cells. 
In our system, we found that T cells from both the single and the triple mutant were able 
to expand in response to alloantigen, as demonstrated by CFSE dilution in MLR. In 
addition, both mutants also acquire effector functions such as IFN-γ production after 
immunisation with protein antigen. In both strains, the spleens harvested from 
immunised mice displayed marked splenomegaly, indicating that splenocytes had 
undergone clonal expansion following HEL challenge. This result was not solely an 
adjuvant effect, as mice challenged with CFA alone did not produce IFN-γ in vitro. 
Thus, in vivo HEL immunisation of single and triple mutant mice results in expansion of 
HEL-specific T cells capable of IFN-γ secretion in vitro.  
Although not statistically significant, we observed that overall triple mutant mice 
were geared towards lower magnitude responses. Typically, HEL challenge in triple 
mutant mice yielded an average SFC count of 533 ( + 190) compared to 733 ( + 260) in 
single mutants. The magnitude of a T cell response depends on several factors, 
including but not limited to affinity for the stimulating ligands, naïve precursor 
frequency (Jenkins and Moon, 2012) and local inflammatory environment (reviewed by 
Steletaki and Wherry, 2012). Taking these factors into account, we anticipate that the 
different magnitude of T cell responses seen in single and triple mutant mice will 
directly relate to changes in affinity for pMHC ligands resulting from structural 
alteration of the CDR loops. One possibility is that the mutations in the triple mutant 
TCR-β are less compatible with the induction of productive T cell signalling. The 
alternative explanation is that structural changes brought in the triple mutant chain 
result in enhanced so that triple mutant T cells engage with pMHC with affinity, leading 
to peripheral anergy or deletion.  The latter explanation is the one that seems most likely 
to us given the results shown in previous Chapters. In the thymus (Chapter 3), we saw 
evidence that the triple mutant TCR-β mediated enhanced binding to pMHC resulting in 
increased rates of negative selection. It seems likely that, in the periphery, T cell 
carrying the triple mutant chain will also recognise pMHC antigen with high affinity.  
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5.3.4. Immune responses to histocompatibility antigens 
 
Allogeneic stimulation is a very robust stimulus for the T cell compartment 
because a high precursor frequency is amenable to activation by alloantigens. We first 
demonstrated that T cells from immunised mice were functional. In order to determine 
whether T lymphocytes provided effective immunity in the triple mutant, we conducted 
a series of experiments involving histocompatibility antigens. In vitro, we found that 
both the single and the triple mutant mediated a strong MLR against several H-2 
haplotypes (H-2
b
, H-2
d
 and H-2
g7
). The ability to respond to alloantigens differed from 
single mutants in several respects. The alloreaction rates, defined as the frequency of 
alloreactive T cells less the frequency of cells responding to syngeneic challenge, were 
marginally reduced in triple mutant mice. However, this did not affect the ability of 
triple mutant mice to reject allogeneic cells in vivo. Using CFSE-labelled cells we 
shwed that single and triple mutant mice were able to reject minor H mismatched cells 
from non- H-2
q
 donor mice. Immunity against minor H antigens usually requires the 
presence of both CD4
+
 and CD8
+
 T cells, indicating that in triple mutant mice, both 
populations are functional and mediate the anti-minor H response. 
 
5.3.5. Conclusions 
 
In light of the results shown here and in the previous Chapter, we propose that 
structural alteration of the germline-encoded CDR is largely tolerated by peripheral T 
cells. Mature T cells from single and triple mutant mice are functional, providing 
immunity against complex antigen mixtures and robust stimuli. Like normal T cells, the 
preferred ligand for the CDR-mutated TCR is a peptide bound to a self MHC molecule. 
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Chapter 6: Breadth, magnitude and cross-reactivity of T cell 
responses in single and triple mutant mice 
 
 
 
6.1. Background 
 
 
The clonal selection theory posits that the T cell-mediated response is a specific 
phenomenon. For example, an immune response to any particular pathogen will rarely 
provide protection against unrelated pathogens. T cell responses are also assumed to be 
highly specific because T cell clones isolated with a given antigen do not usually elicit a 
response against a different antigen. However, as discussed in the Introduction, it has 
been postulated that full immune coverage by the T cell arm of the adaptive immune 
system would require substantial TCR cross-reactivity (Mason, 1998). All TCR must be 
potentially cross-reactive to some extent because they are positively selected by self 
pMHC complexes in the thymus, but the peptides needed for positive selection will 
inevitably differ from those that initiate antigen-specific responses. Thus, although 
cross-reactivity in the T cell repertoire is an established notion, it is also difficult to 
reconcile antigen cross-recognition with TCR specificity. Moreover, adding another 
layer of complexity to this issue, it has been noted that tolerance to amino acid 
substitutions in cognate peptide varies widely between T cell clones. Indeed, the effects 
of mutations on cognate antigen range from affinity gain to loss of activity or even 
antagonism (Vidal et al., 1996; Sloan-Lancaster and Allen, 1996; Combadière et al., 
1998). Some TCR will not tolerate a single amino acid substitution (Windhagen, 1995), 
while others will recognise peptides that are entirely dissimilar in amino acid sequence 
(Ishizuka et al., 2009). 
 
6.1.1.    Features of TCR cross-reactivity 
 
The 1934.4 T hybridoma is an elegant example for TCR specificity and cross-
reactivity. 1934.4 recognises an MBP-derived peptide in the context of I-A
u
, through 
contacts made at position 3 (P3, Gln) and position 6 (P6, Pro) of the peptide. Wraith et 
al. (1992) used altered peptide ligands where P3 or P6 had been exchanged for each of 
the twenty naturally occurring amino acids to stimulate 1934.4.  
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Strikingly, all mutations at P6 abrogated antigen recognition, but P3 mutations 
were largely tolerated. This study thus demonstrated that a single TCR could be either 
cross-reactive or highly specific and that the extent of cross-reactivity was position-
dependent (Wraith, Bruu and Fairchild, 1992).  
One component of cross-reactivity, referred to as “antigenic sin”, was originally 
described in the early 1950s in the anti-influenza virus response. This was later 
observed in CD8
+
 T cells responding to different dengue virus serotypes 
(Mongkolsapaya et al., 2003). These early observations indicated that the immune 
system was capable of mobilising pre-existing T clones primed against a particular virus 
strain in order to mount a response against related, but different strains.  
In the most straightforward cases, cross-reactivity can simply involve mimicry or 
as seen in peptides with extensive sequence homology (Fujinami et al., 1983). This is 
because peptide recognition depends on very few amino acids. Indeed, class I and class 
II MHC molecules will typically bind peptides through anchor residues, with protruding 
peptide side chains available to make contact with the TCR. Nonetheless, cross-
reactivity is not limited to promiscuous recognition of homologous motifs and has also 
been described for peptides that are entirely unrelated (Bhardwaj et al., 1993; Hemmer 
et al., 1998a; Ishizuka et al., 2009). Bhardwaj et al. (1993) showed that T cell clones 
specific for the MBP Ac1-9 peptide could elicit a response against peptide variants that 
did not share a single amino acid with the native antigen. In fact, some clones in this 
study recognised peptide variants lacking the entire Ac1-6 stretch, which had previously 
been identified as the minimal recognition unit for MBP-specific clones. 
 
6.1.2.    Methods for the examination of T cell cross-reactivity 
 
Synthetic peptide libraries have become widely used and have generally proven 
useful in determining potential T cell epitopes or peptide binding to MHC molecules, 
for example in the design of vaccine strategies (Estaquier et al., 1996). Early studies 
were focused on limited sets of peptide analogues focused around known antigenic 
sequences. For instance, Estaquier et al. (1996) developed a combinatorial peptide 
library around the V3 loop of the gp120 envelope protein from HIV-1. This library, 
referred to as “mixotope antigen”, contains 7.5 × 105 related V3 peptide variants and has 
been shown to be a potent immunogen for B and T cells.  
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More recently, the more thorough approach involves the use of considerably 
larger peptide libraries containing trillions of peptides (Wilson et al., 1999; Wilson et 
al., 2004). What emerged from studies carried out using such libraries is that a single T 
cell clone can recognise over a million peptides in vitro (Wilson et al., 2004; 
Wooldridge et al., 2012). A million peptides may appear a large set, but considering the 
size of the peptide repertoire (5 × 10
11
 nonamers for instance), cross-reactivity would 
still be a rare event. Thus, analyses conducted using such libraries suggest that the 
specificity of a T cell clone is geared towards sets of ligands rather than single ligands 
(reviewed by Sparbier and Walden, 1999). However, whether the peptides deduced 
from such library scans can stimulate the corresponding clones in vivo is still unclear. 
Nonetheless, degeneracy in ligand recognition implies that under physiological 
conditions, sensitivity to multiple ligands must be tightly regulated in order to preserve 
the specificity that is typical of a classical T cell response. 
 
6.1.3.    Peripheral regulation of TCR degeneracy 
 
Although the inherent cross-reactivity of the TCR to pMHC complexes has been 
demonstrated by numerous studies, it must to be reconciled with the need to 
discriminate between relevant antigens, such as pathogen-derived complexes, from 
innocuous ones in order to achieve protective immune coverage. In addition to central 
and peripheral tolerance mechanisms, the T cell co-receptors have been proposed to 
provide an additional level of regulation (van den Berg et al., 2007; Wooldridge et al., 
2010b). Van den Berg et al. (2007) demonstrated that the CD8 co-receptor differentially 
modulated TCR avidity to one potential ligand while allowing the T cell to become less 
responsive to other ligands. In this way, T cells can achieve specificity by regulating 
CD8 expression levels. Therefore, while the TCR may have several ligand candidates, 
only a subset are potent, optimal agonists, and this subset can be focused on by CD8-
mediated modulation.  
It has been shown however that, unlike CD8, CD4 is unable to stabilise the TCR 
interaction with MHC, although it does enhance T cellular responses. Based on this 
observation it has been suggested that the main role for the CD4 co-receptor would 
predominantly be Lck recruitment rather than TCR stabilisation upon pMHC 
engagement (Artyomov et al., 2010). Thus, whether CD4 can, like the CD8 co-receptor, 
modulate T cell cross-reactivity remains to be determined. 
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6.1.4.   Aims 
 
In Chapter 5, we demonstrated that T cells from single and triple mutant mice 
were able to mount a classical immune response against a model antigen, HEL. In order 
to further characterise foreign antigen recognition in our mice, we designed a small 
peptide pool derived from HEL. Using this peptide pool we further describe the immune 
response to HEL in single and triple mutant mice, with emphasis on the breadth of the 
immune response. By consistently identifying stimulatory epitopes for both lines, we 
demonstrate that HEL-specific T cells from triple mutant mice respond to a larger set of 
epitopes, but with lower magnitude. 
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6.2. Results 
 
6.2.1. Designing a HEL peptide pool for characterisation of HEL-specific 
immune responses in single and triple mutant mice 
 
 
Having established that single and triple mutant mice could be primed to respond 
to a foreign antigen, we designed a peptide pool to further characterise this response. 
The HEL peptide pool consists of 15-mers overlapping by ten amino acids. Therefore, 
each peptide in the HEL pool can represent a potential epitope for either class I or class 
II restricted T cells. Indeed, a 15-mer has the potential to be taken up by professional 
APC, processed and presented as a 9 to 15 residue peptide by class II MHC, or as 8 to 
10-mer cross-presented by class I MHC molecules. The master pool contains a total of 
twenty four peptides and was further divided into ten sub-pools, as shown in Figure 6.1. 
A peptide matrix was designed so that each peptide is represented in two sub-pools 
only. For example, pool I contains peptides pp1-15, pp26-40, pp51-65, pp76-90 and pp101-105. 
Pool VI contains pp1-15, pp6-20, pp11-25, pp16-30, and pp21-35. Thus, pp1-15 is shared between 
pool I and pool VI. If, for instance, pool I and pool VI both show a positive response, it 
follows that pp1-15 contains an epitope for this response because only pp1-15 is shared 
between these two pools (Figure 6.1.). 
One special case arises when two consecutive peptides within the HEL sequence 
yield a positive response. Because the peptides contain a ten amino acid overlap, in this 
situation two consecutive hits are likely to represent a single epitope. For example, if we 
observe a positive response to pool I and II, together with pool VI, pp1-15 and p6-20 will 
both constitute a “hit”, but the actual T cell epitope is likely to correspond to the overlap 
region CELAAAMKRH.  
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A) KVFGRCELAAAMKRH (pp 1-15) 
     CELAAAMKRHGLDNY (pp 6-20) 
          AMKRHGLDNYRGYSL (pp 11-25) 
               GLDNYRGYSLGNWVC (pp 16-30) 
                    RGYSLGNWVCAAKFE (pp 21-35) 
                         GNWVCAAKFESNFNT (pp 26-40) 
                              AAKFESNFNTQATNR (pp 31-45) 
                                   SNFNTQATNRNTDGS (pp 36-50) 
                                        QATNRNTDGSTDYGI (pp 41-55) 
                                             NTDGSTDYGILQINS (pp 46-60) 
                                                  TDYGILQINSRWWCN (pp 51-65) 
                                                       LQINSRWWCNDGRTP (pp 56-70) 
                                                            RWWCNDGRTPGSRNL (pp 61-75) 
                                                                 DGRTPGSRNLCNIPC (pp 66-80) 
                                                                      GSRNLCNIPCSALLS (pp 71-85) 
                                                                           CNIPCSALLSSDITA (pp 76-90) 
                                                                                SALLSSDITASVNCA (pp 81-95) 
                                                                                     SDITASVNCAKKIVS (pp 86-100) 
                                                                                          SVNCAKKIVSDGNGM (pp 91-105) 
                                                                                               KKIVSDGNGMNAWVA (pp 96-110) 
                                                                                                    DGNGMNAWVAWRNRC (pp 101-115) 
                                                                                                         NAWVAWRNRCKGTDV (pp 106-120) 
                                                                                                              WRNRCKGTDVQAWIR (pp 111-125) 
                                                                                                                   KGTDVQAWIRGCRL (pp 116-129) 
 
 
 
 
 
 
 
 
Figure 6.1. The HEL peptide pool and peptide matrix.  A) The master pool contains 24 HEL-derived peptides, which were synthesised as 15-mers 
overlapping by 10 amino acids. B) This master pool was further divided as ten sub-pools containing five peptides each, with the exception of pool V 
and pool X, so that each peptide is represented in two sub-pools only.  
Pool 
Number I II III IV V 
VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35 
VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60 
VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85 
IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110 
X pp101-115 pp106-120 pp111-125 pp116-129 empty 
B) 
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6.2.2. Single and triple mutant mice can be primed with HEL peptides in vivo 
 
Six week old single and triple mutant mice (n = 4 in each group) were primed and 
boosted in vivo as described in Chapter 5 with the HEL master pool emulsified in 
adjuvant. Immunised mice were euthanized at the end of the immunisation period and 
splenocytes were plated in duplicate wells as 10
5
 cells in the presence of peptide and 4U 
IL-2. The peptide sub-pools contain five peptides (except for pool V and pool X), each 
at a working concentration of 1 μg/ml in 0.1% DMSO.  
 
 
 
 
Figure 6.2. Single and triple mutant mice produce IFN-γ in response to HEL-
derived peptides. Single and triple mutant mice (n = 4 in each group) were primed and 
boosted with HEL emulsified in adjuvants. Splenocyte suspensions from each animal 
were plated in duplicate wells as 10
5
 cells in the presence of peptide pools and 4U IL-2 
for IFN-γ ELISpot. Results are shown as average SFC and SEM for individual mice 
(top) and as pooled data (bottom). 
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As before, following 24h incubation with antigen, single and triple mutant mice 
responded by producing IFN-γ in vitro. We summarise the data below as a heat map by 
sorting the pools according to SFC yield in each mouse (Figure 6.3). Immunised mice 
responded to distinct peptide sub-pools with varying magnitude. In the single mutant 
group, the mice responded to between five (mouse 2) and nine pools (mouse 1). Only 
pool I, V and VII elicited a response in all four animals. Most pools triggered a low-
magnitude response (500 to 100 SFC), but some yielded a minimum of 1500 SFC, such 
as pool V and VII in mouse 1, pool IX in mouse 3 and pool VII in mouse 4. 
Remarkably, all animals in the triple mutant group responded to virtually every pool. In 
contrast to single mutants, most pools trigerred a robust response of at least 1000 SFC. 
Against pool III for instance, all triple mutant mice produced more than 1500 SFC. 
 
 
 
Single           
1 I II III IV V VI VII VIII IX X 
2 I II III IV V VI VII VIII IX X 
3 I II III IV V VI VII VIII IX X 
4 I II III IV V VI VII VIII IX X 
           
Triple           
5 I II III IV V VI VII VIII IX X 
6 I II III IV V VI VII VIII IX X 
7 I II III IV V VI VII VIII IX X 
8 I II III IV V VI VII VIII IX X 
  
 
         
  500 to 1000 SFC        
  1000 to 1500 SFC        
  >1500 SFC        
 
 
Figure 6.3. The in vitro response to HEL differs in breadth and magnitude in single 
and triple mutant mice. Single and triple mutant mice (n = 4 in each group) were 
primed and boosted with HEL protein and adjuvants. Splenocyte suspensions from each 
animal were plated in duplicate wells as 10
5
 cells in the presence of peptide and 4U IL-2 
for IFN-γ ELISpot. SFC counts (per million) are indicated for each single (top) and 
triple mutant mouse (bottom) responding to individual pools.  
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As mentioned before, the peptide sub-pools were designed so that each peptide is 
present in two pools only. Two pools constituting a “hit” only contain one stimulatory 
peptide, allowing us to identify potential epitopes for responder T cells. Using the 
matrix described in Figure 6.1, we could identify the corresponding peptides responsible 
for the observed IFN-γ production, which are shown in Table 6.1. In Figure 6.2 and 6.3, 
we showed that the recognition of HEL-derived peptides was shifted towards broader 
recognition in the triple mutant. The triple mutant recognised almost every pool as seen 
in Figure 6.3, which would render the identification of epitopes unnecessary (i.e. every 
peptide would represent a candidate epitope). Therefore we restricted our analysis to the 
pools that yielded an SFC between 1000 and 1500 per million. We hypothesised that 
candidate epitopes within this intermediate SFC range would be common to both 
mutants. 
In this 1000-1500 SFC range, the single mutant mice recognised a surprisingly 
small number of peptides compared to the triple mutants. Animals in the single mutant 
group indeed recognised one to two peptides among the HEL pool. By contrast, three 
out of four triple mutants recognised more than two peptides. The fourth mouse (mouse 
8) recognised only one peptide, pp6-20. Interestingly, recognition of this peptide was 
shared with mouse 5, and also with a single mutant mouse (mouse 1). We also found 
substantial overlap in the peptides recognised by mouse 5 and mouse 6. These two 
animals both recognised common peptides in the HEL1-30, HEL26-50, and HEL51-80 
regions. This suggests that the entire HEL1-80 stretch may contain several potent 
epitopes that elicit robust responses in triple mutant mice. 
In fact, mouse 5 recognised the largest set of peptides (fifteen peptides in total). 
Some of these represented two consecutive “hits”, indicating that the candidate epitope 
lied in the overlap region of the two peptides. This was the case for pp26-40 and pp31-45, 
pp51-65 and pp56-70, pp76-90 and pp81-95, and for pp101-115 and pp106-120. The overlap in these 
peptide pairs correspond to the following sequences: AAKFESNFNT; LQINSRWWCN; 
SALLSSDITA; and AWVAWRNRC.   
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Table 6.1. List of HEL candidate epitopes in single and triple mutant mice. 
  
 
Single                                                                                                                         
Mouse 1 I II III IV V  Mouse 2 I II III IV V 
VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35  VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35 
VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60  VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60 
VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85  VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85 
IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110  IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110 
X pp101-115 pp106-120 pp111-125 pp116-129 empty  X pp101-115 pp106-120 pp111-125 pp116-129 empty 
            
 
 
 
 
 
Mouse 3 I II III IV V  Mouse 4 I II III IV V 
VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35  VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35 
VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60  VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60 
VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85  VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85 
IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110  IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110 
X pp101-115 pp106-120 pp111-125 pp116-129 empty  X pp101-115 pp106-120 pp111-125 pp116-129 empty 
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Triple 
 
Mouse 5 I II III IV V  Mouse 6 I II III IV V 
VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35  VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35 
VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60  VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60 
VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85  VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85 
IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110  IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110 
X pp101-115 pp106-120 pp111-125 pp116-129 empty  X pp101-115 pp106-120 pp111-125 pp116-129 empty 
 
 
 
Mouse 7 I II III IV V  Mouse 8 I II III IV V 
VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35  VI pp1-15 pp6-20 pp11-25 pp16-30 pp21-35 
VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60  VII pp26-40 pp31-45 pp36-50 pp41-55 pp46-60 
VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85  VIII pp51-65 pp56-70 pp61-75 pp66-80 pp71-85 
IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110  IX pp76-90 pp81-95 pp86-100 pp91-105 pp96-110 
X pp101-115 pp106-120 pp111-125 pp116-129 empty  X pp101-115 pp106-120 pp111-125 pp116-129 empty 
 
177 
 
6.2.3. HEL-specific T cells from triple mutant mice cross-react with unrelated 
antigen 
 
We next sought to determine whether triple mutant mice would be enriched with 
cross-reactive TCR, allowing these mice to respond to foreign antigen after 
immunisation with another, unrelated antigen. Six week-old single (n = 10) and triple 
mutant mice (n = 9) were immunised with HEL in four independent experiments, as 
described before. Ten days post-challenge the mice were sacrificed and splenocyte 
suspensions prepared for 24 hour incubation in the presence of EBNA-1 (hereafter 
referred to as EBNA). EBNA is a 247 amino acid protein with no sequence similarity to 
HEL. The EBNA peptide mixture was supplied as lyophilised material and prepared 
according to the manufacturer’s recommendations for a final 6 nmol per well. Samples 
from individual mice were plated in triplicate of 10
5
 cells in the presence of antigen. 
As shown in Figure 6.4, we found that only the triple mutant cross-reacted to in 
vitro challenge with EBNA by producing IFN-γ. All single mutant mice displayed SFC 
below background. This result was observed in two independent experiments. However, 
the triple mutant mice consistently responded to EBNA challenge with an SI above 2, 
with the exception of mouse 4, which had an SI of 1.6. Overall the SI was significantly 
higher in triple mutant mice (p = 0.0078).  
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A)                       Single                                 Triple 
  
 
B) Cross-reactive IFN-γ production in response to EBNA challenge in vitro 
 
C) Stimulation index (SI) 
 
Figure 6.4. Triple mutant mice immunised with HEL cross-react with unrelated 
antigen in vitro. Six week old single (n = 10) and triple mutant female mice (n = 9) 
were immunised as described before. Ten days post-challenge, mice were euthanized 
and splenocyte suspensions were used for in vitro stimulation with EBNA and ELISpot. 
A) Representative picture of individual wells from single and triple mutant mice. B) 
Summary graph representing the results obtained in SFC for individual mice (left) or 
pooled (right). For each mouse, cells were plated in triplicate and the results are shown 
as mean and SEM. C) Results are expressed as SI absolute value. 
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In Table 6.2, we summarise the data as SI values in HEL to EBNA challenge 
(HEL → EBNA) compared to standard HEL challenge (HEL → HEL). As shown here, 
average SFC counts and SI were higher on average for single mutant mice compared to 
triple mutants immunised and re-challenged with HEL in vitro. This tendency was 
reversed in HEL → EBNA heterologous challenge, where only the triple mutant was 
found to cross-react with EBNA. For triple mutants, SFC counts and SI values were 
lower in EBNA challenge compared to HEL, indicating that triple mutant mice 
immunised with HEL retained this antigen as their preferred target antigen, despite 
cross-reacting with EBNA. 
 
 
 
Table 6.2. Comparative results in HEL → HEL challenge and HEL → EBNA 
heterologous challenge. The magnitude of the response from EBNA in vitro cross-
challenge is compared to standard HEL immunisation and in vitro challenge. Results are 
shown as mean SFC and SEM, as well as absolute SI values. SFC counts and SI values 
for HEL → HEL challenge are taken from Chapter 5. 
 
 Absolute SFC count SI 
 HEL → HEL HEL→ EBNA HEL → HEL HEL→ EBNA 
 
Single 
 
1538+ 277 
 
65 + 34 
 
12 
 
less than 1 
 
Triple 
 
828 + 255 
 
617 + 288 
 
12 
 
3 
 
 
 
 
To confirm these findings, we set up a reverse experiment in which triple mutant 
mice (n = 5) were first immunised s.c. with EBNA emulsified in CFA. Ten days post 
challenge, splenocytes suspensions were subjected to in vitro stimulation with four 
arbitrarily selected HEL peptide sub-pools (pool I, IV, VI and X). Splenocyte 
suspensions from individual mice were plated on PVDF-coated ELISpot plates as 
triplicates of 10
5
 cells in the presence of antigen and 4U IL-2. Peptide sub-pools were 
prepared at a final concentration of 1 μg/ml for each peptide in TCM with 0.1% DMSO. 
After 24h incubation, the plates were developed as described before and IFN-γ SFC 
were enumerated (Figure 6.5.) 
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A)                 I                                     IV                                       
  
                      VI                                          X 
 
                    TCM 
 
B) 
 
Figure 6.5. Triple mutant mice immunised with EBNA cross-react with unrelated 
antigen in vitro. Six week old triple mutant female mice (n = 5) were immunised as 
described before with EBNA. Ten days post-challenge, mice were euthanized and 
splenocyte suspensions were used for in vitro stimulation with select HEL peptide pools 
and ELISpot. A) Representative picture of individual wells pulsed with pool I, IV, VI, 
X, or TCM alone. B) Summary graph representing the results obtained in SFC for 
individual mice (left) or pooled (right). For each mouse, cells were plated in triplicate 
and the results are shown as mean and SEM.  
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As before, we observed a number of cross-reactions between HEL and EBNA 
(Figure 6.5.). With the exception of mouse 3, all other animals responded to at least one 
HEL pool. In these recipients, all pools yielded at least 100 SFC. Splenocytes from 
mouse 1 and mouse 5 responded to all the selected pools with SI ranging from 2 to 9. 
Mouse 2 responded to pool I only, and mouse 5 to pool I and X (Table 6.3.). Analysis of 
the pooled data (including the non-responder mouse 3) indicates that the mean SI value 
was above 2 for pools I and X, and only slightly above 1 for pools IV and VI. Thus, 
triple mutant mice immunised with EBNA are capable of producing IFN-γ in response 
to HEL peptides in vitro, but with varying magnitude. 
 
 
Table 6.3. Stimulation index for EBNA → HEL heterologous challenge. 
 
  Pool I Pool IV Pool VI Pool X 
Mouse 1 4 3 2 4 
Mouse 2 2 1 0.3 1 
Mouse 3 0.2 1 0.2 0.2 
Mouse 4 3 1 0.9 3 
Mouse 5 9 3 3 6 
 
 
 
6.2.4. T cell lines can be generated from immunised single and triple mutant 
mice  
 
Polyclonal T cell cultures were set up as described in Chapter 2. Splenocyte 
suspensions from a single and triple immunised donor were initially subjected to in vitro 
stimulation with the HEL master pool, i.e. the peptide pool spanning the whole HEL 
protein described in Chapter 5. After three rounds of in vitro expansion in the presence 
of HEL master pool and 20U IL-2, cultured splenocytes were plated in 1.5 ml cultures 
as 1000 responders per well with 10
4
 autologous APC and peptide sub-pools I to X and 
expanded for another two weeks. We performed an initial screen to isolate the wells 
which showed signs of expansion under microscopy. At this stage, we found that only 
pool I, III, IV, V, VI and X were stimulatory and all other wells stimulated with the 
remaining pools were discarded (Figure 6.6.) 
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    I                             II                           III                           IV                            V  
 
            VI                            VII                         VIII                          IX                            X 
 
 
 
Figure 6.6. Polyclonal T cells from single and triple mutant mice proliferate in 
response to HEL peptides in vitro. Histograms showing CFSE dilution in triple mutant 
responders following challenge with HEL peptides. The background control (TCM 
only) is shown by the grey solid line. Positive wells defined as wells showing signs of 
expansion by microscopy and CFSE dilution were harvested, washed and plated again 
by limiting dilution of 0.1 T cells with 100 APC and IL-2 in a 96-well plate. 
 
 
Limiting dilution analysis (LDA) is widely used to measure the ability of cells to 
form a homogenous colony. One application of LDA is to identify the frequency of 
lymphocytes that form a monoclonal population (Taswell, 1981). Here, we adapted the 
method described by Moretta et al. (1983) to produce T cell lines with single 
specificity. Further advice regarding the generation of such T cell clones was kindly 
provided by Dr Diane Scott. A limiting dilution was performed by plating the responder 
cells to 1 cell per well together with 10
4
 APC, 4U IL-2 and the corresponding peptide 
pool (pool III, IV, V, VI or X) in a final culture volume of 200 μl. Briefly, the APC and 
peptide mixture was prepared as a master mix and distributed to the corresponding 
wells. For each mutant, we plated each line in 48 replicates. Individual wells were 
passaged by limiting dilution three times for a stimulation period of 14 days. The 
limiting condition ensures that most wells will contain more than one cell or no cells at 
all, and few wells will contain exactly one cell. These outcomes follow a Poisson 
distribution (Taswell, 1981).  
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Therefore, our next step was to screen oligoclonal lines by assessing T cell 
expansion relative to the corresponding negative control wells, which were left un-
stimulated. Thus, positive wells containing putative T cell lines were scored by 
assessing survival and cell proliferation at the end of the 14 day stimulation period 
(Appendix E). All wells which failed to show any sign of expansion at the end of the 
third round of stimulation were discarded. A graphic representation of this protocol is 
shown in Figure 6.7 below.  
 
 
 
 
 
 
Figure 6.7. Protocol for isolation of oligoclonal T cell lines. Splenocytes from single 
and triple mutant mice immunised with HEL were subjected to a total of seven rounds 
of in vitro stimulation with HEL protein and pools. All wells showing signs of 
expansion by microscopy and CFSE dilution were harvested, washed and plated again 
by limiting dilution of 0.1 T cells with 100 APC and IL-2 in a 96-well plate. Candidate 
oligoclonal lines were then expanded by peptide stimulation stored in liquid nitrogen. 
 
 
 
 
Pool wells
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After three rounds of limiting dilution, we identified three sets of T cell lines, 
obtained by stimulation with pool III, IV, and VI, respectively. The LDA step described 
above allowed us to discard empty wells and to score positive wells, but cannot 
distinguish populations raised from a single cell (homogeneous) from those raised from 
multiple cells (heterogeneous). Thus, to identify the wells that are most likely to contain 
T cells with single specificity, twenty candidate lines were initially stained for CD4 and 
CD8 expression (Table 6.4). The lines were initially defined as clones if extracellular 
co-receptor expression was limited to either CD4, or CD8. This, together with the 
limiting dilution conditions, ensures that the T cell lines generated according to our 
protocol are monoclonal or at best oligoclonal lines with single specificity.  
We found that most lines contained a mixture of both CD4
+
 and CD8
+
 T cells, 
indicating that these lines were raised from a heterogeneous population rather than a 
homogeneous population or a single cell. Overall, only eight clones complied with our 
criteria and were designated as putative clones for further analysis, as summarised in 
Table 6.4.  
 
Table 6.4. T cell clones derived from single and triple mutant mice. 
 
Clone name Phenotype Origin Specificity 
A6 CD8+ Single Pool IV 
B3 CD4+ Single Pool IV 
D5 CD4+ Single Pool IV 
D6 CD8+ Single Pool IV 
H4 CD4+ Single Pool VI 
E9 CD4+ Triple Pool VI 
F9 CD4+ Triple Pool III 
C10 CD8+ Triple Pool III 
 
The clones described above were further characterised by assessing cytokine 
production in vitro following 24 hour stimulation with the appropriate pools. 10
6
 cells 
from each line were washed and allowed to rest for 48h. Stimulations were carried out 
with titrating doses of peptide mix ranging from 0.001 to 1 μg/ml, 107 autologous APC 
and 20U IL-2 for 24 hours in a 24-well plate. At the end of the stimulation period, 
culture supernatants were harvested and diluted 1:5 for ELISA. The ELISA was 
performed as described in Chapter 2 (Figure 6.8). 
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Figure 6.8. T cell clones derived from single and triple mutant T cells produce 
MIP-1β in response to HEL peptide challenge. Eight CD4+ or CD8+ T cells clones 
were rested for 48h then stimulated with appropriate pools overnight with each peptide 
prepared at the final concentration indicated on the x-axis. 
 
 
All clones produced MIP-1β after overnight stimulation with the appropriate 
peptide mix. Overall, cell lines derived from the single mutant donor were more potent 
MIP-1β producers than those derived from the triple mutant. Indeed, with the exception 
of the CD8
+
 clone D6, the single mutant clones produced between 90 to 150 pg/ml at 
the highest dose of peptide. By contrast, at this same dose of peptide mixture, the triple 
mutant clones E9, F9 and C10 only produced an average 33.5 pg/ml ( + 10.5). 
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6.3. Discussion 
 
6.3.1. Summary 
 
The clonal selection theory states that the specificity of an antigen receptor is 
genetically determined and directed against a single determinant. Nevertheless, as 
discussed previously, the peptide universe always exceeds the total number of TCR that 
can be accommodated in a host. For instance, the total number of possible decamer 
peptides is 10
20
 but a mouse can only ever have about 10
10
 T cells. In spite of the fact 
that the size of the antigenic repertoire is far greater than the TCR repertoire itself, T 
cells provide effective immunity against most pathogens. Therefore, it immediately 
seems reasonable to assume that the TCR must be cross-reactive to some extent. 
However, the degree of cross-reactivity that can be achieved by T cells is ill-defined. 
Clearly, tolerance to amino acid substitutions will greatly vary between different T cell 
clones (Sloan-Lancaster and Allen, 1996). 
In Chapter 5, we demonstrated that T cells bearing TCR-β chains lacking all three 
CDR loops are functional but that the qualitative aspects of the immune response were 
altered so that the magnitude of the response is lower in triple mutant mice. Indeed, 
triple mutant mice responded to allogeneic stimulator cells at a slower rate. Here, we 
extend these findings and show evidence that the breadth of the immune response is 
also altered by structural alteration of CDR loops. Indeed, we found that peripheral T 
cells harvested from immunised triple mutant mice recognised a greater number of 
peptide epitopes in vitro. Finally, we also demonstrated that antigen-specific T cells 
from triple mutant mice, but not single mutants, we able to mount an immune response 
against unrelated antigen. The major findings of this Chapter are summarised in Table 
6.5 below. 
 
Table 6.5. Summary of selected results from Chapter 6. 
  
Single 
 
Triple 
 
 
Number of stimulatory HEL pools 
 
 
2 to 8 
 
 
8 to 9 
 
Average SI in HEL → HEL challenge 
 
12 
 
12 
 
Average SI in HEL → EBNA challenge 
 
 
 
 
 
less than 1 
 
3 
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6.3.2.    Breadth of immune responses in triple mutant mice 
 
In Section 6.2.2, we used a heat map to illustrate the peptide pools that elicited a 
low magnitude (500 to 1000 SFC), intermediate (1000 to 1500 SFC) or a high 
magnitude (more than 1500 SFC) response in single and triple mutant mice. 
Unexpectedly, we found that triple mutant mice immunised with HEL were capable of 
eliciting a response to almost every pool, although with varying magnitude. Compared 
to single mutants, triple mutant mice responded to more pools with high magnitude. By 
contrast, we also observed that a high number of pools were capable of eliciting lower 
magnitude responses in the single mutant. Thus, recognition of foreign antigen was 
shifted towards a higher affinity range in the triple mutant. In previous Chapters, we 
showed that T cells from the triple mutant mouse displayed an activated phenotype 
resulting from the triple mutant TCR-β chain recognising pMHC ligands with high 
affinity. Here, we provide functional evidence that indeed, mature T cells bearing CDR-
mutated TCR-β chains respond vigorously to foreign peptides.  
 
6.3.3.    TCR cross-reactivity in triple mutant mice 
 
In this Chapter, we demonstrate that triple mutant mice immunised with HEL are 
capable of mounting a vigorous response following heterologous stimulation in vitro. 
This acquired ability to cross-react to unrelated peptides must come from structural 
alterations of the germline-encoded CDR, and not those confined to the CDR3 loops, 
because cross-reactivity was not observed in the single mutant. 
Peptides recognised as potent T cell epitopes must simultaneously satisfy two 
conditions. On one hand, the processed peptides must stably bind to MHC and be 
expressed at the surface of the APC as a pMHC complex. This predominantly involves 
main-chain interactions between the peptide backbone as well as complementarity in the 
side chains buried in anchor pockets. On the other hand, it is usually assumed that the 
binding of the peptide in the MHC antigen-binding site must also allow recognition of 
distinct peptide side chains by the TCR. Peptide recognition by the TCR has long been 
thought of as highly specific and discriminatory because in most cases mutating TCR-
peptide contacts abrogates the T cell response, even if this does not interfere with MHC 
binding (Harding and Unanue, 1990). As mentioned above, Bhardwaj et al. were the 
first to demonstrate that cross-reactivity did not require similarity between ligands. 
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Indeed, cross-reactivity can occur between peptides which do not have a single amino 
acid in common. The exact criteria which permit cross-reactivity are poorly understood. 
Nonetheless, what is clear from this study and other recent reports is that the number of 
peptides that can be recognised by a single clone is extremely large, as anticipated by 
Mason (Mason, 1998; reviewed by Maverakis, van den Elzen and Sercarz, 2001). 
HEL and EBNA are structurally unrelated and we predict that cross-reactivity in 
heterologous antigenic challenge experiments does not represent a case of molecular 
mimicry. Holler and Kranz (2004) explained TCR degeneracy by suggesting that in the 
steady state, a single TCR pre-exists as multiple conformational isomers in equilibrium. 
According to the conformational diversity model, one TCR can adopt different 
conformations prior to pMHC binding and each “conformer” can recognise one or more 
different ligands. The ligands for the collection of conformers can either be similar or 
unrelated because the fine specificity of TCR binding to MHC-bound peptides relies on 
few peptide side chains (Reay et al., 1994). Recently, Jones et al. (2008) and Yin et al. 
(2011) provided the structural data supporting this model.  
Thus, one explanation for increased cross-reactivity in our model is that the triple 
mutant presents more conformational diversity than does the single mutant. The 
structural modifications introduced to the CDR loops may allow for more flexibility 
compared to the native loops, leading to the productive recognition of a larger array of 
peptides by multiple TCR conformational isomers. Conversely, the flexibility of the 
triple mutant CDR loops may allow them to reduce steric constraints when docking with 
pMHC (Ferreira et al., 2006). Therefore, we propose that the triple mutant TCR-β chain 
facilitates the recognition of multiple epitopes, some of which are shared with the single 
mutant, but the flexibility brought by the removal of the germline-encoded CDR allows 
the recognition of additional, unique epitopes. In line with previous reports of cross-
reactivity for unrelated peptides, our own results indicate that structural and 
conformational flexibility is a crucial feature of the TCR. To explain this flexibility, it 
has been suggested that the largest contribution to the TCR-pMHC interaction comes 
from the MHC molecule and that little constraint is imposed by the MHC-bound peptide 
(Hemmer et al., 1998b). Here, we extend this idea by proposing that the requirements 
for antigen recognition by the TCR are much less stringent than previously thought. 
Structural modification of the CDR loops allow for more plasticity, which in turn 
permits recognition of a wider set of ligands, as suggested by Holler and Kranz (2004). 
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6.3.4.   Conclusions 
 
In the previous Chapter, we demonstrated that peripheral T cells from single and 
triple mutant mice could elicit a classical immune response against foreign antigen. We 
observed that triple mutant mice overall responded with similar magnitude. Indeed, 
HEL protein challenge in vitro led to the generation of similar numbers of IFN-γ 
producing cells. We extend these results here by showing that a HEL peptide pool does 
indeed contain potential class I and class II epitopes for peripheral T cells. While the 
single and triple mutants may share some epitopes, the triple mutant TCR-β chain is 
compatible with the recognition of a wider array of peptides. Our results therefore 
suggest that the germline-encoded CDR loops may function to limit the number of 
potential cross-reactions that can occur between distinct pMHC complexes. Amino 
acids within the germline loops do not favour recognition of pMHC as proposed in the 
germline theory for MHC restriction. Instead, they may impose greater structural 
rigidity in MHC recognition, which restricts the ability to recognise multiple, distinct 
MHC-bound peptides. 
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Chapter 7 
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Chapter 7: Selection and functionality of T cells expressing B cell 
receptor hypervariable regions 
 
 
 
 
7.1.    Background 
 
 
T and B lymphocytes are morphologically similar and are derived from a common 
lymphoid precursor (Chi et al., 2009; Ichii et al., 2010). The antigen receptor they bear 
at their surface are highly homologous in terms of primary sequence and overall 
structure and yet also very different in several respects. The BCR, unlike the TCR, is a 
bivalent molecule composed two heavy chains and two light chains. Each antigen-
binding site recognises a complementary surface on native antigen (Padlan, 1994). The 
TCR, by contrast, recognises processed peptides only in the context of MHC. Naive B 
cells first express a membrane-bound form of the BCR. Following antigen exposure, B 
cells proliferate and differentiate into antibody-secreting plasma cells producing more 
than 10
12
 antibody molecules a day, or into long-lived memory cells providing 
protection from secondary infection (Harwood and Batista, 2010). The antibodies 
secreted after antigen challenge can be of different isotypes and are of higher affinity 
due to somatic hypermutation and class switch recombination (reviewed by Stavnezer, 
Guikema and Schrader, 2008). 
 
7.1.1. Structure and composition of Ig CDR loops 
 
The structure and composition of the B cell CDR have been extensively studied. 
As mentioned before, like the TCR, the CDR loops of the BCR can adopt one of the 
canonical structures described by Al-Lazikani et al. (2000). Kabat et al. (1977) initially 
observed that histidine and asparagine residues were twice as likely to occur in the Ig 
CDR as in the framework region. Moreover, the amino acid composition of the CDR3 
loop may also be related to the general class of antigen recognised by the BCR (Collis 
et al., 2003). Numerous studies have since accumulated in the literature reviewing the 
propensity of distinct amino acids to occur in CDR loops, compared to framework 
regions, or to proteins in general (reviewed by Davies and Cohen, 1996).  
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Recently, a comprehensive analysis of CDR sequences available in the protein 
data bank has provided much information about the amino acid composition of B cell 
hypervariable loops. It was noted in this study that CDR sequences were “peculiar”, to 
use the term employed by the authors (Ofran, Schlessinger and Rost, 2008). The amino 
acids used by the BCR to contact B cell epitopes differ from those seen in other protein-
protein interactions. Moreover, the specific residues contacted by the CDR are 
themselves enriched with amino acids that are over-represented compared to protein-
protein interactions in general. 
 
7.1.2. Characterisation of TCR-like antibodies 
 
Antibodies against self pMHC are rarely induced under physiological conditions, 
but the development and isolation of such antibodies from phage libraries has provided 
much insight into how a TCR-like antibody would bind a pMHC complex. Although 
antigen recognition and binding by antibodies is MHC-independent, recent crystal 
structures of a Fab fragment and of a TCR bound to the same pMHC complex have 
shown that the two molecules adopted the same docking orientation to bind pMHC 
(Mareeva, Martinez-Hackert and Sykulev, 2008). 
 Mareeva et al. have analysed the binding of the 25-D1-16 antibody to the OVA 
peptide pOV8 complexed with H-2K
b
 and compared it with the well-characterised OT-1 
TCR (Mareeva et al., 2004). The pMHC-specific antibody had a higher affinity 
compared to its TCR counterpart, which was shown to be the result of a faster on-rate 
with no significant changes in the off-rate of the reaction. Later the same group 
published the crystal structure of the 25-D1-16 Fab fragment complexed to pOV8 
bound to H-2K
b
. Similar to the canonical TCR binding mode, they found that 25-D1-16 
used its CDR3 loops to contact the peptide, while CDR1 and -2 were positioned over 
the MHC α1 and α2 helices. Three key residues in CDR3 of both heavy and light chain 
were important in the formation of hydrogen bonds with the MHC-bound peptide. 
Moreover, mutating any of these amino acids had a negative effect on recognition by 
both the 25-D1-16 Fab and by the OT-1 TCR, clearly indicating a common strategy 
employed by TCR and antibody in recognition of pMHC complexes (Mareeva, 
Martinez-Hackert and Sykulev, 2008). Similarly, Stewart-Jones et al. (2009) have 
described the structure of two Fab molecules complexed to NY-ESO-1157–165   in the 
context of HLA-A2, in comparison to the 1G4 TCR bound to the same complex.  
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Again, Fab fragments and TCR used similar binding modes with a diagonal 
orientation to engage the pMHC complex, although in this case only four out of the six 
CDR were used for direct contact. Finally, Biddison et al. (2003) demonstrated that 
Tax-specific, HLA-A2 restricted TCR and Fab fragments recognised the same 
determinants on MHC helices. Mutating these residues abrogated recognition of Tax-
HLA-A2 by TCRs and Fab molecules. Thus, it appears that TCRs are not really unique 
in their ability to recognise MHC, since antibodies can be raised against MHC 
molecules and can bind to MHC in a TCR-like fashion. 
 
7.1.3. Aims 
 
We sought to exploit the dissimilarities between the generation of diversity and 
recognition of antigen in T and B cells to test the currently accepted concept that MHC 
reactivity is predominantly encoded in the germline. We have therefore designed two 
additional constructs in which the CDR1 and the CDR2 regions from the C6 TCR-β 
chain have been exchanged with CDR1 and -2 from either IGHV or IGLV segments (in 
their germline configuration). Put in other words, T cells are MHC-restricted whereas B 
cells are not; thus our system will allow us to test directly whether the basis of MHC 
restriction is intrinsic to TCRαβ. Indeed, T cells bearing non-TCR variable elements 
might be able to negotiate a favourable interaction with selecting MHC-peptide 
complexes, thereby allowing the development of MHC-restricted T cells independently 
of TCR variable segments. We hypothesise that TCR might not be so unique in their 
ability to react with MHC and we predict that our TCR-Ig chimaeric receptors might 
fulfill the requirements for thymic selection and maturation of potentially functional T 
cells by negotiating a low-affinity interaction with selecting pMHC complexes. 
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7.2.    Results 
 
7.2.1.    Amino acid composition of Ig and TCR CDR loops and generation of          
the IGHV and IGLV constructs 
 
Analysis of TRBV and IGHV amino acid sequences available on the IMGT 
website indicates that the composition of Ig segments is surprisingly less variable than 
TRBV (Figure 6.1, and reviewed by Litman et al., 1999). For instance, IGHV has the 
potential to mobilise up to 124 functional gene segments (270 in total), but these 
segments are highly homologous and often differ by only one codon. Thus, the 
composition and length of germline-encoded CDR1 and CDR2 is fairly conserved 
across IGHV domains. The TCR on the other hand, appears to use a limited set of V 
segments that are considerably more dissimilar. IGLV and IGHV CDR are also 
different in composition, length and identity of amino acid at the CDR-framework 
boundary (Figure 7.1 and 7.2). Because the tra and trb loci are composed of a restricted 
number of V gene segments compared to Igh loci, combinatorial diversity resulting 
from rearrangement and from V domain pairing is limited in T cells, but exacerbated in 
B cells. In fact, as suggested by Davis and Bjorkman (1988), TCR diversity is heavily 
biased towards junctional diversity. The most extreme example for this is the TCR-δ 
chain where N-region diversification combined with the unique use of both D segments 
and the ability to translate in all three reading frames yield tremendous diversity, 
estimated at 10
13
 sequences from junctional diversity alone (Davis and Bjorkman, 
1988). 
Thus, although the BCR and secreted antibody molecules can recognise an 
immense variety of antigenic structures, diversity is not manifest in the germline 
sequences of their V gene segments. Thus, for B cells, a large number of relatively 
similar V segments appears to provide enough diversity to generate a sizeable primary 
repertoire. For the TCR however, primary amino acid sequence diversity is likely to be 
an important factor.   
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Figure 7.1. Amino acid usage in IGHV and TRBV CDR regions. Amino acid composition of CDR1 (left) CDR2 sequences (right) are shown. 
Amino acid frequency is shown for each of the naturally occurring amino acids. Positions are numbered according to the IMGT nomenclature.
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To ensure adequate protein folding and stability, we chose the mutant sequences 
based on CDR length and on the identity of the amino acids at the CDR extremities, 
which are important in determining TCR structure (Jung et al., 2001 and Honegger et 
al., 2009). This is further illustrated in Figure 7.2. The IGLV construct contains the C6 
TCR-β chain where the germline CDR have been exchanged with the CDR sequence 
from the Ig light chain V gene 3 (IGLV3). Similarly, the IGHV construct contains the 
CDR1 and CDR2 sequence from the IGHV1.4 segment. The IGLV3 was chosen 
because it is the only segment with appropriate CDR1 and -2 lengths, as other segments 
all had CDR2 lengths of three amino acids only, which is considerably shorter than 
TRBV CDR2 lengths (usually 5 to 7 amino acids). The IGHV1.4 segment was picked 
because it had important serine, methionine and tyrosine residues at the boundary 
positions 26, 39 and 55 respectively, which seemed to be conserved between TRBV and 
IGHV framework sequences (IMGT website). Complete amino acid sequences are 
shown in Table 7.1 below. 
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Figure 7.2. Amino acid usage at the CDR-framework boundary in IGHV, IGLV 
and TRBV gene segments. 
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Table 7.1. CDR1 and CDR2 amino acid sequences in IGHV and IGLV gene 
segments. CDR1 and CDR2 sequences for IGHV and IGLV mutants were picked from 
the IMGT website as described in Section 7.2.1. The TRBV sequence of the original C6 
TCR-β chain used in this study is also shown. Amino acids in red represent residues at 
the CDR-framework boundary. 
 
 
 
  
CDR1 
 
  CDR2 
 
CDR3 
 
C6 TCR-β 
 
ISGHSAV 
 
YFRQNAPI 
 
CASSGGGT 
IGHV 
 
SSQHSTYTM 
 
YLKKDGSN 
 
CASSGGGT 
IGLV 
 
SGYTFTSYTI 
 
EINPSSGYTS 
 
CASSGGGT 
 
 
 
7.2.2.   IGHV and IGLV mutant TCR-β chains restore the T cell compartment in 
FVB TCR-β/δKO “retrogenic” mice 
 
IGHV and IGLV constructs were used to transfect the Phoenix
TM
 packaging cell 
line. Viral supernatant was then harvested and used to transduce bone marrow cells 
harvested from eight week old FVB TCR-β/δKO mice. Efficiency of transfection and 
transduction was determined on the basis of GFP expression. Irradiated FVB TCR-
β/δKO mice were injected with 2 × 105 GFP+ donor cells, as described in Chapter 2. Five 
weeks after reconstitution, blood samples were taken from the three IGHV and the three 
IGLV donors and analysed by multicolour flow cytometry. Lysed samples were stained 
with fluorochrome-conjugated anti-CD4 and anti-CD8 monoclonal antibodies to detect 
the presence of T cells. In addition, the MigR1 vector used here contains a GFP 
cassette, allowing us to gate on cells of donor origin based on GFP positivity. The 
IGHV and IGLV mutants showed similar GFP expression, ranging from 30 to 40% 
across all six animals (Figure 7.3). The average frequency of CD4
+
 T cells was 70.3% in 
IGHV and 68.5% in IGLV. The mean frequency of CD8
+
 T cells was 22.7% for IGHV 
and 11.6% in IGLV. Thus, amongst GFP
+
 cells, similar CD4
+
 and CD8
+
 T cell 
frequencies were detectable, demonstrating that Ig-derived CDR loops are compatible 
with T cell development. 
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Figure 7.3. Analysis of blood samples from IGHV and IGLV “retrogenic” mice. 
Blood samples were taken from IGHV and IGLV “retrogenic” mice five weeks after 
immune reconstitution. Samples were lysed, washed and stained with fluorochrome-
conjugated monoclonal antibodies against CD4 and CD8. Flow cytometry profiles are 
representative of IGHV and IGLV mice (n = 3 in each group). The CD4 versus CD8 
plot is gated on GFP
+
 lymphocytes.  
 
 
7.2.3.    Distribution of T cell subsets in IGHV and IGLV thymi and periphery 
 
Having established that the IGHV and IGLV mutants would both reconstitute the 
T cell compartment on a FVB TCR-β/δKO background, we sought to examine the 
distribution of thymocyte subsets (Figure 7.4). As before, thymocyte suspensions were 
prepared from “retrogenic” mice seven weeks after initial bone marrow injection. 
Samples were stained with fluorochrome-conjugated monoclonal antibodies against 
CD4, CD8 and CD5, and analysed by flow cytometry. In the thymus, the frequencies of 
DN, DP and SP thymocytes are strikingly similar in IGLV and IGHV mice, indicating 
that the proportion of DP cells auditioning for selection are comparable in these 
mutants.  
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The percentage of CD5-expressing cells as wells as CD5 MFI in DP thymocytes 
are also very similar, suggesting that MHC-dependent selection efficiency does not 
significantly differ between the two mutants. Strikingly, CD5 levels were consistently 
higher in either mutant, compared to normal FVB/n controls, clearly indicating that the 
“retrogenic” TCR-β chain mediates enhanced binding to selecting ligands. Because the 
frequency of DP thymocytes from the IGLV mutant are similar to FVB/n control mice, 
it is safe to conclude that mutations to Ig CDR regions do not affect selection efficiency 
but may have an important effect in the periphery with regards to peripheral survival 
and for homeostasis of T cell numbers.  
 
 
A)  Gated on GFP+ cells                  B)   Gated on GFP+ DP cells 
                                      
                                      
                                                         
 
 
Figure 7.4. Distribution of thymocyte subsets and CD5 expression in DP 
thymocytes from IGHV and IGLV “retrogenic” mice. Thymocyte suspensions from 
IGHV and IGLV “retrogenic” mice were stained with anti-CD4, CD8 and CD5 
fluorochrome-conjugated monoclonal antibodies. A) Flow cytometry profiles are 
representative of thymi from IGHV (top) and IGLV (bottom) mutants (n = 3 in each 
group) and from control FVB/n mice (n = 2), examined in independent experiments. 
CD4 and CD8 expression is gated on GFP
+
 thymocytes. B) Histograms for CD5 
expression are gated on DP thymocytes from “retrogenic” mice (blue) and wild-type 
FVB/n control mice (orange). The negative control is shown in grey. 
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We next looked at the distribution of peripheral T cell subsets in IGHV and IGLV 
“retrogenic” mice (n = 3 in each group). Splenocyte suspensions were stained as before 
and analysed by flow cytometry (Figure 7.5). We also used wild-type FVB/n mice as 
control. The frequency of CD4
+
 T cells was significantly increased in splenocytes from 
IGHV (p = 0.0215) and IGLV mice (p = 0.0457) compared to FVB/n. There was also an 
increase in the percentage of CD8
+
 T cells, but this was not statistically significant.  
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Figure 7.5. Distribution of peripheral CD4
+
 and CD8
+
 T cells in IGHV and IGLV 
“retrogenic” mice. Splenocyte suspensions from IGHV and IGLV “retrogenic” mice 
were stained with anti-CD4 and anti-CD8 fluorochrome-conjugated monoclonal 
antibodies. A) Flow cytometry profiles are representative of spleen from IGHV and 
IGLV mice (n = 3 in each group) and from control FVB/n mice (n = 2) examined in 
independent experiments. CD4 and CD8 expression is gated on GFP
+
 lymphocytes. B) 
Results are summarised as percentage CD4
+
 and CD8
+
 T cells in the GFP
+
 gate. 
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We also looked at CD44 expression in spleen and lymph node suspensions from 
IGHV and IGLV mice as a marker for T cell memory (Figure 7.6). CD44 MFI was 
computed within the CD4
+
 and CD8
+
 T cell gates. Similar to what we described 
previously for single and triple mutant transgenic mice, we found that CD44 expression 
was increased compared to age-matched FVB/n mice. This was particularly apparent in 
the CD4
+
 T cell compartment (p = 0.0056 for IGHV and p = 0.0006 for IGLV 
splenocytes). Thus, CD44-expressing memory cells accumulate in the periphery of 
IGHV and IGLV mice. 
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Figure 7.6. CD44 expression in peripheral T cells from IGHV and IGLV 
“retrogenic” mice. Splenocyte and lymph node suspensions from IGHV and IGLV 
mice (n = 3 in each group) were stained for CD4, CD8 and CD44 expression. CD44 
MFI is shown for spleen (left) and lymph node CD4
+
 and CD8
+
 T cells (right), gated on 
GFP
+
 cells. 
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7.3.   Discussion 
7.3.2.      Summary 
 
TCRαβ is unique in its ability to recognise peptide antigen in the context of MHC 
and MHC only. All other antigen receptors, including TCRγδ (Sandstrom et al., 2011) 
and BCR (Padlan, 1994) recognise ligands in a direct fashion. Strikingly however, Fab 
fragments raised against MHC in vitro display remarkable similarities with TCR-pMHC 
complexes. We generated two TCR:Ig chimaeric constructs in which TCR-β chain 
CDR1 and CDR2 loops were exchanged for IGHV or IGLV CDR. In the design of 
these constructs we observed that the extent of diversity in the germline-encoded CDR 
loops was generally restricted in Ig and significantly more extensive in TCR-β, as 
reported previously (Davis and Bjorkman, 1988). Furthermore, TCR and Ig CDR loops 
are largely dissimilar in amino acid composition and length. Despite these differences, 
we found that the chimaeric constructs would restore the T cell compartment when 
retrovirally transduced into HSC delivered to FVB TCR-β/δKO recipients. Thus, like 
single and triple mutant transgenic mice described in previous Chapters, T cell selection 
also takes places in the context of CDR loops derived from Ig. In single and triple 
mutant mice, we showed that the generation of CD4
+
 and CD8
+
 T cells was 
compromised due to increased affinity for selecting pMHC ligands. By contrast, 
immune reconstitution in IGHV and IGLV “retrogenic” mice is associated with over-
representation of CD4
+
 T cells, compared to wild-type FVB/n mice. Key results from 
this Chapter are summarised in Table 7.2. 
 
Table 7.2. Summary of selected results from Chapter 7. For each parameter, the 
average is indicated under the “IGHV”, “IGLV” and “FVB/n” columns. 
  IGHV IGLV FVB/n 
% DN 11.6 12.6 4.9 
% DP 61.5 43.9 70.2 
% CD4+ SP 23.4 10.9 10.5 
% CD8+ SP 13.4 19.7 7.6 
CD5 MFI in DP 591 618 347 
% CD4+ T cells 59.97 43.27 28.3 
%CD8+ T cells 17.07 11.51 9.05 
CD44 MFI in CD4+ 2654 2546 987 
CD44 MFI in CD8+ 1428 1097 873 
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7.3.2. T cell selection in IGHV and IGLV “retrogenic” mice 
Similar to single and triple mutant transgenic mice, IGHV and IGLV mutants 
restore the T cell compartment in TCR-β deficient mice. Thus, TCR-β chains in which 
the germline-encoded CDR loops are replaced either with artificial linkers or with B cell 
hypervariable loops are compatible with T cell selection. In contrast to the single and 
triple mutant TCR-β chains described in previous Chapters, expression of the Ig mutants 
does not result in a reduction in the size of the T cell compartment. Indeed, we found 
that the frequency of CD4
+
 and CD8
+
 T cells was in fact increased compared to wild-
type FVB/n mice. This would suggest that the introduction of Ig hypervariable loops 
impacts positively on the efficiency of T cell selection. Supporting this idea, we found 
that the levels of CD5 expression were elevated at the DP stage of development. 
 
7.3.3. Conclusions 
Antibodies and Fab fragments specific for pMHC bind their targets with a 
surprisingly similar topology, compared to TCR with the same specificity. The germline 
theory for MHC restriction predicts that to achieve this binding mode, antibodies would 
have to mobilise the same “interaction codons” as the TCR. However, it has previously 
been shown that this is not the case. Indeed, while the broad binding orientations 
relative to the pMHC ligand may be preserved between antibody and TCR, the atomic 
contacts made with MHC helices actually differ (Biddison et al., 2003). Moreover, the 
amino acid compostition of CDR loops from Ig and TCR are dissimilar. 
In this Chapter, we provide further evidence that pMHC recognition is not 
hardwired to the germline. TCR-β chains carrying CDR loops from an unrelated antigen 
receptor, the BCR, can be selected with remarkable efficiency. This, together with the 
data obtained from our two transgenic mouse lines strongly supports the role of the 
thymus in imprinting MHC reactivity on developing thymocytes.  
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Chapter 8: Discussion 
 
 
The importance of the adaptive immune system has been recognised for more than 
a century and our knowledge about its molecular and cellular components is constantly 
progressing. The first important observation came with the realisation that circulating 
antibodies could neutralise an immense variety of foreign agents. The cellular origin of 
antibody responses came later, when Paul Ehrlich anticipated that specialised cells, now 
known as B cells, would express proteins identical to these antibodies at their surface. 
Their cousins, the T cells, were identified much later still but were found to be equally 
important in providing protection against invading organisms. Although the clonal 
selection theory written by Burnet did accurately foresee that antibody responses 
reflected the selection and expansion of pre-existing lymphocytes, it could not predict 
the additional layer of complexity brought about by T cell specificity for products of the 
MHC. T cell biology has long been concerned with this cardinal property of T cells: 
their ability recognise only processed peptides in the context of a self MHC molecule. 
Notably, one major issue that has perplexed many immunologists for several decades 
was the evolutionary purpose of the TCR-pMHC interaction. 
Zinkernagel and Doherty were the first to describe the “altered self” hypothesis 
based on their findings that LCMV-specific T cells from H-2 heterozygous mice “A×B” 
would kill virus-infected cells A or B only in mice of the corresponding haplotype. 
Later, Townsend et al. elegantly concluded this important chapter in Immunology by 
explaining how class I MHC products would in fact, present peptide derived from the 
cytosol, allowing MHC-restricted T cells to recognise these peptides (Zinkernagel and 
Doherty, 1974; Townsend, Gotch and Davey, 1985). It is now clear that MHC 
restriction has evolved to allow T cells to perform highly specific functions that are 
crucial to host defense (Litman, Rast and Fugmann, 2010). Class II-restricted CD4
+
 T 
cells recognise peptides sampled from the extracellular milieu and provide help to B 
cells in fighting the source of these peptides, including bacteria and fungi, to name but a 
few. Class I-restricted CD8
+
 T cells are unique in their ability to visualise the inside of a 
cell, a property mastered only by this cell subset. Class I MHC molecules process and 
bind peptides derived from the cytosol, allowing the CD8
+
 T cell compartment to 
eradicate virus-infected cells or even transformed cells for instance. While the 
physiological importance of the TCR-pMHC interaction is largely understood, its 
molecular basis is still a matter of fierce debate. 
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8.1.    Implications of this study 
 
8.1.1.   MHC restriction is not encoded in the germline 
 
The principal aim of this study was to probe the idea of TCR “germline bias” 
towards MHC. The conserved docking orientation of the TCR relative to pMHC 
complexes is thought to reflect this genetic preference towards MHC molecules. In this 
study, we sought to investigate the role of the germline-encoded CDR in the TCR-β 
chain by replacing the whole loops with artificial linkers made of glycine and alanine 
residues. TCR-β chains with such linkers will have lost any putative “interaction 
codons”, and the germline theory for MHC restriction predicts that thymic selection and 
maturation of T cells in this setting should be severely impaired. The key finding of this 
study is that structural alterations spanning all of CDR1 and CDR2 do have 
considerable impact on T cell development, although not in the way predicted by the 
germline theory for MHC restriction.  
In Chapter 3, we show that triple mutant mice are capable of generating both 
CD4
+
 and CD8
+
 SP thymocytes, which are successfully recruited to the periphery as 
functional T cells. In a normal setting, thymocytes up-regulate TCR expression at the 
DP stage as they encounter and engage pMHC complexes. The DP population in triple 
mutant mice is associated with TCR up-regulation on a higher fraction of cells, 
indicating that DP thymocytes are engaging selecting pMHC ligands at this stage. Thus, 
similar to normal individuals, engagement to selecting ligands occurs at the DP 
transition, which points to a role for T cell co-receptor in the process. Indeed, the work 
carried out by Van Laethem et al. (2007) indicates that MHC restriction is imprinted on 
the developing T cell repertoire at the DP stage where CD4 and CD8 are simultaneously 
expressed because they favour recognition of pMHC complexes and prevent the 
induction of MHC-independent signalling. Similarly, in the triple mutant mouse, we 
anticipate that selection at the DP stage is highly likely to be based on recognition of 
pMHC and not on stochastic engagement with non-MHC ligands. In parallel, CD5 
expression levels at this stage are consistently higher in triple mutants, an observation 
we interpret as enhanced binding to selecting pMHC complexes. In light of these 
results, we conclude that the reduction in CD4
+
 and CD8
+
 SP thymocyte frequency is 
the consequence of enhanced negative selection resulting from enhanced interaction 
with MHC. 
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Moreover, functional analysis of peripheral T cells in vitro also brings further 
evidence supporting our view that T cells from triple mutant mice are selected on MHC. 
In a series of MLR experiments, we demonstrate that triple mutant T cells proliferate in 
the presence of allogeneic stimulator cells, except those that are MHC-deficient (B6 
MHC
KO
). Therefore, like normal T cells, pMHC complexes are the preferred ligands for 
T cells lacking all three native CDR sequences. The observation that recognition of 
antigen in the periphery of triple mutant mice takes place only in the context of MHC 
implies that thymic selection must have occurred on pMHC ligands as well. Last but not 
least, MHC-deficient hosts reconstituted with bone marrow from single and triple 
mutant mice fail to repopulate the T cell compartment. This observation provides the 
final piece of evidence supporting the idea that triple mutant T cells develop, like 
normal T cells, only in the context of MHC-based selection. Altogether our findings 
indicate that the germline-encoded CDR loops are dispensable for MHC-dependent 
selection in the thymus and for MHC-dependent antigen recognition in the periphery. 
Rather, we interpret our results to mean that recognition of pMHC ligands is not strictly 
dependent on the identity of specific amino acids within the germline CDR loops. 
Indeed, this study, together with previous findings from our laboratory, demonstrates 
that random linkers, as well as CDR loops derived from Ig V segments or from TCR-γ 
V gene segments also support T cell maturation (Holland et al., 2012). 
The germline theory for MHC restriction states that evolutionary pressure on the 
T cell compartment is at work to ensure that only MHC-specific TCR are retained in the 
germline, while TCR with non-MHC specificities are lost from the germline. Although 
logical, this model also implies that all tr rearrangements must yield TCR that are 
MHC-specific prior to thymic selection, and there is now a large body of evidence to 
suggest that this assumption is incorrect. Our study indicates that TCR-β chains that 
suffer large structural alterations in the germline-encoded CDR loops maintain the 
ability to recognise MHC, an observation that irrevocably refutes the idea that 
evolutionarily conserved amino acids are needed for MHC recognition.  These amino 
acids termed “interaction codons” may at best be important for some TCR – those 
studied to date – but are highly unlikely to underlie MHC recognition by all possible 
TCR. Thus, the structural requirements that entail MHC recognition appear much less 
stringent than previously thought and it seems likely, to us, that future work will have 
structural flexibility and plasticity emerging as a key component of the TCR-pMHC 
interaction. 
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8.1.2.    Homeostatic cues are altered by the removal of germline encoded CDR 
 
Chapter 4 describes how the distribution of functional T cell subsets is affected by 
structural alteration of the germline CDR. The maintenance and survival of peripheral T 
cells is a tightly regulated process which requires, in part, tonic signals generated from 
encounter with self pMHC complexes. The nature of the signals required for T cell 
homeostasis has long been open for debate. The finding that T cells decay rapidly 
following TCR ablation clearly highlights the role of T cellular signalling in 
maintenance of the T cell pool (Polic et al., 2001). Recently, Wiehagen et al. (2010) 
provided direct evidence for this. Using a conditional knockout of the SLP-76 T cell 
adaptor molecule the authors demonstrated that T cell signalling was strictly required 
for the generation and maintenance of naïve and TCM cells and for activation of TEM 
cells. Antigen-specific TEM cells could persist in the periphery in the absence of tonic 
TCR signals, but were unable to produce cytokine in response to secondary challenge 
(Corbo-Rodgers et al., 2012). These tonic TCR signals are presumed to include signals 
that promote expression of pro-survival molecules but are thought to be below the 
threshold needed for full activation (reviewed by Sprent and Surh, 2011). 
Because TCR-pMHC interactions regulate homeostasis of T cell numbers, 
changes in the size of the naïve and memory T cell pools should be expected in the 
triple mutant mouse. The total frequency of CD4
+
 and CD8
+
 T cells is significantly 
reduced in six week old triple mutants, indicating that recent thymic emigrants are 
relatively inefficient at populating the T lymphocyte compartment. As before, there may 
be two possible explanations for this. In the first weeks after birth when lymphopaenia 
is severe, newly generated thymic emigrants may not be able to fully exploit the space 
available in the form of pMHC complexes and cytokine resources, presumably due to 
poor interaction through the altered TCR. However, the accumulation of memory-
phenotype cells indicates that T lymphocytes are able to interact with pMHC ligands. 
The presence of TCM cells shows that a reasonable proportion of the T cell pool 
undergoes homeostatic division, while the accumulation of TEM cells suggests that a 
significant fraction is amenable to TCR triggering. Thus, as peripheral T cell survival 
strictly depends on TCR-pMHC interaction, the fact that peripheral T cells from the 
triple mutant can transduce pMHC-derived signals suggests that the reduction in the 
size of the CD4
+
 and CD8
+
 T cells pools is not likely the result of poor interaction with 
MHC.  
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The alternative explanation, which has not been tested directly in this study, is 
that peripheral T cells in the triple mutant mouse are subjected to peripheral deletion. 
We could presume that the TCR-β chain mediates a high affinity interaction with 
peripheral pMHC antigens, which leads to activation-induced cell death. In support of 
this idea, we found that, similar to thymocyte subsets, peripheral T cells from triple 
mutant mice display extremely low surface levels of TCR, while intracellular TCR-β 
and TCR-α levels are significantly increased. Given the results presented in Chapter 3, 
we propose that DP thymocytes from the triple mutant mouse are deleted as TCR 
expression is up-regulated during the final stages of maturation. By extension, we also 
suggest that mature T cells from the triple mutant can persist in the periphery if and 
only if they maintain low TCR levels. As proposed by Schonrich et al. (1991), TCR 
down-modulation would allow T cells to readjust their activation threshold so that 
signals from self pMHC are sufficient to promote survival but not high enough to 
induce full T cellular activation. Lastly, signalling through the triple mutant TCR, in 
turn, appears to modify the expression of other surface markers, some of which are 
known to act directly as homeostatic cues. For instance, expression of the IL-7R α chain 
is drastically reduced, which is likely to affect T cell maintenance and cause the loss of 
CD4
+
 and CD8
+
 T cells from the periphery of triple mutant mice. 
 
 
8.1.3.   Removal of germline encoded CDR does not abrogate T cell function 
 
Having established that peripheral T cells from triple mutant mice displayed an 
effector-like phenotype, one of the main aims of this study was to determine whether 
these cells could mount a bona fide immune response against foreign antigen. We 
designed a series of immunisation regimens; first to test whether peripheral T cells from 
single and triple mutant mice would respond to antigen and if so, whether this response 
would be MHC-restricted. Moreover, we sought to determine the effect of CDR 
structural alteration on specificity and degeneracy of antigen recognition. From these 
experiments, we demonstrate for the first time that TCR-β chains lacking all three CDR 
support recognition of protein antigen, but also of more complex antigen mixtures 
derived from minor H-mismatched donor cells (DBA1/J, H-2
q
) or from allogeneic 
donors of different H-2 haplotypes (B6, H-2
b
; Balb/c, H-2
k
; NOD H-2
g7
). 
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Our HEL immunisation regimen first establishes that single and triple mutant 
mice recognise a protein antigen, much like normal T cells. The relevant ligand for both 
mice is therefore likely to be a peptide bound to a self MHC molecule. This is 
confirmed by the fact that stable T cell lines derived from immunised single and triple 
mutant mice can directly be generated by in vitro stimulation with peptide pools. As 
mentioned above, we also demonstrated in another series of experiments that single and 
triple mutant mice fail to expand in response to stimulation with MHC-deficient APC, 
again showing that MHC recognition in the periphery is not lost with the removal of 
CDR loops. Taking these two sets of results together, we conclude that single and triple 
mutant mice are able to mount a classical T cell response, recognising peptides derived 
from foreign proteins and bound to self MHC molecules.  
The fact that T cells preserve their preference for peptide ligands even in the 
context of CDR loops that are completely artificial is a remarkable finding. Intuitively, 
one could speculate that if thymocytes from triple mutant mice can be selected in the 
thymus on self pMHC ligands, they might also be amenable for activation by pMHC 
complexes in the periphery. However, thymocytes are known to be much more sensitive 
to antigenic stimulation than their mature cousins. Therefore, even in light of our 
analysis of thymocytes, we did not anticipate that peripheral T cells from this mouse 
would necessarily be functional, let alone that the response would take place in the 
context of MHC molecules. Nonetheless, we demonstrate in Chapter 5 and Chapter 6 
that CD4
+
 and CD8
+
 peripheral T cells from triple mutant mice can and do respond to 
antigen in vitro by proliferating and producing IFN-γ. 
In a nutshell, it appears that nature has not favoured TCR with an inherent bias 
toward MHC over evolutionary time. Rather, selection mechanisms in the thymus have 
evolved to discriminate between MHC-restricted and MHC-independent elements, most 
likely through the action of the T cell co-receptors. Thus, in the periphery, most T cells 
recognise pMHC complexes not because they are genetically poised to do so but 
because their TCR are selected for MHC restriction early in T cell ontogeny. 
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8.1.4.   Peripheral control of TCR triggering in triple mutant mice 
 
Analysis of co-receptor levels on peripheral CD4
+
 and CD8
+
 T cells in Chapter 4 
gave us the first clue regarding the nature of the mechanisms in place for the regulation 
T cell immune responses in triple mutant mice. Co-engagement of T cell co-receptors to 
class I and class II pMHC is well documented and is known to play a crucial role in T 
cell activation. The current view is that co-receptors impose a critical binding geometry 
on TCR-pMHC, which is conserved across all TCR studied to date. This binding 
orientation is assumed to be the only one that permits simultaneous binding to pMHC, 
and interaction with TCR and CD3 components (van der Merwe and Davis, 2003). For 
instance, if the binding orientation of the TCR relative to pMHC were reversed, CD3 
would be away from the co-receptor, a configuration presumed to be incompatible with 
efficient and productive signalling (Adams et al., 2011). Yin et al. (2012) recently 
presented the structure of a full TCR-pMHCII-CD4 trimolecular complex, which was 
found to be consistent with this notion (Yin, Wang and Marriuzza, 2012). In addition to 
these structural considerations, functional studies illustrate the importance of the T cell 
co-receptors. As described in the Introduction, there is ample evidence in the literature 
to suggest that functional outcomes of TCR ligation to pMHC ligands are greatly 
influenced by recruitment and engagement of co-receptors (Jameson, Hogquist and 
Bevan, 1994; Mannie et al., 1995; Vidal et al., 1996; Maile et al., 2005). 
Our own findings also highlight the importance of co-receptors in selection and 
function of T cells that are MHC-restricted. Artificial CDR loops in the triple mutant 
mouse are compatible with MHC-based selection at the DP transition. At the DP stage 
co-receptors will favour recognition of MHC molecules and recruitment of Lck to the 
TCR complex, thereby ensuring that TCR triggering and selection will only occur in the 
context of pMHC ligands. In the periphery, co-receptor expression will also force 
recognition of pMHC complexes and allow MHC-restricted recognition of foreign 
antigen. Thus, the reduced CD8 levels observed in our transgenic system are somewhat 
not surprising, because indeed CD8 modulation in response to TCR engagement is well-
documented. It has been suggested that a T cell can regulate peripheral activation 
through modulation of co-receptor expression (Maile et al., 2005; Takada and Jameson, 
2009b), including readjustment of CD8αβ and CD8αα ratios in the case of CD8+ T cells 
(Gangadharan and Cheroutre, 2004). Down-regulation of CD8 in the periphery of triple 
mutant mice is consistent with the activation status described in Chapter 4, and may 
simply reflect the accumulation of effector-like T cells.  
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The affinity of CD8 for class I MHC is largely conserved across different MHC 
alleles and is consistently lower than that of the TCR for pMHCI (KD ranging from 100 
to 200 μM).  The precise affinity between CD4 and class II MHC has been somehow 
more difficult to ascertain, but is now also known to be characteristically low (KD > 200 
μM). Thus for both receptors, the general rule is that the co-receptor-pMHC interaction 
is considerably weaker than the cognate TCR-pMHC interaction, indicating that the co-
receptor may act only to reinforce an interaction that is already in place (Thome et al., 
1996; Jiang et al., 2011; Laugel et al., 2011). Cole et al. (2012) recently suggested that 
CD8 probably evolved to operate exclusively at low affinities, as CD8 molecules with 
enhanced MHC binding properties activate T cells non-specifically (Wooldridge et al., 
2010a). For class I MHC-restricted complexes, the affinity of the TCR-pMHC 
interaction is inversely correlated to CD8 dependence (Laugel et al., 2007). High 
affinity TCR do not require much participation from the co-receptor and reciprocally, 
low affinity TCR are dependent on the contribution of CD8. Thus, CD8 down-
regulation in our model again indicates that triple mutant TCR-β chains participate in 
high affinity interactions.  
Therefore, we propose that TCR lacking all three CDR loops are able to mediate 
pMHC binding on their own and become largely CD8 co-receptor independent. CD4 
levels are not known to undergo peripheral tuning (Artyomov et al., 2010). Thus, unlike 
CD8
+
 T cells, CD4
+
 T cells from the triple mutant mouse cannot readjust antigen 
sensitivity through CD4 co-receptor, which may in fact explain the drastic loss in CD4
+
 
T cells from the periphery. 
 
 
 
8.2.   Future perspectives 
 
          8.2.1.     Structural basis of MHC recognition by artificial CDR loops 
 
The work presented in this Thesis demonstrates that in vivo the germline-encoded 
CDR loops of a given TCR-β chain are dispensable for the generation of a functional 
TCR repertoire. Our study, however, does not evaluate how artificial CDR loops 
compensate structurally for the removal of the original TCR-β hypervariable loops. 
Future work should bring about further information of the structural basis of this 
interaction.  
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All protein-protein interactions rely on fundamental biochemical forces that are 
highly specific and selective for atomic configuration. TCR are not an exception to this 
law and bind to MHC by virtue of hydrogen bonding, electrostatic forces and van der 
Waals interaction, all of which depend on the presence of given atoms within amino 
acid side chains. In light of this fundamental knowledge alone, the germline theory for 
MHC restriction can already be described as inaccurate because it has been 
demonstrated that even in cases where the same germline amino acids are involved in 
binding, specific interatomic interactions are not conserved (Turner and Rossjohn, 
2011). For example, although the conserved Y48 in Vβ8.2 CDR1 region is almost 
always involved in contacting MHC, it rarely does so using the same atom-atom 
interactions (reviewed by Garcia et al., 2009). 
In our study, at this stage, we can only speculate about the structural basis of 
MHC recognition by TCR that use artificial CDR loops. One critical question arises 
with this respect. If distinct CDR1 and CDR2 sequences are not required, why have 
them in the germline at all? Perhaps conserved amino acids in certain positions within 
the germline CDR do not dictate specific hydrogen bonding patterns with the MHC, but 
their overall positioning do. In fact, the answer to the question raised here could actually 
be the simplest: the T cell compartment has no need for TCR that rely on germline-
encoded recognition of MHC alleles. It has been shown recently that the role of 
individual amino acids in engaging MHC is entirely contextual. For instance, Borg et al. 
(2005) demonstrated that mutating a single amino acid within the germline CDR loops 
in some instances has little or no impact at all on MHC recognition, unless the 
neighbouring amino acids are simultaneously mutated. In a recent study, single amino 
acid substitution in TCR-β CDR2 enhanced reactivity for the tumour-derived MART-1 
antigen in the context of HLA-A2 (Robbins et al., 2008). Thus, it appears that selective 
pressure does not act on the T cell compartment to preserve those amino acids that 
contribute favourably to MHC recognition but to conserve entire amino acid stretches 
which, together, promote MHC binding. This concept is interesting indeed because it 
would explain why single amino acid mutagenesis, as shown by Garcia et al., and whole 
CDR mutagenesis, as described in this Thesis, produce drastically different outcomes. 
Glycine and alanine are the smallest naturally occurring amino acids, with side 
chains composed of a hydrogen atom and a methyl group (-CH3), respectively. The fact 
that such amino acids can fulfil the conditions that allow the TCR-pMHC interaction to 
take place is remarkable.  
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Polyglycine peptides are known to display remarkable flexibility. It is likely that 
the high glycine and alanine content of the CDR loops used in our transgenic system 
also allows considerable flexibility in recognition of pMHC ligands. Glycine and 
alanine side chains are non-polar and thus sometimes referred to as “inert”. This 
adjective is somewhat unfair because the hydrogen atoms within the amino group can in 
some instances act as strong hydrogen bond donors, as seen in the components of 
collagen. Thus, one possibility is that glycine and alanine peptide linkers are inherently 
a good replacement for native CDR sequences. Nevertheless, we do not believe that the 
triple mutant phenotype is solely the result of specifically having glycine and alanine 
replacing the native CDR sequences. In fact, recent work done in our laboratory 
suggests that TCR have no stringent requirements at all when it comes to amino acid 
composition of the germline-encoded CDR. “Retrogenic” TCR-β chains in which RSS 
sequences flank the CDR1 and CDR2 loops have been generated in our laboratory. This 
system ensures that mice transduced with such TCR-β chains will be populated with a 
TCR-β repertoire containing CDR1 and CDR2 sequences diversified via the enzymatic 
action of TdT. We recently found that in such “retrogenic” mice, the diversified CDR1 
and CDR2 loops show no bias towards the original sequences, nor do they show any 
preference towards given amino acid residues. Thus, the germline- encoded CDR loops 
are highly tolerant of amino acid variation. 
 
8.2.2. Polymorphism at the mhc locus and the TCR-pMHC interaction 
 
The other notion to consider is the fact that in order to unravel the molecular basis 
of the TCR-pMHC interaction, considerable attention in recent years has been given to 
the antigen receptor alone, and not enough to its ligand. The mhc is the most gene-dense 
locus and the most polymorphic genetic complex known to date, a characteristic that is 
probably essential in understanding how TCR bind MHC products. In light of the 
results described in this Thesis, we suggest that germline-encoded recognition of MHC 
allelic variants is inherently incompatible with extreme polymorphism at the mhc locus. 
In order to reconcile the extreme diversity of the TCR repertoire with specificity for 
MHC variants, it is likely that recombination at the TCR locus works to promote 
maximal diversity but that the mhc locus is subjected to selective pressure 1) from the 
need to retaliate against highly mutable pathogens and 2) from the need to be 
recognisable by the TCR. Therefore, MHC polymorphism at the population level is 
needed 1) to ensure optimal presentation of pathogen-derived peptides and 2) to allow 
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recognition by TCR that are somatically rearranged in every individual. To complete 
our model, we highlight the fact that TCR cross-reactivity in this context emerges as a 
cardinal feature of T cells.  TCR degeneracy would be essential for full immune 
coverage and for the maintenance of TCR that are “selectable” on several MHC 
variants. It follows that germline-encoded recognition is not compatible with optimal 
recognition of MHC variants, because introducing a limited number of conserved amino 
acids within CDR1 and CDR2 that control MHC reactivity entirely could in fact lead to 
allele-specific bias in MHC recognition. In parallel, TCR specific for ligands other than 
MHC do exist but are not necessarily apparent in the periphery as a result of thymic 
selection, which ensures that useless TCR are discarded early in T cell ontogeny. In 
fact, examples of MHC-independent TCR are very scarce in the literature.  
The maintenance of TCR reactive to non-MHC ligands does not need to be seen 
as a waste. Rather, the maintenance of these non-productive TCR may represent a TCR 
reserve that will recognise the future MHC products that will arise over evolutionary 
time (reviewed by van Laethem, Tikhonova and Singer, 2012). The rate at which MHC 
allelic variants arise, in essence, far exceeds the rate at which new V gene segments 
would be incorporated to the germline. Thus, it seems reasonable to think that a 
substantial degree of structural flexibility and plasticity is required to cope with 
polymorphism at the mhc locus. If this were not the case, new MHC variants and their 
peptide cargo would likely go unnoticed by the T cell compartment and confer no 
selective advantage overall. 
 
8.2.3. Evolution of lymphocyte antigen receptors 
 
Another general implication of our study is one that extends to receptors of other 
lymphocytic lineages, namely, B cells and γδ T cells. Among all classes of antigen 
lymphocytic antigen receptors, TCRαβ is unique in its ability to recognise antigen 
indirectly while B cells, and presumably γδ T cells, recognise antigen directly in its 
native conformation. In the phylogeny of antigen receptors, TCRγδ is the most ancient 
lymphocytic receptor. TCRαβ, and more importantly, its ability to recognise antigen 
only in the context of MHC would have arisen later. Eason et al. (2004) suggested that 
the primordial immune receptor, from which γδ, αβ and Ig are derived, should be a 
rearranging, membrane-bound receptor involved in direct ligand recognition. 
Accordingly, it is generally accepted that direct recognition of antigen is indeed the 
primitive condition of lymphocyte receptors, while MHC restriction is a derived feature 
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of αβ T cells only (Richards and Nelson, 2000). It seems likely to us that αβ T cells may 
have retained the ability to recognise antigen directly, similar to B cells and γδ T cells, 
but that this recognition mode is simply not apparent in peripheral T cells. Most T cells 
will not exhibit this feature because the T cell compartment is purged from non-MHC 
specific TCR during thymic selection.  
Examples of MHC-independent TCR are scarce in the literature, but such TCR 
specific for non-MHC ligands can and do exist. One recent example is the HC/2G1 T 
cell clone presented by Hanada et al. (2011). This TCR recognised soluble TRAIL 
derived from a renal carcinoma cell line. Remarkably, the authors also found that 
TRAIL was only recognised when bound to a TRAIL receptor called DR4. Thus, 
although the HC/2G1 TCR was MHC-independent, a restricting element, the DR4 
receptor, was still required for T cell activation. Recently, Tikhonova et al. described a 
TCR with direct specificity for the surface antigen CD155. The TCR was derived from 
the “quad-deficient” mouse (MHC-deficient and double co-receptor deficient), in which 
positive and negative selection do not take place on pMHC. Strikingly, this TCR 
recognised its ligand in its native form, in a manner reminiscent of antibody 
neutralisation. Altogether it appears that within the small compendium of MHC-
independent TCR, there may be two categories of TCR. Those, like the TCR described 
by Hanada et al., that require a restricting element, and those, like the F12 TCR 
(Tikhonova et al., 2012) that behave much more like antibody and bind antigen in its 
native form. Although very little can be speculated from these few examples, the 
unifying theme is that the TCR repertoire prior to selection is a collection of very 
disparate receptors with a range of specifities. Most of these are not MHC-specific; 
rather, a considerable number of pre-selection TCR may resemble primordial antigen 
receptors with direct recognition properties, much like γδ TCR and antibody. 
Interestingly, the two MHC-independent TCR described above were both poised to 
recognise a membrane-bound ligand, even in the absence of a restricting MHC 
molecule. Perhaps the most general interpretation that can be made from this is that the 
TCR-pMHC system is one that has evolved to promote connectedness between T cells 
and APC. In line with our own results, it becomes clear that the thymus functions as a 
highly specialised organ which promotes the generation of T cells that are highly 
capable of interacting with APC. Thus, although TCRαβ are not genetically 
programmed to recognise MHC ligands, thymic selection will work to favour only those 
TCR that promote recognition of APC through pMHC complexes. 
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8.3.    Concluding remarks 
 
 
The “codon hypothesis” for the TCR-pMHC interaction is written from the 
standpoint of the structural biologist, describing the interaction between two proteins 
and attempting to identify the individual amino acids that dictate this interaction. This 
hypothesis appears to derive from the theoretical observation that a single TCR can bind 
to MHC along distinct registers, implying that each TCR-α or TCR-β will engage each 
MHC molecule using characteristic interatomic signatures, as proposed by Garcia et al. 
The basis of TCR reactivity for MHC molecules is a truly unique case in biology 
and our understanding of this interaction is still incomplete. Therefore, further analysis 
is required to describe the reactivity of this large set of highly diverse proteins, the TCR, 
for another class of proteins, the MHC molecules, which are also diverse themselves. 
Many studies have attempted to demonstrate that in murine systems where negative 
selection is limited, the T cell compartment is enriched with cells that are alloreactive, 
suggesting that in normal mice, most T cells are deleted because they intrinsically react 
with MHC with high affinity (Ignatowicz et al., 1996). This conclusion must be based 
on the assumption that the requirements for T cell activation in the periphery and those 
of T cell selection in the thymus are the same, which is almost invariably incorrect. The 
work done in our laboratory so far with our novel transgenic mouse lines suggest that 
the requirements for selection are less stringent than previously thought, implying a key 
role for positive selection in shaping a wide repertoire of relatively flexible TCR that are 
not intrinsically biased towards MHC recognition. T lymphocytes and their B cell 
cousins are morphologically similar and the antigen receptor they bear at their surface 
are highly homologous.  In particular, the structure and topology of their antigen-
binding sites are the same. Strikingly, despite these similarities, evolution has allowed 
the T and B cell compartment to perform drastically different functions and to specialise 
in recognition of remarkably different ligands. For T cells, cognate ligand exists in the 
form of a composite surface made of a self protein and a peptide. B cell antigens are 
conformational determinants of virtually any chemical class. How do TCR and BCR, 
despite the obvious similarity in their antigen binding sites, become dedicated to such 
distinct antigenic targets? 
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This difference highlights the importance of other components of the TCR 
complex and the BCR complex that take part in cellular activation, rather than the 
specificity of the antigen receptor themselves. T cells express co-receptors CD4 and 
CD8 early in development and retain one of these two molecules in the periphery, 
which then participate in T cellular activation in response to pMHC complexes. It is the 
specificity of T cell co-receptors for MHC products that dictates MHC reactivity of the 
TCR itself. As discussed above, it is perhaps the overall geometry of the antigen 
binding site that imparts MHC recognition rather than the exact amino acid composition 
of the CDR loops forming the binding site. 
The existence of mature, functional T lymphocytes in the periphery of mice 
lacking germline TCR-β CDR implies that these loops are not essential in T cell 
development. Several mechanisms regulate T cell selection and functionality at the 
population level and at the cellular level, both in the thymus and in the periphery. Our 
study suggests that in the context of the TCR-pMHC interaction, all three CDR play an 
important role in the control of T cell specificity for MHC and peptide, thereby 
providing an additional regulatory unit for T cell selection, diversity, sensitivity and 
function. 
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Appendix A. Luminex detection of pro-inflammatory cytokines in single 
and triple mutant mice: Standard curves 
 
Serum samples were prepared as described in Chapter 2 and stored at -20ºC. All 
samples were then used in a Luminex assay to determine the concentration of selected 
analytes: GM-CSF, IL-1β, TNF, IFNγ, IL-2, IL-4, IL-5, IL-6, IL-10, and IL-12. 
Standard curves for each analyte are shown below. All concentrations are given in 
pg/ml. 
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Appendix B. Minor H mismatched bone marrow injection into single and 
triple mutant mice 
 
Bone marrow was harvested from donor DBA1/J and FVB/n mice and differentially 
labelled with 10 and 1 nM of CFSE respectively. Cells were co-injected i.v. at a 1:1 
ratio.  
Recipient mice were bled on Day 2, 4 and 21 p.i. and samples analysed for CFSE 
expression. The frequencies of CFSE
dim
 syngeneic cells (left) and CFSE
bright
 
mismatched cells (right) are shown for single and triple mutant mice (n = 4 each). 
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Appendix C. Single and triple mutant mice respond to alloantigen stimulation with H-2
Ag7
 cells 
 
 
Single Day 1 NOD  FVB  
APC dose 0 3 5 10 0 3 5 10 
FVB 1 4 55.8 66.1 69.4 4 32 35.6 40.6 
FVB 2 1 55.8 60.9 67.1 0.9 26.4 29.8 36.1 
FVB 3 1 54.9 63.8 68.2 0.5 31.6 34 39.3 
Mean 2 55.5 63.6 68.23333333 1.8 30 33.13333333 38.66666667 
SD 1.414213562 0.424264069 2.127596453 0.939266854 1.564182428 2.550816863 2.445858177 1.890913947 
         Single Day 3 NOD  FVB  
APC dose 0 3 5 10 0 3 5 10 
FVB 1 1.2 47.9 71 83.8 1.2 33 35.4 46 
FVB 2 0.1 53.1 73.7 85.2 0.1 27.9 34 47.2 
FVB 3 0.1 50.1 67.9 84.5 0.1 30.2 38 43.8 
Mean 0.466666667 50.36666667 70.86666667 84.5 0.466666667 30.36666667 35.8 45.66666667 
SD 0.518544973 2.131248982 2.369716345 0.571547607 0.518544973 2.085398976 1.657307053 1.407914139 
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Triple Day 1 NOD  FVB  
APC dose 0 3 5 10 0 3 5 10 
FVB 1 0.4 45.6 51.3 55.4 0.4 29.6 37.7 47.3 
FVB 2 0.5 43.8 52.2 57 0.5 30 39.3 50.5 
FVB 3 0.6 42.1 45.8 51.6 0.6 27.3 38.5 51.4 
Mean 0.5 43.83333333 49.76666667 54.66666667 0.5 28.96666667 38.5 49.73333333 
SD 0.081649658 1.429063407 2.828819935 2.264705034 0.081649658 1.18977122 0.653197265 1.759419096 
         Triple Day 3 NOD  FVB  
APC dose 0 3 5 10 0 3 5 10 
FVB 1 3.5 46.9 51.6 60.2 3.5 27.1 28.3 39.6 
FVB 2 0.1 44.4 51.8 60.8 0.035 21.6 24.8 36 
FVB 3 0.1 36.6 42.7 50.8 0.1 17.1 22.1 31.4 
Mean 1.233333333 42.63333333 48.7 57.26666667 1.211666667 21.93333333 25.06666667 35.66666667 
SD 1.602775371 4.386595744 4.243426289 4.579179936 1.618313594 4.089281382 2.538153309 3.355923453 
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Appendix D. Single and triple mutant mice respond to alloantigen stimulation with H-2
b 
and H-2
d
 cells  
Splenocytes from single and triple mutant mice were labelled with CFSE for MLR. Responders were plated as 10
5
 cells per well in the presence 
of allogeneic (H-2
b 
and H-2
d
 respectively) donor cells, MHC
KO
 B6 cells, syngeneic FVB TCR-β/δKO controls, or TCM only. The responders were 
plated in duplicate with different doses of stimulator cells for a final responder to stimulator ratio of 1:3, 1:5 or 1:10 in a flat-bottomed 96-well plate. 
The frequency of dividing cells is given as %CFSE
dim
 cells, gated on total lymphocytes. 
 
 
Single Day 2 B6 Balbc MHCKO FVB 
APC dose 3 5 10 3 5 10 3 5 10 3 5 10 
Single 1 1.95 13.3 13.4 25.8 33 33.9 0.53 1.44 2.9 9.96 14.1 37.8 
Single 2 9.97 15.9 11.8 24.5 32 41.1 0.54 1.89 2 6.17 12.1 36.8 
Mean 5.96 14.6 12.6 25.15 32.5 37.5 0.535 1.665 2.45 8.065 13.1 37.3 
SD 4.01 1.3 0.8 0.65 0.5 3.6 0.005 0.225 0.45 1.895 1 0.5 
 
Single Day 5 B6 Balbc MHCKO FVB 
APC dose 3 5 10 3 5 10 3 5 10 3 5 10 
Single 1 0 0 0 0.164 1.39 17.2 0 0 0 0.391 1.83 16.6 
Single 2 0 0 0 0.087 0.883 15.9 0 0 0 1.76 3.84 16.6 
Mean 0 0 0 0.1255 1.1365 16.55 0 0 0 1.0755 2.835 16.6 
SD 0 0 0 0.0385 0.2535 0.65 0 0 0 0.6845 1.005 0 
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Appendix D - continued 
 
 
 
Triple Day 2 B6 Balbc MHCKO FVB 
APC dose 3 5 10 3 5 10 3 5 10 3 5 10 
Triple 1 8.43 10.7 12.7 18.2 29.7 52.1 0.19 1.22 2.17 4.31 7.17 18 
Triple 2 2.6 10.4 12.3 23.5 30.3 31.8 0.23 0.4 1.69 5.28 10.6 30 
Mean 5.515 10.55 12.5 20.85 30 41.95 0.21 0.81 1.93 4.795 8.885 24 
SD 2.915 0.15 0.2 2.65 0.3 10.15 0.02 0.41 0.24 0.485 1.715 6 
 
 
Triple Day 5 B6 Balbc MHCKO FVB 
APC dose 3 5 10 3 5 10 3 5 10 3 5 10 
Triple 1 0 0 0 0.128 0.835 23 0 0 0 0.499 1.71 18.6 
Triple 2 0 0 0 0.253 6.56 20.4 0 0 0 0.206 1.48 30.2 
Mean 0 0 0 0.1905 3.6975 21.7 0 0 0 0.3525 1.595 24.4 
SD 0 0 0 0.0625 2.8625 1.3 0 0 0 0.1465 0.115 5.8 
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Appendix E. LDA scores for the generation of T cell lines derived from 
immunised single and triple mutant mice 
 
LDA was performed as described in Chapter 5. Individual wells were passaged by 
limiting dilution three times for a stimulation period of 14 days. T cell expansion was 
assessed relative to the corresponding negative control wells; positive wells containing 
putative T cell lines were scored by assessing survival and cell proliferation at the end 
of a 14 day stimulation period. All wells which failed to show any signs of expansion at 
the end of the third stimulation round were discarded.  
 
 
 
ROUND 1 
 
        Pool III                                                                              Pools IV (Single) and V (Triple) 
        
       Pool VI                                                                             Pool X 
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Appendix E – Continued  
 
ROUND 2 
 
       Pool III                                                               Pools IV (Single) and V (Triple) 
 
 
        Pool VI                                                                   Pool X 
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Appendix E – Continued  
 
ROUND 3 
 
             Pool III                                                                      Pools IV (Single) and V (Triple) 
 
        Pool VI 
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